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CHAPTER 1. GENERAL INTRODUCTION 
Dissertation Organization 
The following dissertation consists of a general introduction, a review of the 
literature contained within Chapter 2, three separate manuscripts, a general conclusion, and 
acknowledgments. The doctoral candidate, Jeremy James Kroll, is the senior author and 
principal investigator for all manuscripts. 
Introduction 
Proliferative Enteropathy (ileitis, PE) is a common intestinal disease affecting 
susceptible pigs raised under various management systems around the world. The disease is 
characterized by a thickening of the mucosal lining of the small, and sometimes large 
intestine (29). Other distinguishing features include proliferation of the immature epithelial 
cells of the intestinal crypts, forming a hyperplastic to adenoma-like mucosa (25). 
Histological lesions can be confirmed as Lawsonia-specific by visualization of the 
tiny, vibrioid shaped bacteria found in the enterocytes of the terminal ileum, cecum and 
spiral colon, but also within macrophages located in the lamina propria between intestinal 
crypts, and in the mesenteric lymph nodes (5, 25, 28). 
There are several different syndromes of PE. Porcine intestinal adenomatosis (PIA) 
is considered to be the chronic form of PE mainly affecting young growing pigs (25). 
Proliferative hemorrhagic enteropathy (PHE) is often seen in adult pigs and is classified as 
acute PE resulting in bloody diarrhea, blood clots and sudden death (25). Necrotic enteritis 
is less common than PIA and PHE and is found in pigs of all ages exhibiting severe 
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thickening of the mucosa with brownish-yellow necrotic lesions on the luminal surface (25). 
Recently, a new form of PE has been described in sows in which L. intracellularis 
infections are sub-clinical (no sign of disease) and persist in a "carrier" state (26). 
Initially, the bacteria were referred to as "Campylobacter-like organisms" or "CLO" 
because of their similarities in morphology to Campylobacter species (25). Later, the 
intracellular bacteria were given the name Ileal Symbiont (IS) intracellularis and were 
identified as a distinct genus that differed from Campylobacter species (6). The name 
Lawsonia intracellularis was formally given to the organism in 1995 in honor of the 
Scottish scientist G. H. K. Lawson who discovered the bacterium (22). 
Lawsonia intracellularis is classified as a gram-negative, microaerophilic, obligate 
intracellular, non-flagellated, non-spore forming, curved or S-shaped bacillus (16). 
Recently, a long, single, polar flagellum has been observed by electron microscopy in 
multiple pure culture isolates of L. intracellularis (17). The bacterium measures out to 1.25 
to 1.75 pm long and 0.25 to 0.43 (im wide and is comprised of a trilaminar outer envelope 
separated from the cytoplasmic membrane by an electron-lucent zone; neither fimbriae nor 
spores have been observed (17). The entire genome has recently been sequenced by the 
University of Minnesota (7) and contains approximately 1.46 Mb. 
Currently, the growth of L. intracellularis in cell free media or broth has not been 
accomplished. Therefore, successful cultivation relies on growth of this bacterium on 
susceptible tissue culture cells in a reduced oxygen or anaerobic atmosphere (4, 9, 11, 16, 
31). Koch's postulates were fulfilled when pure cultures of the intracellular bacterium 
induced PE in pigs (20). 
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Diagnosis of PE in pigs relies on various ante and post mortem methods that 
exclude conventional bacteriological and biochemical techniques as routine isolation of the 
bacterium in pure culture is not practical. Histopathology and silver staining of tissue 
sections use to be the preferred methods of diagnosis for determining microscopic lesions 
and morphologic features of L. intracellularis infections. Since then, more sensitive and 
specific detection techniques such as polymerase chain reaction (PGR) (1, 10, 18, 21), 
immunohistochemistry (IHC) (12, 19) immunoflourescence/immunoperoxidase antibody 
tests (IFAT/IPMA) (8, 12) and an LPS-based enzyme-linked immunosorbent assay (LPS-
ELISA) (2, 15) have been developed to assist veterinarians and pig farmers in determining 
with better precision when to implement control and prevention measures in herds where 
PE is endemic. 
Proliferative enteropathy is an endemic disease that is widespread among swine 
herds and production systems across every continent where pork production is found. It has 
been determined that 20% to 50% of farms are infected with L. intracellularis world wide 
(3, 26, 30, 32). The disease may be more prevalent in the USA and Northern Europe where 
greater than 90% and 70% of the farms, respectively, are positive for PE based on serology 
(26). Most recent estimated losses exceed €100 ($121 USD) per affected breeding pig 
which translates to an extra €0.50 ($0.61 USD) per growing pig (27). The total losses due 
to endemic PE on most European farms could potentially exceed €1 ($1.22 USD) per 
affected grower-finisher pig (27). 
The challenges of isolating and maintaining L. intracellularis cultures in vitro have 
made antimicrobial susceptibility testing an extremely difficult task. Regardless of this fact, 
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in vitro evaluations of the minimum inhibitory concentration (MIC) of 20 different 
antimicrobial agents and the minimal bactericidal concentration (MBC) of 10 of these 
agents indicate a broad range of antibiotic activity against L. intracellularis (23, 24). 
Included in this list are the macrolides (i.e. erythromycin and tylosin), tetracyclines, 
pleuromulins (i.e. tiamulin), penicillins, and fluoroquinolones. Antibiotics that have no 
activity against L. intracellularis include the aminoglycosides and aminocyclitols (i.e. 
neomycin, gentamicin and apramycin) (23, 24). The preferred treatment of PHE in adult 
pigs is one of the following antibiotics delivered orally for 14 days in pre-mixed feed; 
tiamulin at 120 ppm, tylosin at 100 ppm, licomycin at 110 ppm, or chlorotetracycline at 
300 ppm (25). Where PE is endemic in grower-finisher pigs, the preferred treatment is 
continuous in-feed medication with one of the following antibiotics in pre-mix feed; 
tiamulin at 50 ppm, chlortetracycline at 200 ppm, lincomycin at 110 ppm and tylosin at 
100 ppm to minimize severe production losses caused by the disease (25). 
Currently, an avirulent live L. intracellularis vaccine (Enterisol® Ileitis) was 
developed by Boehringer Ingelheim Vetmedica, Inc. for use in pigs 3 weeks of age or older 
for control and prevention of gross and microscopic lesions typical of PE after virulent 
challenge (13, 14). 
The goals of the following studies were to identify the effectiveness of a new 
lyophilized, European-derived, avirulent live L. intracellularis vaccine in animals 
challenged with a virulent pure culture challenge model, to evaluate various clinical 
applications for effective delivery and stimulation of protective immunity against PE in 
susceptible age pigs, and to evaluate the level of maternal immunity and safety of 
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vaccination in late-term pregnant swine. Studies were also conducted to develop and 
validate an improved diagnostic method for detecting L. intracellularis exposure in 
vaccinated or experimentally challenged pigs. 
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CHAPTER 2. PROLIFERATIVE ENTEROPATHY: A GLOBAL ENTERIC 
DISEASE OF PIGS CAUSED BY LAWSONIA INTRACELLULARIS 
A paper submitted to Animal Health Research Reviews 
Jeremy J. Kroll,1'2 Michael B. Roof,1 Lorraine J. Hoffman,3 
James Dickson,3 and D. L. Hank Harris'1 
Abstract 
Proliferative Enteropathy (ileitis, PE) is a common intestinal disease affecting 
susceptible pigs raised under various management systems around the world. Major 
developments in the understanding of PE and its causative agent, Lawsonia intracellularis, 
have occurred that have led to advances in the detection of this disease and methods to 
control and prevent it. Diagnostic tools have improved overall detection and early onset of 
PE in pigs includes various serological and molecular-based assays. Histological tests such 
as immunohistochemistry continue to be the gold standard in confirming Lawsonia-specific 
lesions in pigs post mortem. Despite extreme difficulties in isolating L. intracellularis, 
innovations in the cultivation and the development of pure culture challenge models, have 
opened doors to better characterization of the pathogenesis of PE through in vivo and 
in vitro L. intracellularis-host interactions. Advancements in molecular research such as 
the genetic sequencing of the entire Lawsonia genome have provided ways to identify 
various immunogens, metabolic pathways and methods for understanding the epidemiology 
1 Department of Biological Research and Development, Boehringer Ingelheim Vetmedia 
Inc., 2501 N. Loop Dr., Ames, IA 50010. 
2 Corresponding author: jkroll@bi-vetmedica.com. 
3 Iowa State University, Ames, IA 50011. 
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of this organism. The determinations of immunological responsiveness in pigs to virulent 
and attenuated isolates of L. intracellularis and identification of various immunogens have 
led to progress in vaccine development. 
Introduction 
Lawsonia intracellularis is an obligate intracellular bacterium causing proliferative 
enteropathy (PE) in many mammalian species and rodents, most notably pigs. The infection 
causes diarrhea, stunted growth and, in rare instances, sudden death in pigs and is one of the 
most economically important diseases in the swine industry worldwide (Lawson and 
Gebhart, 2000). The disease is characterized by a thickening of the mucosal lining of the 
small, and sometimes large intestine (Rowland and Lawson, 1992). Other distinguishing 
features include proliferation of the immature epithelial cells of the intestinal crypts, 
forming a hyperplastic to adenoma-like mucosa (McOrist and Gebhart, 1999). Histological 
lesions can be confirmed as Lawsonia-specific by visualization of the tiny, vibrioid shaped 
bacteria found in the enterocytes of the terminal ileum, cecum and spiral colon, and also 
within macrophages located in the lamina propria between intestinal crypts, and mesenteric 
lymph nodes (Frisk and Wagner, 1977; Roberts et al., 1980; McOrist and Gebhart, 1999). 
There are several different syndromes of PE. Porcine intestinal adenomatosis (PIA) 
is considered to be the chronic form of PE mainly affecting young growing pigs (McOrist 
and Gebhart, 1999). Proliferative hemorrhagic enteropathy (PHE) is often seen in adult 
pigs and is classified as acute PE resulting in bloody diarrhea, blood clots and sudden death 
(McOrist and Gebhart, 1999). Necrotic enteritis is less common than PIA and PHE and is 
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found in pigs exhibiting severe thickening of the mucosa with brownish-yellow necrotic 
lesions on the luminal surface (McOrist and Gebhart, 1999). Recently, a new form of PE 
has been described in pigs in which L. intracellularis infections are sub-clinical (no sign of 
disease) and persist in a "carrier" state (McOrist et al., 2003). 
Proliferative enteropathy is most commonly found in pigs, however, it has also been 
described in hamsters (Frisk et al., 1977), ferrets (Fox and Lawson, 1988), rabbits (Fox 
et al., 1994), foxes (Eriksen et al., 1985), dogs (Collins et al., 1983), rats (Vandenburghe 
et al., 1985), horses (Williams et al., 1996), sheep (Chalmers et al., 1990), deer (Drolet 
et al., 1996), emus (LeMarchand et al., 1995), ostriches (Cooper et al., 1997), primates 
(Klein et al., 1999) and guinea pigs (Elwell et al., 1981). Intestinal lesions are strikingly 
similar among all above mentioned species with intracellular bacteria identified as 
L. intracellularis observed in the proliferative epithelia (Lawson and Gebhart, 2000). 
Despite its ubiquitous nature, L. intracellularis has never been identified in humans with 
enteric disease, even those affected with Crohn's or other related diseases such as colon 
cancer (McOrist et al., 2003). Therefore, Lawsoma-specific PE is not considered to be a 
zoonotic disease (McOrist et al., 2003). 
Etiology 
Proliferative enteropathy has been described as an important enteric disease that has 
affected pigs for the past 50 years. Characteristic lesions of PE found in pigs were first 
described by Beister and Schwarte in 1931. It wasn't until the 1970's when the presence of 
intracellular bacteria was found within proliferating crypt cells in cases of PHE in pigs 
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(Rowland et al., 1973). A variety of Campylobacter species having morphologically similar 
features to L. intracellularis have been isolated from lesions of PE. Those include 
Campylobacter mucosalis (Rowland and Lawson, 1974; Love et al., 1977), 
C. hyointestinalis (Gebhart et al., 1983), C. jejuni and C. coli (Ericksen et al., 1990). 
Despite the routine recovery of the above mentioned Campylobacter species in proliferative 
lesions, none of these organisms specifically cause PE or colonize intracellularly under 
experimental conditions (Kashiwazaki et al., 1971; McCartney et al., 1984; Boosinger et al., 
1985; Alderton et al., 1992). It wasn't until Lawson et al. (1985) inoculated rabbits with an 
extract containing intracellular bacteria from an intestinal lesion that did not contain 
Campylobacter, that a new and novel intracellular bacterium was discovered. Convalescent 
serum containing antibodies from inoculated rabbits did not react to various isolates of 
Campylobacter but reacted to intracellular bacteria in formalin-fixed sections of PE-
affected intestines (Lawson et al., 1985). Progress in cultivation of this organism ensued 
and Koch's postulates were fulfilled when pure cultures of the intracellular bacterium were 
shown to cause PE in pigs (McOrist et al., 1993). Initially, the bacteria were referred to as 
"Campylobacter-like organisms or CLO" because of their similarities in morphology to 
Campylobacter species (McOrist and Gebhart, 1999). Later, the intracellular bacteria were 
given the name Ileal Symbiont (IS) intracellularis and were identified as a distinct genus 
that differed from Campylobacter species (Gebhart et al., 1993). The name Lawsonia 
intracellularis was formally given to the organism in 1995 in honor of the Scottish scientist 
G.H.K. Lawson as the primary discoverer of the bacterium (McOrist et al., 1995a). 
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(photograph courtesy of Dr. Connie Gebhart) 
Figure 1. An electron micrograph of Lawsonia intracellularis in pure culture. Arrow 
indicates a single polar flagella. Bar = 10 fjjn 
Lawsonia intracellularis is a member of the delta division of Proteobacteria 
(Gebhart et al., 1993) and is taxonomically distinct from other intracellular pathogens 
(McOrist et al., 1995a). DNA sequences of the 16S ribosomal RNA gene from 
L. intracellularis were found to be closely related to Bilophila wadsworthia (Sapico et al., 
1994) and the sulfate-reducing proteobacterium, Desulfovibrio desulfuricans (Gebhart et al., 
1993) with 92% and 91% homology respectively. Lawsonia intracellularis is classified as a 
gram-negative, microaerophilic, obligate intracellular, non-flagellated, non-spore forming, 
curved or S-shaped bacillus (Lawson et al., 1993). Recently, a long, single, polar flagellum 
has been observed by electron microscopy in multiple pure culture isolates of 
L. intracellularis; see Figure 1 (Lawson and Gebhart, 2000). The bacterium measures 1.25 
to 1.75 um long and 0.25 to 0.43 um wide comprising of a trilaminar outer envelope 
separated from the cytoplasmic membrane by an electron-lucent zone; neither fimbriae nor 
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spores have been observed (Lawson and Gebhart, 2000). The entire genome has recently 
been sequenced by the University of Minnesota (Gebhart and Kapur, 2003) and contains 
approximately 1.46 Mb. 
Isolation and Cultivation of L. intracellularis 
Isolation and cultivation of an obligate intracellular organism is one of the most 
daunting tasks in bacteriology. Lawsonia intracellularis is no exception. Currently, the 
growth of L. intracellularis in cell free media or broth has not been accomplished. 
Therefore, successful cultivation relies on growth of this bacterium on susceptible 
eukaryotic tissue culture cells including rat intestinal cells (IEC-18) (Lawson et al., 1993), 
human fetal intestinal cells (Int 407) (Lawson et al., 1993), rat colonic adenocarcinoma cells 
(Lawson et al., 1993), pig kidney cells (PK-15) (Lawson et al., 1993), piglet intestinal 
epithelial cells (IPEC-J2) (McOrist et al., 1995a), GPC-16 cells (Stills, 1991), and mouse 
fibroblast cells (McCoy) (Knittel and Roof, 1999). Cultivation techniques include culturing 
L. intracellularis with adherent (Lawson et al., 1993; McOrist et al., 1995a; Collins et al., 
1996) or suspension (Knittel and Roof, 1998) tissue culture cells at reduced oxygen 
atmospheres, preferably an anaerobic environment, at 37°C for 5 to 7 days post inoculation. 
Adherent cultures can be propagated in tissue culture flasks (T-flasks) of various volumes 
(25cm2 to 150cm2) and require incubation in humidified chambers such as anaerobic gas 
jars or modified incubators containing 80 - 90% N2, 4 - 10% CO? and 0 - 10% O? (Lawson 
et al., 1993; McOrist et al., 1995a; Collins et al., 1996). In contrast, suspension cultures do 
not need specialized growth chambers and are propagated in spinner flasks or bioreactors of 
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various sizes (250 ml to 300 L) that regulate the temperature, gas mix, pH, and agitation 
automatically (Knittel and Roof, 1998). This method (Knittel and Roof, 1998) has allowed 
the potential growth of large-scale cultures for use in the production of vaccine and 
diagnostic reagents and has also been used for the attenuation of a Danish isolate of 
L. intracellularis as a potential vaccine candidate (Kroll et al., 2004a). 
The preferred media for growing Lflwroma-susceptible tissue culture cells is 
Dulbecco's Modified Eagles Media (DMEM) with bovine serum at concentrations of 5-10% 
(Lawson et al., 1993; Knittel and Roof, 1998; Guedes and Gebhart, 2003b). Tissue cultures 
are usually infected with 10% v/v of inoculum containing L. intracellularis and are 
monitored daily by taking a representative sample (supernatant containing sloughed off or 
suspended cells and bacteria) and staining them with Lawsonia-specific monoclonal 
antibodies (McOrist et al., 1987; Guedes and Gebhart 2003c) followed by various 
secondary staining techniques including immunofluorescence (Lawson et al., 1993; Knittel 
et al., 1996), immunogold (Collins et al., 1996) or immunoperoxidase assays (Lawson et al., 
1993; Guedes et al., 2002a). Cultures are monitored for increases in percent cell infections 
and are typically harvested, passed or used for inoculating animals when they reach 80% to 
100% infectivity. 
The conventional method for isolating L. intracellularis from infected tissue was 
developed by Lawson et al. (1993). This method requires homogenization of infected areas 
of the intestinal mucosa and subsequent treatment with 1% trypsin in phosphate-buffered 
saline (0.1M, pH 7.4). The mucosal homogenates are passed through a series of filters 
(200-mesh stainless steel, Whatman glass fiber filter, 1.2 |im, 0.8 ^m and 0.65 fxm syringe 
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filters) to make a filtrate containing L. intracellularis and other intestinal organisms and 
then, stored in a sucrose potassium glutamate solution with 10% FBS at -70°C (Lawson 
et al., 1993). The filtrates are used to inoculate partially confluent cell monolayers which 
are incubated with media containing Lawsonia-resistant antibiotics that inhibit growth of 
confounding bacteria and fungi (Lawson et al., 1993). Co-cultivation of L. intracellularis 
with tissue culture cells continue until high levels of the bacteria is achieved in pure culture 
(Lawson et al., 1993). 
Disease Reproduction 
The development of in vitro cultivation methods as described above has provided 
the means for fulfilling Koch's postulates for PE in pigs. Germ-free pigs developed PE 
from crude intestinal filtrates containing L. intracellularis and other enteric bacteria 
(McOrist and Lawson, 1989) whereas those only exposed to pure cultures of 
L. intracellularis failed to develop disease (McOrist et al., 1993). Additionally, gnotobiotic 
pigs inoculated with Lawsonza-containing gut homogenates developed intestinal lesions 
typical of PE (McOrist et al., 1994a). These observations strongly suggest that intestinal 
flora influences the development of PE by modifying or supporting the ability of 
L. intracellularis to colonize the intestinal tract (Smith and Lawson, 2001). However, the 
roles of commensal bacterial and other enteric pathogens potentially present during a 
Lawsonia infection are still undefined (Smith and Lawson, 2001). 
Proliferative enteropathy can be reproduced by challenging pigs with 
L. intracellularis using pure culture or intestinal mucosa homogenates from previously 
infected pigs. The advantages of a pure culture challenge are that an infective dose can be 
quantified for stringent control of a more defined and consistent reproduction of PE in pigs 
(Kroll et al., 2004a). Pure culture inoculums contain no confounding effects due to 
potentially pathogenic intestinal bacteria or viruses (Guedes and Gebhart, 2003b). The 
disadvantage is the difficulties involved in the isolation and cultivation of L. intracellularis 
in vitro (Guedes and Gebhart, 2003b). The advantages of an intestinal mucosa homogenate 
challenge are that it's relatively easy to produce by scraping the Lawsonia-infected ileal 
mucosa from PE previously affected pigs and then, administering the scrapings immediately 
to naïve susceptible pigs. Also, it has proven to be successful over the years in effectively 
reproducing all forms of PE in pigs and hamsters (Lomax et al., 1982a and 1982b; 
Mapother et al., 1987; McOrist et al., 1993). The disadvantage is that mucosal 
homogenates contain other microflora and potentially pathogenic organisms (bacteria, 
viruses and fungi) that confound the effects of a Lawsonia-only challenge. Mucosal 
homogenates are not easily quantified for determining the proper infectious dose and these 
enumeration methods have been unable to differentiate between live vs. dead 
L. intracellularis organisms (Guedes and Gebhart, 2003b). A direct comparison of both 
L. intracellularis challenge models was done by Guedes and Gebhart (2002c and 2003b) 
which demonstrated that reproduction of clinical signs and lesions typical of PE was similar 
in both models. 
19 
Gut homogenate challenge model 
The earliest experiments designed to reproduce PE in pigs were only successful 
when the orally administered inocula contained fresh, unadulterated L. intracellularis 
derived directly from affected pigs (Roberts et al., 1977; Lomax et al., 1982a and 1982b; 
Mapother et al., 1987; McOrist and Lawson, 1989). This model is commonly used because 
it can be rapidly produced with minimal effort or technical skill. Until recently, gut 
homogenate or mucosal derived Lawsonia challenges had a history of providing a severe 
challenge in pigs that may not have correlated to typical PE found in nature. Guedes and 
Gebhart (2003a) reported the use of a refined gut homogenate challenge model using lower 
concentrations of semi-quantified L. intracellularis in the challenge inoculum. In this 
study, 10-fold dilutions of a highly virulent gut homogenate challenge resulted in disease 
reproduction that closely resembled field outbreaks. The lowest dose administered 
(approximately 5.4 x 108 Lawsonia!dose) induced infection in susceptible pigs indicating a 
low infectious dose is sufficient to reproduce field-type clinical symptoms of PE. These 
results were consistent with studies in which pigs challenged with approximately 107 to 108 
Lawsonia organisms per dose developed moderate to severe diarrhea beginning 2 weeks 
post inoculation (Collins et al., 2001). To date, a minimal infectious dose has not been 
determined. 
Pure culture challenge model 
The L. intracellularis pure culture challenge model was originally developed by 
McOrist and colleagues (1993) in order to demonstrate reproduction of PE in pigs when 
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orally inoculated with Lawsonia-mfected enterocytes. In this study, 4 pigs were challenged 
with 106 Lawsonia organisms per dose and developed subclinical PE. There were no 
clinical signs, but the animals had gross and microscopic (IHC) lesions consistent with the 
presence of L. intracellularis. 
Gross and IHC lesions typical of acute PE were induced in dexamethasone treated 
and untreated pigs using a pure culture L. intracellularis isolate (Joens et al., 1997). This 
study showed that stress induced by dexamethasone had no effect on the development of 
intestinal lesions (Joens et al., 1997). A pure culture L. intracellularis isolate N343 has 
been successfully used in multiple controlled challenge exposure studies for determining the 
efficacy of Denagard™ (tiamulin hydrogen fumarate) when given orally to pigs in the feed 
or drinking water (McOrist et al., 1996b; Schwartz et al., 1999; Walter et al., 2000a and 
2000b). Additionally, virulent L. intracellularis pure culture challenge exposure studies 
have been performed to establish vaccine efficacy against PE (Kroll et al., 2004a). Uses of 
pure culture L. intracellularis challenge models have provided valuable information on the 
transmission of the organism within pig herds (Smith and McOrist, 1997; Jordan et al., 
2004). This model is used in limited fashion because of the extreme difficulties in the 
isolation and cultivation of L. intracellularis in the laboratory. 
Pathogenesis 
Exposing pigs to L. intracellularis or to diseased mucosa containing these 
intracellular bacteria can reproduce PE. In typical oral challenge exposure studies of 
weaned pigs (3-4 weeks-old) with a standard inoculum of 108 L. intracellularis bacteria, 
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numerous intracellular bacteria can be visualized in the developing proliferative small and 
large intestines and feces one to three weeks following inoculation with a peak of infection 
and lesions 3 to 4 weeks after challenge (McOrist et al., 1996a). In most of these pigs, 
intestinal infection, proliferative lesions and excretion persists for approximately 4 weeks, 
but in some exposed pigs, excretion may persist for at least 10 weeks (Smith and McOrist, 
1997). At the peak of infection, moderate diarrhea and histologic lesions of PE are usually 
observed in 50% and 100% of the animals challenged with this inoculum (McOrist et al., 
1996a; McOrist et al., 1997b). Infection and lesions in the large intestine (colon and 
cecum) generally start to occur a week or two after small intestinal infection, following an 
oral challenge (McOrist et al., 1996a). Naïve pigs of a wide age range (neonates to grower-
finishers) are susceptible to oral challenge (McOrist and Gebhart, 1999). 
Proliferative enteropathy initially develops as a progressive proliferation of 
immature epithelial cells, following invasion of the intracellular Lawsonia bacteria. In most 
cases, no significant inflammatory reaction occurs and the bacteria remain in the epithelium 
at this stage (McOrist et al., 1996a). In severe cases of PE, L. intracellularis can also be 
observed in the mesenteric lymph node and tonsils, but these appear to be secondary sites of 
infection (Jensen et al., 2000b). In vivo and in vitro studies have elucidated some of the 
early events in bacteria-cell interaction (Lawson et al., 1993; McOrist et al., 1995c). 
Bacteria associate closely with the cell membrane and then quickly enter the enterocytes via 
an entry vacuole (McOrist et al., 1995c). Specific adhesins or receptors have not been 
identified but attachment and entry appear to require specific bacterium-host cell interaction 
(McOrist et al., 1997c). The genomic sequence of L. intracellularis indicates that it may 
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possess a type III secretion system. This outer membrane protein complex commonly found 
in gram negative bacterial pathogens may assist the bacterium during cellular invasion, 
evasion of the host's immune system and could be a mechanism for inducing cellular 
proliferation. The entry of Lawsonia bacteria into cells is dependent on host cell activity, 
but not necessarily bacterial viability, possibly indicating a type of induced phagocytosis 
like receptor mediated endocytosis (Lawson et al., 1993). Actin rearrangement is important 
for entry of obligate intracellular bacteria and may be a key component of entry for 
L. intracellularis (Lawson et al., 1995). Lawsonia gene sequence analysis has revealed 
several flagellar genes that are involved in producing a single polar flagellum which may 
also play a role in entry of the host cell (Nuntaprasert et al., 2004). Morphological 
associations of L. intracellularis and small pits or vesicles of the cell membrane were 
observed immediately upon entry (McOrist et al., 1995c). These events are similar to the 
association between Chlamydia trachomatis and C. psittaci entry and clatherin-coated pits 
(Reynolds and Pearce, 1991). Other factors may be involved as experiments using 
cytochalasin D (blocks cytoskeleton rearrangements) indicate that there may also be a non-
actin dependent pathway utilized by L. intracellularis for successful host cell invasion 
(Lawson et al., 1995). The entry vacuole rapidly breaks down (within 3 hours) and 
L. intracellularis flourish and multiply (not membrane-bound) within the apical cytoplasm 
(McOrist et al., 1995c). This mechanism would explain how L. intracellularis escapes 
proteolytic degradation due to endosome-lysosome fusion. Many other species of 
intracellular bacteria including Shigella, Listeria, and some Rickettsia species also escape 
into the cytoplasm and avoid the damaging effects of phagolysosomal fusion. Escape from 
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the endosome is mediated by producing membrane-damaging cytolytic enzymes or toxins 
such as phospholipase or listeriolysin (Ewing et al., 1978; Gaillard et al., 1987; Sansonetti 
1992; Todd et al., 1981). Lawsonia intracellularis exhibits cytolytic (hemolytic) activity 
in vitro through expression of a novel hemolysin, Lawsonia hemolysin A (LhyA), which 
may be one of the main virulence factors involved in intracellular vacuole escape (Smith, 
2001). Following vacuolar escape, the bacterial-host cell relationship observed in vitro is 
similar to that found in animals (McOrist et al., 1995c). Typically, Lawsonia bacteria 
located in the apical cytoplasm do not localize to any cell structures except for some 
association with the cell mitochondria (McOrist et al., 1995c) and the rough endoplasmic 
reticulum (Jansi et al., 1994). 
Intracellular multiplication and cell to cell spread of L. intracellularis was revealed 
when co-cultivation experiments identified cells infected with bacteria continue to divide 
and spread the bacteria into newly developed daughter cells (Lawson et al., 1993). 
Additional evidence suggests that actively dividing cells promote bacterial propagation 
better than non-dividing, mature cells (Lawson et al., 1993; McOrist et al., 1995c). 
Experiments using cycloheximide or colchicine to stop eukaryotic cell division also 
inhibited L. intracellularis growth (Lawson et al., 1995). Furthermore, growth promotion 
of L. intracellularis was better in rapidly growing enterocyte cultures than confluent 
monolayers (Lawson et al., 1993). Lawsonia proliferation in the host is benefited by 
actively dividing enterocytes that facilitates bacterial expansion through continued 
enterocyte replication and migration, and mediates spread of the bacteria throughout the 
epithelium (Smith and Lawson, 2001). 
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Cell proliferation in PE only cases (presence of the disease in the host 
uncomplicated by other confounding pathogens) when cells are infected by 
L. intracellularis only and in cases where islands of hyperplasia occur amidst normal 
epithelium, only infected cells are proliferative (McOrist et al., 1996a). Infection 
experiments in hamsters indicate crypt cells start to divide at an increased rate (up to four­
fold) two days after bacterial infection (Jansi et al., 1994). The stimulatory effect of the 
bacteria on host cell division does not persist once the lesion becomes fully developed 
despite the constant presence of L. intracellularis (McOrist et al., 1996a). The mechanism 
whereby L. intracellularis prevents cell maturation (enterocyte replication, migration 
upwards to the top of intestinal crypts and sloughing off into the lumen) is not known. 
However, Lawsonia-infected cells continue to undergo mitosis and proliferation within 
those pockets of infected cells, and form hyperplastic crypts which prevent cell sloughing 
and regeneration of healthy, mature enterocytes (McOrist et al., 1996a). Lawsonia 
intracellularis-infected intestinal crypts can become enormously elongated and often 
branched (McOrist and Gebhart, 1999). Loss of protein and amino acids into the intestinal 
lumen and reduced nutrient absorption by the intestinal mucosa are the likely causes of the 
reduction in weight gain and feed conversion efficiency seen in pigs affected with chronic 
uncomplicated proliferative enteropathy lesions (McOrist and Gebhart, 1999). 
Clinical Signs 
Clinical cases of PIA, the chronic form of proliferative enteropathy, are observed 
most commonly in the post-weaned pigs between 6 and 20 weeks of age (McOrist and 
Gebhart, 1999). The predominant signs of PIA include anorexia, diarrhea, and poor growth 
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which persist for a period of weeks (Lawson and Gebhart, 2000). Diarrhea may occur only 
when significant lesions are present (McOrist and Gebhart, 1999), which makes this form of 
PE very difficult to detect in clinically healthy pigs. In PIA endemic herds, pigs will exhibit 
normal feed intake, but will fail to sustain normal growth (McOrist and Gebhart, 1999). 
Severely infected pigs are often associated with varying degrees of thickening in the 
mucosal lining or necrotic lesions of the small intestine commonly described as "hose pipe" 
or "garden hose" gut (Rowland and Lawson, 1992). 
Cases of PHE occur more commonly in young adult pigs between the ages of 4-12 
months (McOrist and Gebhart, 1999). Black tarry feces are the first visible clinical sign 
commonly followed by a loose, red-tinged, watery stool (McOrist and Gebhart, 1999). 
However, some of the pigs die without fecal abnormality (McOrist and Gebhart, 1999). It 
has been estimated that half of the pigs affected with PHE will die and the other half 
recover over a short period of time without visible signs of reduced weight or changes of 
body condition (Roland and Lawson, 1992). 
Subclinical PE may be the most common disease among growing pigs, but the 
syndrome is rarely recognized because there are no observable clinical indications in pigs 
with Lawsonia-specific subclinical enteritis. This variation of PE closely resembling PIA is 
defined as active L. intracellularis infection with the presence of microscopic and/or gross 
lesions resulting in reduced productivity (average daily gain with +/- feed efficiency). This 
occurs often in the absence of observable clinical signs of disease such as PE-associated 
mortality, diarrhea or other symptoms consistent with PE morbidity. Evidence of a 
subclinical L. intracellularis infection may or may not be detected by serological or PCR 
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methods as pigs may be colonized but not severe enough to induce shedding or 
seroconversion (Guedes, 2004). 
With increasing incidence of other enteric diseases displaying similar clinical 
symptoms to the various forms of PE (hemorrhagic bowel syndrome, Coliobacillosis, 
Porcine circo virus type 2, transmissible gastroenteritis virus, rotavirus, Salmonellosis, and 
swine dysentery), it is important to differentiate among all of the common factors by 
performing a thorough post mortem examination and implementing proper diagnostic 
evaluations. 
Lesions 
Histopathologic lesions common to all forms of PE are characterized by the 
adenomatous proliferation of the epithelium in the crypts of the small intestine and in 
mucosal glands of the large intestine, and by the presence of curved intracellular bacteria 
within these enterocytes (Rowland and Lawson, 1974). The crypts are elongated, enlarged 
and lined with crowded immature epithelial cells with mitotic events (McOrist and Gebhart, 
1999). Goblet cells are absent from the affected epithelium and the infiltration of 
inflammatory cells are not a common characteristic of PE (Rowland and Lawson, 1992). 
The proliferating epithelial cells contain intracytoplasmic, slender, curved, rod-shaped 
bacteria (Ward and Winkelman, 1990). 
Proliferative hemorrhagic enteropathy 
The acute and most severe form of PE is considered to be proliferative hemorrhagic 
enteropathy (PHE) and typically affects the terminal ileum and colon. This form of PE is 
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most often associated with young adult pigs 4-12 months old (McOrist and Gebhart, 1999) 
and commonly found in high health herds when replacement gilts and boars have been 
introduced into a new farm site. Clinical manifestations of PHE include extended and 
thickened intestines with serosal edema and a severely proliferated mucosa (McOrist and 
Gebhart, 1999). The lumen contains either fresh blood or a solid cast of blood and fibrin 
clots as seen in Figure 2 (Ward and Winkelman, 1990). However, focal points of bleeding, 
ulcerations or erosions are not observed (McOrist and Gebhart, 1999). Proliferative 
hemorrhagic enteropathy is differentiated from hemorrhagic bowel syndrome (HBS) in 
which there is no abnormal crypt proliferation associated with HBS and the hemorrhage 
occurs throughout all layers of the intestinal wall (Knittel, 1999). 
(photograph courtesty of Dr. Jeff Knittel) 
Figure 2. Above: A gross lesion of the ileum containing fibrinous blood clots indicative of 
porcine hemorrhagic enteropathy (PHE) caused by Lawsonia intracellularis. 
Below: The normal appearance of an ileum from a healthy pig 
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Porcine intestinal adenomatosis 
The chronic and most common form of PE is considered to be porcine intestinal 
adenomatosis (PIA). This form of PE is commonly found in actively growing pigs from 
late nursery to late finishing stages and affects the terminal 50 cm of ileum and the upper 
third of the proximal colon (McOrist and Gebhart, 1999). Lesions in PIA consist of 
intestinal mucosa thickening by epithelial proliferation but relatively free from 
inflammation or only mildly inflamed on the mucosal surface as seen in Figure 3 (Knittel, 
1999). Histologically, the mucosa is enlarged with branching crypts lined with immature 
epithelial cells (McOrist and Gebhart, 1999). Mitotic figures are evident throughout the 
crypt while goblet cells are nonexistent (McOrist and Gebhart, 1999). Intracellular bacteria 
Figure 3. A gross lesion of the ileum containing mild to moderate thickening of the 
intestinal mucosa indicative of porcine intestinal adenomatosis (PIA) caused by 
Lawsonia intracellularis 
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are a common feature residing in the apical cytoplasm of the affected epithelial cells 
(McOrist and Gebhart, 1999). 
Necrotic enteritis 
Considered a result of end-stage PIA, necrotic enteritis involves deep coagulative 
necrosis of the adenomatous mucosa (Rowland 1978). Yellowish-gray lesions are evident 
on the surface of the mucosal lining in the terminal portion of the ileum (Rowland and 
Lawson, 1992), see Figure 4. Severe thickening of the ileum in these cases have given the 
disease a unique characteristic of PE called "hose pipe or garden hose" gut (Rowland and 
Lawson, 1992). 
Figure 4. A gross lesion of the ileum containing severe thickening and hemorrhaging of the 
intestinal mucosa, necrotic ulcerations and evidence of a fibrinous cast indicative 
of necrotic enteritis (NE) caused by Lawsonia intracellularis 
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Diagnosis 
For many years, diagnosis of PE in pigs was speculative as clinical symptoms such 
as diarrhea or gross and microscopic examination of the intestines were the only way to 
determine if pigs were affected with the disease. With the advent of sensitive and specific 
diagnostic methods, new strides have been made to identify L. intracellularis specific 
infections and the prevalence of PE in pig herds. These methods have assisted veterinarians 
and pig producers in determining with better precision when to implement control and 
prevention measures in herds where PE is endemic. A summary of the various diagnostic 
techniques available for detecting L. intracellularis exposure in animals are listed in 
Table 1. 
Histolopathology and immunohistochemistry 
Proliferative enteropathy is often diagnosed post mortem by the characteristic gross 
pathology associated with L. intracellularis infections. However, confirmation of PE 
through histopathological analysis is necessary in order to ensure proper diagnosis. 
Hematoxylin and eosin (H&E) staining of tissue sections exhibiting severe PE identifies 
proliferative changes in the enterocytes of the intestines (Rowland, 1978). Warthin Starry 
(WS) silver stain allows the detection curved, rod-shaped, intracellular bacteria in histologic 
sections, but this staining technique is non-specific and has limitations when applied to 
necrotic or autolytic samples (Ward and Winkelman, 1990; Rowland and Lawson, 1992; 
Jensen et al., 1997). A modified Ziehl-Neelsen stain on mucosal and fecal smears or fixed 
infected eukaryotic cell samples of L. intracellularis provides a non-specific, simple 
Table 1. Summary of diagnostic techniques for detection of Lawsonia intracellularis and/or antibodies to the organism in pigs 
Diagnostic 
technique Detection method Advantages Disadvantages Reference 
H&E 
Warthin 
Starry Silver 
Stain 
IHC/IFA 
PGR 
Crypt hyperplasia, 
cell abnormalities 
Identification of 
intracellular 
organisms 
Lawsonia-specific 
immunoflourescence 
or 
immunoperoxidase 
staining 
Lawsonia-specific 
DNA sequences 
Confirms cell abnormalities 
with bacterial involvement in 
tissues 
Rapid detection of bacterial 
involvement in tissues 
Highly sensitive and 
specific 
• Ante mortem diagnosis 
• Highly specific 
• Detects active colonization 
and shedding 
• Detection of multiple 
pathogens in one test 
• Real time detection 
Post mortem diagnosis only Rowland, 1978 
• Non-specific 
• Post mortem diagnosis only 
• Post mortem diagnosis only 
• Requires a monoclonal 
antibody 
• Less sensitive 
• Possible inactivation of test 
reagents 
• Possible cross-
contamination of samples 
• Possibility of false negatives 
Ward and 
Winkelman, 
1990 
Rowland and 
Lawson, 1992 
Jensen et al., 1997 
McOrist et al., 1987 
Knittel et al., 1997 
Guedes et al., 
2003c 
Gebhart et al., 1991 
and 1993 
Jones et al., 1993a 
and 1993c 
Cooper et al., 1996 
and 1997 
Elder et al., 1997 
Lindecrona et al., 
2002 
Lù 
Table 1. (continued) 
Diagnostic 
technique Detection method Advantages Disadvantages Reference 
IFAT serum IgG • Ante mortem diagnosis 
• Highly sensitive and 
specific 
Requires manual 
determination of results 
Knittel et al., 1998 
IPMA serum IgG • Ante mortem diagnosis 
• Highly sensitive and 
specific 
Requires manual 
determination of results 
Guedes et al., 
2002a 
LPS-ELISA serum IgG • Ante mortem diagnosis 
• Highly sensitive and 
specific 
• Automated determination 
of results 
• Rapid detection 
• High through-put testing 
• Possible batch-to-batch 
variation 
• Possible lab to lab variation 
• Not commercially available 
Kroll et al., 2005 
Boesen et al., 2005 
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confirmatory test as the intracellular bacteria stain red within the cytoplasm of infected cells 
(Ward and Winkelman, 1990; Rowland and Lawson, 1992). Immunohistochemistry (IHC) 
and immunoflourescence antibody (IFA) procedures have made it possible for specific 
detection of L. intracellularis within tissue sections affected with various forms of PE 
(Knittel et al., 1997). With the use of Lawsonia-specific monoclonal antibodies, the 
bacteria can be identified in fecal smears of cases involving high levels of actively shedding 
L. intracellularis or in fixed tissue sections from various sources (McOrist et al., 1987; 
Guedes et al., 2003c). A comparative study revealed that the IHC (86.8%) stain was much 
more sensitive than H&E (36.8%) and WS (50%) staining methods for detecting 
L. intracellularis in PE-affected tissue samples (Guedes et al., 2002b). In addition, there 
was a high correlation (82.5%) between the IHC results and the presence of macroscopic 
lesions 4 weeks after infection (Guedes and Gebhart, 2002b). These results are consistent 
with previous reports that a histological staining technique involving the use of an anti-
Lawsonia monoclonal antibody was highly specific and more sensitive in detecting 
L. intracellularis infections than other non-specific histological stains (McOrist et al., 1987; 
Jones et al., 1993b; Huerta et al., 2003). Using IHC, L. intracellularis positive antigen can 
be detected even in cases of severe necrosis in which the mucosa is completely destroyed, 
or during recovery stage when the bacterial antigen is found only in the cytoplasm of 
mononuclear cells in the lamina propria (Guedes and Gebhart, 2002b). 
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Serology 
Early accounts of the first serology test for detecting Lawsonia-specïïic IgM and IgA 
antibodies in naturally exposed or experimentally infected pigs were from Lawson et al. 
(1988). In these studies, an indirect fluorescent antibody test (IFAT) was used to determine 
that IgM and, to a lesser extent, IgA was the predominant antibody in early 
L. intracellularis infections in pigs. Antibodies were detected for 8 weeks post inoculation. 
Holyoake et al. (1994) employed an enzyme-linked immunosorbent assay (ELISA) using 
Percoll purified whole cell L. intracellularis from PHE affected pig tissue as the primary 
antigen in the test system. This ELISA was able to detect Lawsonia-specific IgG in field-
exposed pigs as early as 3 weeks of age, and represented the first recorded detection of 
maternally acquired antibodies. However, results indicated the antibody titers were low and 
variable among inoculated and uninoculated test groups and could not be differentiated 
statistically (Holyoake et al., 1994). 
An IF AT test modified to detect IgG instead of IgM or IgA was developed using 
pure culture derived L. intracellularis (Knittel et al., 1998). This assay incorporated the use 
of Lawsonia antigen grown in pure culture that is then stained using serum from test pigs as 
the primary antibody and fluorescein isothiocyanate (FITC) labeled anti-swine IgG (heavy 
and light chains) as the secondary antibody (Knittel et al., 1998). Results from 3 
experiments indicated that the IFAT was more sensitive (90%) and highly specific (96%) 
compared to PGR (47% and 100% respectively) in detecting L. intracellularis in pigs 
challenged with pure culture 21-28 days after inoculation (Knittel et al., 1998). Maternal 
antibodies were detected by the IFAT up to 5 and 6 weeks of age in these evaluations. The 
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IFAT has proven to be an accurate and reliable ante mortem tool for detecting the incidence 
of L. intracellularis in experimental and naturally exposed pigs around the world (Mortimer 
et al., 2000; Fourchon and Chouet, 2000; Dunser et al., 2000; Bakker et al., 2000; Just et al., 
2001; Guedes et al., 2002b). 
An immunoperoxidase monolayer antibody assay (IPMA) was developed to provide 
an alternative to the immunoflourescence-based assay for detecting seroconversion to 
L. intracellularis in pigs (Guedes et al., 2002a). This assay is very similar in design and 
utility as the IFAT except for the following: the secondary antibody is an anti-swine IgG 
peroxidase-labeled conjugate (vs. FITC), the methods by which sample preparations 
observed are different (IPMA= light microscopy; IFAT= UV microscopy), and the IPMA 
requires one more step than the IFAT (incubation with FbCb to remove endogenous 
peroxidase) (Guedes et al., 2002a). The sensitivity (88.9%) and specificity (100%) of this 
assay in detecting imti-Lawsonia antibodies in pigs was also comparable to the IFAT 
(Guedes et al., 2002a). Both assays were compared in parallel in a controlled challenge 
exposure study in which serum was tested on days 7, 14, 21 and 28 after oral inoculation 
with intestinal homogenate from PHE infected pigs (Guedes et al., 2002a). Results showed 
that the percentage of agreement between the IFAT and IPMA was 98.6% (Guedes et al., 
2002a). The serology results agreed in all samples tested except on days 0 and 7 in which 
one control animal (Lawsonia-negative) was positive by the IPMA, but negative by IFAT 
(Guedes et al., 2002a). Therefore, either assay can be used to effectively detect 
L. intracellularis exposure in pigs. 
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Various authors have attempted to develop ELISA methods that would be as reliable 
in detecting anti-Lawsonia antibodies in sera as the previously described assays. An ELISA 
would be the desired test method for detecting exposure to L. intracellularis in pigs because 
it allows for high throughput sample testing, automated reporting of test results and an 
unbiased determination of a Lawsonia-positive or negative sample. An ELISA (Watarai 
et al., 2004) was developed using synthetically produced peptides of the L. intracellularis 
outer surface antigen, LsaA (McCluskey et al., 2002). This ELISA was able to distinguish 
between rabbits naturally infected with L. intracellularis from those that were Lawsonia-
naïve (Watarai et al., 2004). These results indicated that a single antigenic molecule may be 
used as the primary antigen in an indirect ELISA format for successfully detecting anti-
Lawsonia IgG in rabbit serum (Watarai et al., 2004). Recently, an ELISA was developed 
for experimentally detecting anti-Lawsonia IgG in pigs that were previously inoculated with 
virulent pure culture L. intracellularis (Kroll et al., 2005b). In this test system, an indirect 
ELISA format using the lipopolysaccharide (LPS) component of a virulent L. intracellularis 
pure culture isolate as the primary antigen was successful in detecting anti-Lawsonia IgG 
antibodies in pigs. Compared to the IFAT, the LPS-based ELISA detected significantly 
(p<0.05) more anti-Lawsonia IgG positive pigs after vaccination and challenge on days 21, 
28, 35 and 42 of the study (Kroll et al., 2005b). The sensitivity (99.5%) and specificity 
(100%) of this assay was slightly higher than the IFAT suggesting that this test method may 
be better at detecting early onset of L. intracellularis exposure in pigs regardless of isolate 
type (vaccine or wild-type) (Kroll et al., 2005b). Others have used similar technology in a 
capture-antibody or sandwich ELISA format in which L. intracellularis LPS was 
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immobilized with a monoclonal antibody to the bottom of each well in a microliter plate 
(Boesen et al., 2005a and 2005b). In these studies, 36 out of 37 (97%) experimentally 
infected pigs tested positive while 31 out of 31 (100%) weaned pigs 12 weeks of age and 30 
out of 31 (97%) weaned pigs 20 weeks of age tested positive for anti-Lawsonia IgG 
antibodies in naturally infected herds. The reported specificity (99.3%) and sensitivity 
(98%) of the sandwich ELISA is similar to the indirect LPS-based ELISA and higher than 
the IFAT and the IPMA assays (Boesen et al., 2005b). The percentage of agreement 
between the IFAT and ELISA was found to be 98.8% which is similar to the agreement 
found between the IFAT and IPMA (98.6%) (Boesen et al., 2005b). 
Polymerase chain reaction 
Polymerase Chain Reaction (PGR) is a sensitive, molecular based DNA detection 
tool that can detect low levels of microbial pathogens in various biological specimens, 
especially intracellular organisms, which may be difficult to recover using conventional 
isolation methods and/or detect by microscopy or immunodiagnostic tests. This highly 
sensitive, pathogen-specific and rapid method has been used successfully for detection of 
L. intracellularis in feces and mucosal samples (Gebhart et al., 1993; Jones et al., 1993a 
and 1993d) as well as in various tissues including ileum, cecum, colon (Jones et al., 1993b), 
tonsil (Jensen and Svensmark, 2000), liver and lymph nodes (Jensen et al., 2000). Primers 
for the specific unique sequences of DNA based on 16S rDNA found to be conserved 
among all L. intracellularis organisms were developed (Gebhart et al., 1991 and 1993, 
Jones et al., 1993a; Jones et al., 1993c; Cooper, 1996; Cooper et al., 1997). Two sets of 
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primers; an external primer set that amplifies a 319 base pair (bp) fragment of DNA and an 
internal primer set that amplifies a 255-bp fragment have been used in nested PCR assays 
for detecting as little as 103 L. intracellularis organisms within a gram of feces (Jones et al. 
1993b). This nested PCR method was optimized by enhancing procedures for extracting 
genomic DNA from pig feces thus achieving a minimal detection limit of 2 x 102 
L. intracellularis bacteria per gram of feces (Moller et al., 1998b). Still, others have found 
the sensitivity of this assay to be approximately 101 L. intracellularis bacteria per gram of 
feces (Chang et al., 1997). 
Several authors have evaluated PCR for detection of L. intracellularis in the feces of 
experimentally challenged and field exposed pigs (Jones et al., 1993b; McOrist et al., 
1994b; Knittel et al., 1998). McOrist et al. (1994b) suggested that PCR will only detect 
positives in feces when pigs have active lesions and L. intracellularis is present in high 
numbers. However, PCR on pig feces have been used to demonstrate that pigs shed 
L. intracellularis in the presence or absence of clinical signs or gross lesions of PE (Knittel 
et al., 1997; Jordan et al., 1999; Jordan et al., 2004). The PCR method has been a useful 
diagnostic tool to identify the prevalence of L. intracellularis among many different pig 
production systems around the world (Dunser et al., 2000; Vestergaard et al., 2004; Lofstedt 
et al., 2004; Plawinska et al., 2004; Keita et al., 2004; Wendt et al., 2004; Tomanova and 
Smola 2004; Suto et al., 2004). 
Polymerase chain reaction can be used to identify pigs that are actively shedding the 
organism, but it can not detect Lawsonia-colonized pigs that are not shedding the organism 
(Jordan et al., 1999). Due to intermittent shedding commonly found in subclinical or 
chronically infected pigs, false negative results can occur when using PCR on pig feces 
(Jordan et al., 1999; Knittel et al., 1997). Factors that might inhibit successful PCR and 
contribute to false negative results are molecules naturally found in feces that inactivate 
DNA polymerase, degrade or capture nucleic acids or interfere with cell lysis during the 
extraction process (Lantz et al., 2000; Jacobson et al., 2003a). The use of a internal control 
or "mimic" DNA molecule that is amplified by the same primers as those used for 
Lawson/a-specific DNA would validate the PCR reaction and indicate false-negative results 
in clinical specimens (Jacobson et al., 2003a). Jacobson et al. (2003a) successfully 
developed a mimic molecule consisting of a human (3-actin molecule that upon 
amplification results in a larger size (596-bp) DNA fragment than the Lawsonia-specific 
amplicon (319-bp). Due to the size of fragment and the source of mimic DNA (human), 
this mimic is expected not to competitively exclude the target DNA or non-specifically bind 
to DNA of bacterial or pig origin. In a recent study, the sensitivity of Lawsonia-spiked 
tissue samples was 10* to 10" mimic molecules per reaction tube and 102 to 103 mimic 
molecules per reaction tube in fecal samples (Jacobson et al., 2004). Still, some PCR 
inhibitors may exist and interfere with the DNA polymerase since the results improved by 
the use of enzymes (i.e. rTth and Tli polymerases) known to be less sensitive to inhibition 
(Al-Soud and Radstrom, 2001). 
Multiplex PCR assays were developed for simultaneous detection and identification 
of Serpulina (Brachyspira) hyodysenteriae, Salmonella sp. and L. intracellularis in pig 
feces (Elder et al., 1997; La et al., 2004; Zmudzki et al., 2004). A one-step PCR assay was 
developed to detect a Lawsonia-specific 210-bp DNA fragment in clinical specimens (Suh 
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et al., 2000). This method was found to be highly specific in detecting Lawsonia-on\y DNA 
in crude intestinal samples (no reaction to swine genomic DNA and other enteric bacterial 
pathogens) and found to be more sensitive than conventional PCR (Suh et al., 2000). 
Researchers have developed a 5' nuclease assay where the PCR-product amplified 
by two specific primers based on the 16S rRNA gene of L. intracellularis and then, detected 
by fluorescence (Lindecrona et al., 2002). Out of 204 clinical samples, 111 (54%) samples 
tested positive for Lawsonia-specific DNA compared to 98 (48%) samples by IHC making 
it just as sensitive as IHC in detecting L. intracellularis in pig feces (Lindecrona et al., 
2002). The detection limits were determined to be approximately 4 x 104 L. intracellularis 
bacteria per gram of feces (Lindecrona et al., 2002). Others have designed a real-time PCR 
method for rapid detection and quantification of Lawsonia DNA in high throughput 
situations (Beckler et al., 2003). Of the 45 known positive samples, 31 were PCR positive 
by conventional PCR and 36 were positive by real-time PCR, showing a 69% and 80% 
sensitivity, respectively (Beckler et al., 2003). Real-time PCR methods like those 
mentioned above are more attractive than conventional PCR because they allow for 
immediate confirmation of a Lawsonia-positive within a sample and provide the option of 
quantification. In addition, real-time PCR may be done with pure cultures, mucosal 
homogenates or feces and eliminates the need to visualize PCR products via gel 
electrophoresis leading to a reduction of time, labor and inherent problems of cross-
contamination. More studies are necessary to optimize real-time PCR technology for the 
detection and quantification of L. intracellularis in pigs. 
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Other diagnostic techniques 
Prior to the development of PCR, a DNA hybridization technique with an 
L. intracellularis specific DNA probe was used to detect Lawsonia-specific genomic DNA 
in the feces of experimentally infected pigs (Jones et al., 1993d). DNA was extracted from 
fecal samples and bound to a nylon membrane, then probed with a digoxigenin-labeled 
Lawsonia DNA probe (Gebhart et al., 1991). Another hybridization technique using 
Lawsonia DNA hybridized in situ to tissue samples taken from PHE and PIA cases 
confirmed that sequence similarities are evident in L. intracellularis from both forms of PE 
(Gebhart et al., 1991). 
An enzyme-linked oligosorbent assay (ELOSA) was developed to specifically 
identify 328-bp PCR amplified L. intracellularis DNA in clinical samples (Zhang et al., 
2000). Positive test results involved a signal greater than or equal to the optical density of 
0.375 at 450 nm wavelength after hybridization of biotin-labeled PCR products with an 
amine-modified Lawsonia-specific internal oligonucleotide capture probe immobilized in 
96-well microtiter plates forming an avidin-biotin-peroxidase complex (Zhang et al., 2000). 
An immunological method using immunomagnetic separation and ATP 
bioluminescence was developed for the detection of L. intracellularis in fecal samples 
(Watarai et al., 2005). Magnetic beads coated with an anti-Lawsonia LsaA antibody were 
used to capture whole cell L. intracellularis in fecal samples from infected rabbits. The 
beads containing captured L. intracellularis were treated to release ATP and assayed to 
determine the amount of ATP in each sample. Results from these experiments revealed 
ATP concentrations higher for anti-LsaA antibody coated magnetic beads exposed to fecal 
samples from infected rabbits than those exposed to fecal samples from uninfected rabbits 
(Watarai et al., 2005). This method could be useful as an alternative to PCR for the 
detection of active L. intracellularis infections in animals. 
Epidemiology and Economics 
Proliferative enteropathy is an endemic disease that is widespread among swine 
herds and production systems across every continent where pork production can be found. 
Previous estimates indicated that PE in growing pigs resulted in direct financial losses of $3 
to $11 US dollars (USD) per pig in the United Kingdom (McOrist et al., 1997a). In the late 
1980's and 1990's, annual costs to global pig production were estimated at $20 million 
USD in the United States (Mapother et al., 1987), $3-6.5 million USD in the United 
Kingdom (McOrist et al., 1997a) and $25 dollars per sow in Australia (Cutler and Gardner, 
1989). However, these estimates reflect pigs having clinical symptoms of PE or growing 
pigs with chronic PIA (McOrist 2005). This leads to an underestimation of the overall 
economic impact of PE that includes clinical (chronic and acute PE) and subclinical 
(presence of intestinal lesions but without clear diarrhea or weight loss) cases in adult and 
growing pigs (McOrist 2005). Most recent estimated losses exceed €100 ($121 USD) per 
affected breeding pig which translates to an extra €0.50 ($0.61 USD) per growing pig 
(McOrist 2005). The total losses due to endemic PE on most European farms could 
potentially exceed €1 ($1.22 USD) per affected grower-finisher pig (McOrist 2005). 
Many factors contribute to the prevalence and economic impact of L. intracellularis 
on pig farms including age, breed, diet, herd health status, use of antibiotic, vaccines, 
disinfectants and differences in management and production systems. Other contributing 
factors having strong influence in maintaining PE in pig herds are the transmission and 
survival of L. intracellularis in the environment. However, the understanding of the true 
nature of the epidemiology and economics of PE on pig farms is largely contingent upon the 
availability and extensive use of more refined and reliable ante mortem diagnostic assays. 
Rates of exposure or prevalence of L. intracellularis in swine herds have been determined 
through serological techniques such as immunoflourescence antibody test (IFAT) (Knittel 
et al., 1998) and the immunoperoxidase monolayer assay (IPMA) (Guedes et al., 2002a). 
Polymerase Chain Reaction (PCR) (Jones et al., 1993a) methodology has proven to be a 
reliable molecular diagnostic tool for specifically detecting Lawsonia DNA in pig feces. 
Serology can provide historical information on exposure to the bacteria while PCR are 
measures of actual infection (Guedes 2004). Another option for tracking L. intracellularis 
isolates from different geographical origins is a PCR-based molecular tool that detects 
variable number tandem repeats (VNTR) within the Lawsonia genome (Beckler et al., 
2004). Gebhart and colleagues have demonstrated that this assay can be used to screen 
Ltiiwonzti-infected tissues and can discriminate between isolates based on the number of 
highly variable tandem repeat among 4 different loci (Beckler et al., 2004). High 
discrimination of isolates into genotypic subtypes was possible between outbreaks of PE on 
geographically distinct pig farms and between animal species including pigs, horses, 
hamsters, ferrets, ostrich and spider monkey (Weber et al., 2004). However, this test can 
not differentiate among high and low in vitro and in vivo passages of the same Lawsonia 
isolate or between a vaccine isolate and its parent form (Weber et al., 2004). The VNTR 
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profile consisting of non-essential, intergenic DNA repeats within 4 different loci remains 
stable over time even when manipulated through biological processes (Weber et al., 2004). 
Therefore, the VNTR assay has been proposed to be an efficient research tool for tracking 
different genotypic subtypes of L. intracellularis among animal species and the possibility 
of determining their epidemiological relatedness (Weber et al., 2004). 
Prevalence of disease 
It has been determined that pigs on 20% to 50% of farms worldwide are infected 
with L. intracellularis (Stege et al., 2000; Chouet et al., 2003; McOrist et al., 2003; Suto 
et al., 2004). The disease may be more prevalent in the USA (96%) and Northern Europe 
(70-90%) compared to Southern Europe (50-70%) where higher percentages of pigs are 
positive for PE based on serological prevalence data (McOrist et al., 2003). A longitudinal 
study of a natural L. intracellularis infection in five large Danish pig herds revealed that the 
bacterium was present in all herds, and 75% of pigs examined by PCR were actively 
infected (Stege et al., 2004). In a cross-sectional study of 8 growing swine herds (weaning 
to 24 weeks of age) and 3 breeding herds in the Midwestern United States, L. intracellularis 
exposure was observed by IPMA in 75% of growing herds and 78% of replacement gilt 
herds (Marsteller et al., 2003). 
Prevalence data depicting the true incidence of L. intracellularis-specific disease on 
farms can be skewed high or low depending on sampling times and the diagnostic assay 
used (PCR, IFAT and IPMA). Previous field and controlled challenge exposure studies 
have shown that pigs were fecal PCR positive 1 to 2 weeks before they were IPMA positive 
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to L. intracellularis (Guedes et al., 2002b; Guedes and Gebhart, 2003a). Whereas, other 
studies have revealed seroconversion to L. intracellularis before shedding was evident via 
PCR (Knittel et al., 1998; Kroll et al., 2004a). Guedes (2004) reported that pigs are 
probably in the early stages of infection or have not had time to mount a detectable humoral 
immune response when they are PCR positive, but serologically negative for 
L. intracellularis. Likewise, when pigs are PCR negative, but positive for antibodies, this 
may indicate previous exposure or lack of sensitivity in the PCR assay to detect 
L. intracellularis (Guedes, 2004). These observations stress the need for evaluating 
L. intracellularis prevalence on farms using both PCR and serology when possible (Guedes, 
2004). 
White breed hybrid stock seem to develop PE more readily than Duroc-cross pigs 
(McOrist et al., 2003). Limited contact between sows and their off spring (segregated early 
weaning systems) and the movement of pigs in large groups (all in/all out systems) have 
influenced the dynamics of PE on farms (Bronsvoort et al., 2001). Disease transmission is 
reduced early in life with consequent susceptibility to PE if introduced to them at a later 
developmental stage (McOrist et al., 2003). Lawsonia-specific infections typically reach 
high levels in grower pigs at about 8 weeks of age and remain active throughout the 
finishing and breeding stages (Chouet et al., 2003). 
Modes of transmission 
Transmission of L. intracellularis from pig to pig is efficiently accomplished by the 
fecal-oral route through high levels of bacteria in pig feces. The environment of many pig 
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farms contains a sustained level of L. intracellularis, which allows the reintroduction of 
infection to new groups of pigs at various ages (McOrist et al., 2003). Previous reports 
revealed that pig to pig contact contributed greatly to the transmission of acute PHE among 
breeding stock and recently weaned or adult pigs (Rowland and Rowntree, 1972; Love 
et al., 1977). A controlled challenge exposure study revealed that sentinel pigs became 
infected when housed in contact with pigs inoculated with a relatively low dose of pure 
culture L. intracellularis (Jordan et al., 2004) confirming that pig feces is the main source of 
new infections in susceptible swine (Guedes, 2004). Transmission of L. intracellularis 
from sows to offspring is influenced by the age and parity of the sow (Mauch and Bilkei, 
2004). In this evaluation, sera from 99 healthy, late pregnant, gilts and 98 sows of parity 3 
to 5 were screened by IF AT for anti-Lawsonia antibodies (Mauch and Bilkei, 2004). The 
antibodies detected in the offspring of gilts showed strong seropositivity to 
L. intracellularis from 5 to 26 weeks of age whereas offspring from parity 3 to 5 sows 
showed lower IFA values which declined more rapidly (Mauch and Bilkei, 2004). These 
results indicated that older, seropositive sows either do not excrete sufficient organisms to 
induce detectable seroconversion or protect their offspring passively with maternal 
antibodies (Bronsvoort et al., 2001; Barna and Bilkei, 2003). Therefore, recently infected 
gilts and low-parity sows are the primary source of L. intracellularis infection for their 
piglets (Mauch and Bilkei, 2004). Partial protection against long term infection and 
reinfection may be present in offspring of seropositive gilts (Mauch and Bilkei, 2004). 
However, the longer lasting seropositivity of the offspring of naïve gilts suggests reinfection 
to L. intracellularis (Mauch and Bilkei, 2004). Other possible mechanisms of 
L. intracellularis transmission include fomites (rubber boots, coveralls, etc.) and biological 
vectors such as mice, birds and insects, and should be considered for future evaluations 
(Guedes 2004). 
Persistence 
Persistence of L. intracellularis can be classified into two categories; environmental 
and within the host animal. Environmental persistence consists of the ability of 
L. intracellularis to remain alive and stable for long periods of time among the various 
conditions found in the field. Persistence within the host animal consists of the ability of 
L. intracellularis to successfully colonize and multiply while evading the host's immune 
response to infection over a period of time. Environmental survival of L. intracellularis in 
pig confinements is a key factor to the reinfection among swine herds. However, due to the 
difficulty of isolating L. intracellularis from feces or PE-infected intestines, viability studies 
to determine the resistance of this organism to various environmental and antimicrobial 
stresses are limited. In one study, Collins et al. (2000) investigated the rates of intestinal 
colonization of L. intracellularis in pigs after oral inoculation with feces from Lawsonia-
positive pigs. The Lawsonia-infected feces had been stored at various temperatures 
(between 5-15°C) for up to 2 weeks and were found to be infectious when given to naive 
pigs based on PGR and histological results. 
A recent study revealed that pigs can intermittently shed L. intracellularis for a 
period of 12 weeks after experimental inoculation (Guedes and Gebhart, 2003c). These 
results demonstrated the capability of long term colonization and survival of 
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L. intracellularis in the host animal (Guedes and Gebhart, 2003c). Pigs that may carry and 
frequently shed the pathogen without presentation of clinical symptoms for long periods of 
time are considered to be subclinically infected with PE (Jacobson et al., 2003b). A study 
comparing the clinical, morphological and microbial findings in animals from good and 
poor performance herds found that clinically healthy pigs were often infected by 
L. intracellularis (PGR +) and had poor growth performance compared to uninfected herds 
(Jacobson et al., 2003b). 
Immune Responses and Immunity to L. intracellularis 
The etiological characteristics of L. intracellularis, an obligate intracellular mucosal 
pathogen that is transmitted by the fecal-oral route, suggests that a protective immune 
response against L. intracellularis infections would involve aspects of humoral, mucosal 
and cell-mediated immunity. Many authors have identified specific host immune reactions 
to natural and experimental L. intracellularis exposure while some have identified possible 
mechanisms of protective immunity against PE in pigs. 
Humoral immunity 
The presence of serum antibodies against an intracellular bacterium was first 
described in studies conducted in hamsters where convalescent serum collected from those 
with severe lesions react with the intracellular bacteria embedded within affected tissue 
sections (Jacoby, 1978). An immunoassay was developed to detect serum IgA and IgM 
antibodies against L. intracellularis, but was found to detect antibodies only in pigs with 
severe lesions (Lawson et al., 1988). The anti-Lawsonia antibodies detected in growing 
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pigs were predominantly IgM and were short lived (Lawson et al., 1988). Holyoake et al. 
(1994) developed an ELIS A that was able to detect a weak 'ànïi-Lawsonia IgG antibody 
response in experimentally challenged pigs around 2 to 3 weeks post inoculation. Results in 
younger pigs from other studies revealed passively acquired IgG antibody at 3 weeks of age 
and then appeared to seroconvert between 7 and 24 weeks of age (Holyoake et al., 1994). 
An immunoflourescent antibody test proved to be more sensitive and specific in detecting 
IgG levels in pig sera (Knittel et al., 1998). In these experiments, the majority of pigs 
(90%) seroconverted to an experimental challenge with a virulent pure culture 
L. intracellularis by 3 weeks post challenge (Knittel et al., 1998). The duration of antibody 
detection was not determined in these controlled exposure studies since study termination 
was typically around 3 weeks post challenge. In a comparison study, serological responses 
and duration of antibody detection was evaluated among pigs receiving virulent and 
avirulent (vaccine) isolates of L. intracellularis (Guedes and Gebhart, 2003a). Pigs 
challenged with virulent L. intracellularis elicited a Lawsonia-specific serum IgG response 
2 weeks after inoculation and remained detectable by IPMA up to 13 weeks post challenge 
(Guedes and Gebhart, 2003a). Pigs challenged with an avirulent L. intracellularis elicited a 
delayed Lawsonia-specific IgG response that was not detected until 5 weeks post challenge 
(Guedes and Gebhart, 2003a). A delay in a serum antibody response and lower peak IgG 
titers (3280 and 480 for virulent and avirulent L. intracellw/c/m-c x posed pigs respectively) 
may have been the result of host responses to 2 different antigen types (virulent and 
avirulent), differences in quantity of L. intracellularis within each challenge or due to 
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reinfection because of the higher rates and duration of shedding in the virulent 
L. intracellularis challenge group (Guedes and Gebhart, 2003a). 
Previous studies involving the evaluation of an avirulent live L. intracellularis 
vaccine in pigs have demonstrated that protective immunity against PE does not rely on an 
efficient and robust humoral immune response (Kroll et al., 2004a). In these experiments, 
pigs did not have detectable mti-Lawsonia IgG serum antibodies using the IFAT as the 
detection assay up to 5 weeks post vaccination, but were significantly protected against a 
virulent L. intracellularis challenge exposure (Kroll et al., 2004a). These results were 
consistent with previous assessments that anti-Lawsonia serum IgG levels are not expected 
to correlate with protection because L. intracellularis is an obligate intracellular organism 
that resides in the cytoplasm of enterocytes (Guedes and Gebhart, 2003a). Local mucosal 
IgA levels and cell-mediated immune responses are probably more involved with protection 
against infection, therefore oral or intranasally delivered modified-live vaccines against 
L. intracellularis are preferred over parentally administered vaccines (Guedes and Gebhart, 
2003a). 
Maternally derived IgG, IgA and IgM antibodies specific for L. intracellularis may 
be important against early infections in recently weaned piglets. Results from a controlled 
challenge study revealed that the presence of IFAT-detectable IgG antibodies in piglets up 
to 5-6 weeks of age conferred significant maternal protection against a virulent 
L. intracellularis challenge exposure (Kroll et. al., 2005a). High levels of IgA and IgG and 
to a lesser extent, IgM were found in the colostrum of hyperimmune sows indicating 
passive transfer of Lawsonia-specific maternal antibodies to piglets during the first few days 
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of life (Kroll et al., 2005a). Seropositivity of gilts resulted in protective maternal immunity 
for up to 3 weeks when their piglets were challenged with virulent L. intracellularis (Bilkei, 
1996). It is likely that piglets having maternal antibody protection shed L. intracellularis 
for a shorter period of time compared to piglets born to Lawsonia-naiwe gilts (Gebhart and 
Guedes, 2001). However, effective length of protection provided by maternal immunity for 
pigs has not yet been established (Gebhart and Guedes, 2001). 
A strong positive association between the Lawsonia seropositivity of grower-
finisher pigs and the serological status of their dams was determined by Bronsvoort et al. 
(2001). The positive Lawsonia serological status of the sows was associated with lower 
anti-Lawsonia IgG antibodies in their offspring as a result of lack of exposure or passive 
immunity to the organism (Winkelman, 1996). In a controlled challenge exposure study, 
seropositivity in offspring of IFAT-negative gilts was highest 3 weeks (84%) post challenge 
and declined gradually to only 10% at 24 weeks post challenge (Barna and Bilkei, 2003). 
At the same time, the offspring of IFAT-positive gilts showed lower and faster-decaying 
seroprevalence in which only 32% were IFAT positive at 3 weeks post challenge and no 
anti-Lawsonia antibodies were detected by 15 weeks post challenge (Barna and Bilkei, 
2003). These evaluations suggest that maternally derived, passive immunity may give 
partial protection against L. intracellularis infections to the offspring of seropositive gilts. 
Passive immunization in pigs using chicken egg yolk antibodies has been evaluated 
as an alternative method for prevention of enteric disease (Winkelman et al., 2004). Large 
quantities of Lawsonia-specific antibodies secreted into the yolk of eggs from chickens 
hyperimmunized with purified, whole cell L. intracellularis antigen can be subsequently 
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harvested and fed to pigs. In this study, chicken mti-Lawsonia antibody titers were 
detected up to 1:1,920 in hen sera at 4 weeks after the first immunization while egg yolk 
antibody titers were higher at 1:1000 to 1:10,000 (Winkelman et al., 2004). Pigs that 
received 2 kg of chicken anti-Lawsonia antibodies had significant (p<0.05) increases in 
ADG (25%) and average daily field intake (27%) compared to pigs that received a placebo 
after virulent challenge with a mucosal homogenate containing L. intracellularis 
(Winkelman et al., 2004). However, no statistical differences were noted among treatment 
groups regarding clinical symptoms, fecal shedding (PGR), gross and microscopic (IHC) 
lesions (Winkelman et al., 2004). 
Mucosal immunity 
Intestinal sections from pigs affected with PIA and PHE revealed immense 
accumulations of IgA in the apical cytoplasm of proliferating enterocytes (Lawson et al., 
1979). These accumulations of IgA were also evident in the Peyer's patches (Lawson et al., 
1979) and in the cytoplasm of plasma cells underlying severe proliferative lesions 
(Holyoake, 1993). In other studies, IgA antibodies were detected in macrophages and cell 
debris of the crypt lumen in PHE cases (McOrist et al., 1992). However, in all of these 
reports, the detection of IgA may not have been a specific response to L. intracellularis. 
A study was conducted to observe the progression of an L. intracellularis infection 
through the course of the disease and evaluate the production of Lawsonia-specific mucosal 
secretory IgA (Guedes and Gebhart, 2002c). Immunoglobulin A titers (1:4) in intestinal 
gavages of infected pigs were first detected by day 15 post challenge by a modified IPMA 
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test. Detectable titers were evident up to day 29 challenge with IgA titers ranging from 1:4 
to 1:16 in the affected pig gut (Guedes and Gebhart, 2002c). Positive IHC staining for 
L. intracellularis, microscopic lesions and crypt hyperplasia was evident up to day 29 post 
challenge thus correlating with the production and subsequent detection of IgA in the 
affected intestines (Guedes and Gebhart, 2002c). Further studies are warranted for 
evaluating the level of protective immunity and the IgA response against an 
L. intracellularis infection in pigs. 
Cell-mediated immunity 
The inflammatory response in pigs to PE is minimal which is indicative of a well 
developed lamina propria (Rowland and Lawson, 1974). In previous observations, 
accumulations of eosinophils were observed throughout the mucosa of pigs in the early 
stages of hemorrhage associated with PHE (Love and Love, 1979). Various 
immunocytological evaluations involving intestinal sections from pigs affected with PE 
indicated that the initial cell mediated immune response included a mild infiltration of 
cytotoxic and suppressor T cells, macrophages and B lymphocytes carrying MHC Class II 
motifs (McOrist et al., 1992). Pigs 12 to 16 weeks of age affected with PHE revealed 
moderate infiltration of mononuclear lymphoid cells and polymorphonuclear leukocytes in 
the lamina propria and in the dome area of the Peyer's patches (McOrist et al., 1992). Only 
a mild infiltration of CD8+ and CD25+ T cells were found in the lamina propria during cases 
of PLA, a slightly greater infiltration of these cells along with lamina propria IgM-positive B 
cells were found in hemorrhagic lesions of PHE affected pigs (McOrist et al., 1992). 
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However, Maclntyre et al. (2003) demonstrated in a controlled challenge exposure study an 
association between the presence of L. intracellularis and reduced T cell and B cell 
numbers in affected pigs. These authors have indicated an inverse correlation between the 
level of L. intracellularis infection and lymphocyte populations; T cells decrease as 
L. intracellularis infection increases, thus indicating an immunosuppressive mechanism of 
this bacterium during pathogenesis. Despite an apparent suppression of immune responses, 
antigen-dependent lymphocyte mitogenicity of peripheral blood mononuclear cells from 
Lawsonia infected pigs compared to non-infected pigs has demonstrated specificity of 
lymphocyte responses to L. intracellularis (McOrist et al., 1992 and 1993). 
Other studies have provided further evidence of a cell mediated response in pigs 
exposed to virulent and vaccine isolates of L. intracellularis (Guedes and Gebhart, 2003a). 
Peripheral blood mononuclear lymphocytes were harvested weekly from pigs on days 9 to 
91 post inoculation and levels of IFN-y were determined by an ELISPOT assay (Guedes and 
Gebhart, 2003a). Lawsonia-induced, IFN-y secreting T cell responses became detectable at 
day 9 post-inoculation in pigs receiving 1.76 x 108 L. intracellularis!ml of virulent 
challenge and at day 28 post inoculation in pigs receiving 5.3 x 105 L. intracellularis/ml of 
avirulent challenge (Guedes and Gebhart, 2003a). Pigs that were inoculated with the 
vaccine isolate showed a delayed and lower cell-mediated immune response when 
compared to pigs that received a virulent L. intracellularis challenge (Guedes and Gebhart, 
2003a). However, differences in cell-mediated response among treatment groups may be 
explained similarly to those mentioned above regarding the humoral response in this study 
(Guedes and Gebhart, 2003a). Regardless of these differences, both virulent and avirulent 
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isolates of L. intracellularis induce detectable cell-mediated immunity that lasted for at 
least 13 weeks in some animals (Guedes and Gebhart, 2003a). Significant roles for IFN-y 
have been shown for other intracellular pathogens and from previous studies using a mouse 
L. intracellularis challenge model (Smith et al., 2000). Results from these experiments 
revealed that IFN-y receptor knock out mice were substantially more susceptible and had 
higher levels of L. intracellularis infection and lesion development compared to wild-type 
mice (Smith et al. 2000). Interferon gamma, a Thl cytokine, is involved in directing 
immune responses towards a cell-mediated response when host cells are insulted by 
intracellular pathogens (Smith et al. 2000). Natural infections with L. intracellularis may 
stimulate IFN-y-secreting lymphocytes similar to those in experimental exposure studies 
and that these may be involved in natural clearance of infection (Smith et al. 2000). 
In a L. intracellularis challenge model comparison study, pigs were given intra­
dermal injections of different concentrations of L. intracellularis antigen (formalin-fixed 
whole cell [107/ml to 109/ml], sonicated fractions [25 p-g/ml to 250 ng/ml] or outer 
membrane proteins [7.5 [ig/ml to 75 ug/ml]), 20 days after virulent challenge exposure 
(Guedes and Gebhart, 2002c). Delayed-type hypersensitivity (DTH) reactions involving the 
detection of skin reactions (reddening and swelling) and IFN-y were evaluated 24 h and 
48 h post inoculation (Guedes and Gebhart, 2002c). This type of DTH typically occurs 
within 48 to 72 hours in a sensitized host and activates antigen-specific T cells to secrete 
cytokines that mediate the hypersensitivity reaction (Roitt et al., 1998). Results showed that 
Ltiwmmti-challenged pigs from both treatment groups (pure culture vs. mucosal 
homogenate) showed a dose dependent DTH reaction to the formalin-fixed, whole cell 
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L. intracellularis preparations that was more evident 24 hours after injection (Guedes and 
Gebhart, 2002c). Further studies are necessary for determining Lawsonia-specific induction 
of immunological memory and its duration and how it correlates to protective immunity in 
pigs. 
Control and Prevention Measures 
Several risk factors have been previously defined that predispose pigs to 
L. intracellularis infections and PE. Various control and prevention measures such as 
Lawsonia-susceptible antimicrobials have been implemented in pig production systems 
around the world and have been successful in reducing or controlling L. intracellularis 
infections and PE. However, increasing global pressures to reduce or eliminate the routine 
use of antibiotics as growth promoters in food producing animals have forced farmers, 
producers and veterinarians to rethink how to effectively control enteric diseases such as 
PE. Changes in daily diets, the use of vaccines and disinfectants have shown promise as 
viable alternatives for reducing and eliminating L. intracellularis in pigs without the 
continuous use of antimicrobials. 
Diet 
Different feeding strategies have been investigated to determine their level of 
influence on L. intracellularis infections in pigs (Boesen et al., 2004). Three experimental 
trials involving 144 weaned pigs were fed five different diets all derived from a standard 
diet based on wheat and barley as the primary carbohydrate source and soybean as the 
primary protein source (Boesen et al., 2004). Experimental diets among the 5 treatment 
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groups consisted of standard diets with the following modifications; 1) fine ground and 
pelleted, 2) coarse ground and non-pelleted, 3) fermented liquid feed, 4) 1.8% formic acid 
and 5) 2.4% lactic acid. The effects of fermenting, acidifying and grinding the feed on 
L. intracellularis colonization and the development of PE after experimental challenge with 
a gut homogenate containing a Danish isolate of L. intracellularis were investigated 
(Boesen et al., 2004). The mean duration of fecal shedding of L. intracellularis was 
significantly (p<0.05) lower in pigs consuming a fermented liquid standard diet compared 
to pigs fed a non-fermented standard diet (Boesen et al., 2004). All treatment groups had 
lower average daily weight gains compared to the non-infected controls. Histopathological 
examinations were uneventful as only a few pigs revealed Lawsonia antigen in the surface 
epithelium and surrounding macrophages (Boesen et al., 2004). These results along with 
decreasing PCR positives at the time of necropsy (4-5 weeks post challenge) suggest that 
pigs were recovering from L. intracellularis infections as the peak infection period for this 
organism is generally 3-4 weeks post exposure (McOrist et al., 1996a, Jensen et al., 1997). 
The authors concluded that the fermented liquid diet delayed the excretion of 
L. intracellularis and pigs fed a diet supplemented with 2.4% lactic acid showed signs of 
limited pathological lesions when grossly examined at 4 weeks post challenge (Boesen 
et al., 2004). 
Disinfectants 
Since L. intracellularis is effectively transmitted from pig to pig in the feces, 
reducing cross-contamination between pig groups would help reduce levels of infection and 
incidence of PE. Contaminated feces can be transported on dirty boots, clothing and 
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equipment therefore; simple biosecurity measures such as use of disinfectants should be 
implemented (Guedes, 2004). Previous ex vivo evaluations of various antimicrobial 
disinfectants and their effects on L. intracellularis found the bacteria to be highly 
susceptible to 3% cetrimide (quaternary ammonium), mildly susceptible to 1% providone-
iodine and resistant to 1% potassium peroxymonosulfate or a 0.33% phenolic mixture 
(Collins et al., 2000). Currently, no scientific studies have been published that effectively 
demonstrates the killing rates of these and various other disinfectants on L. intracellularis 
in the field under various production systems. Such evaluations are extremely difficult to 
conduct due to the inherent difficulties of isolating obligate intracellular organisms. Future 
studies are warranted to identify disinfectants that effectively reduce or eliminate 
L. intracellularis in various housing conditions, pig manure and fomites such as boots, 
gloves and clothing. Also, it would be helpful to understand the frequency of which anti-
Lawsonia disinfectants should be applied in typical production settings as well as defining 
the duration of time for effective microbial killing under various environmental conditions. 
Antibiotics 
The challenges of isolating and maintaining L. intracellularis cultures in vitro have 
made antimicrobial susceptibility testing an extremely difficult task. Regardless of this fact, 
in vitro evaluations of the minimum inhibitory concentration (MIC) of 20 different 
antimicrobial agents and the minimal bactericidal concentration (MBC) of 10 of these 
agents indicate a broad range of antibiotic activity against L. intracellularis (McOrist et al., 
1995b; McOrist and Gebhart, 1995). Included in this list are the microlides (i.e. 
erythromycin and tylosin), tetracyclines, pleuromulins (i.e. tiamulin), penicillins, and 
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fluoroquinolones (McOrist et al., 1995b; McOrist and Gebhart, 1995). Antibiotics that have 
no activity against L. intracellularis include the aminoglycosides and aminocyclitols (i.e. 
neomycin, gentamicin and apramycin) (McOrist et al., 1995b; McOrist and Gebhart, 1995). 
Advancements in L. intracellularis pure culture challenge models and diagnostic 
detection systems have enabled in vivo antibiotic sensitivity trials to evaluate numerous 
medication protocols for effective treatment and prevention of PE. Oral administration of 
tiamulin in weaned pigs at 50 ppm (water) from 2 to 21 days pre and post challenge or at 
150 ppm (feed) from 7 to 21 days pre and post challenge was effective at preventing 
microscopic lesion development and reduced clinical symptoms after a virulent pure culture 
L. intracellularis challenge (McOrist et al., 1996b). In another study, tiamulin administered 
at an in-feed inclusion rate of 35 g/ton or 50 g/ton significantly (p<0.05) prevented the 
development of gross lesions in the ileum, significantly (p<0.05) reduced the prevalence 
and severity of microscopic lesions and significantly (p<0.05) reduced fecal shedding of 
L. intracellularis compared to the non-medicated, control group (Schwartz et al., 1999). 
This study also identified significant (p<0.05) reductions in seroconversion to 
L. intracellularis in medicated pigs even though these pigs were shedding the organism in 
their feces during the early infection period (Schwartz et al., 1999). 
Oral administration of tylosin phosphate at lOOppm or 40ppm in feed 4 days pre-
challenge up to 20 days post challenge followed by 40 or 20ppm for an additional 12 days 
prevented Lawsonia-specific microscopic lesions (McOrist et al., 1997b). Tylosin given to 
weaned pigs at lOOppm in feed 7 days after challenge with a virulent pure culture 
L. intracellularis prevented lesion development (McOrist et al., 1997b). Marstellar et al. 
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(2000) demonstrated effective treatment and control of PE through marked reductions in 
diarrhea, quicker resolve of gross lesions in the ileum and significantly (p<0.05) decreasing 
microscopic lesions when administering Tylan 200 by intramuscular injection. 
Chlorotetracycline (CTC) administered to 4 week old pigs at 300 ppm and 600 ppm 
from 4 days pre challenge to 21 days post challenge prevented the development of gross and 
microscopic lesions of PE (McOrist et al., 1999). Weaned pigs treated with 500 ppm of 
CTC for 10 days followed by 100 ppm for 10 days at 2 weeks post inoculation with an oral 
dose of PHE-affected gut homogenate when diarrhea was evident revealed significantly 
(p<0.05) less microscopic lesions of PE (Winkelman et al., 1997). Treatment with 100 ppm 
of CTC in feed at 2 weeks post inoculation with a severe gut homogenate failed to reduce 
the frequency of microscopic lesion development compared to non-medicated control pigs 
(Winkelman et al., 1997). However, lesions were numerically less in medicated pigs at 3 
and 4 weeks post challenge (Winkelman et al., 1997). 
Studies conducted by Shultz et al. (1997) revealed that continuous in-feed 
medication of bacitracin methylene disalicylate and chlortetracycline for 14 days post 
virulent L. intracellularis challenge prevented clinical symptoms of PE. Chlortetracycline 
at 110 ppm, 220 ppm and 440 ppm in feed was effective against development of PE, 
however Bacitracin methylene disalicylate alone will not prevent L. intracellularis 
infections and was added at 33ppm to reduce the levels of confounding bacterial pathogens. 
Lincomycin administered in feed at 44 ppm and 110 ppm for 21 consecutive days 
beginning after the onset of clinical symptoms was effective in reducing diarrhea while 
increasing ADG and feed conversion efficiency after a virulent L. intracellularis gut 
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homogenate challenge (Winkelman et al., 2002). Lincomycin was effective at significantly 
(p<0.05) reducing PE-specific mortality at 110 ppm only (Winkelman et al., 2002). 
However, lincomycin at both concentrations was unable to prevent histological lesions of 
PE in this study. Lincomycin given to pigs at 200 ppm in feed from 7 to 21 days post 
challenge with a virulent gut homogenate containing L. intracellularis effectively controlled 
clinical symptoms and reduced the severity of microscopic lesion development (Winkelman 
et al., 1998). However, these results indicated overall microscopic lesion development was 
not significantly reduced in medicated pigs compared to non-medicated control pigs 
(Winkelman et al., 1998). Medicated pigs showed reduced levels but not elimination of 
fecal shedding 2 to 4 weeks post challenge (Winkelman et al., 1998). 
Increases in average daily weight gains and average daily feed intake was evident in 
pigs receiving 44 ppm/88 ppm/132 ppm and 88 ppm/132 ppm of lincospectin (lincomycin 
and spectinomycin) in feed of 3-4 week old pigs after a virulent pure culture challenge of 
L. intracellularis (McOrist et al., 2000). In another study, treatment with 125 ppm or 
250 ppm of doxycycline for 14 days in 3-4 week old weaned pigs had beneficial effects in 
terms of reductions in diarrhea, prevalence of L. intracellularis in intestinal tissue (PGR or 
histological analysis) and increases in growth performance compared to non-medicated 
control pigs (Kyriakis et al., 2002a). 
Josamycine, belonging to the therapeutic class of macrolides, revealed beneficial 
effects against PE under field conditions when administered to weaned pigs 3-4 weeks of 
age (Kyriakis et al., 2002b). Inclusion levels of 36 mg/kg and 50 mg/kg of feed reduced 
diarrhea, prevalence of L. intracellularis in the intestine (PGR and histological analysis) 
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while enhancing growth performance in medicated pigs compared to non-medicated, 
control pigs (Kyriakis et al., 2002b). 
Several studies have been conducted to evaluate the effectiveness of valnemulin 
hydrochloride (1.45 to 3.75 kg/mg of body weight for 7 to 21 consecutive days post 
exposure) for the control of PE after a mucosal gut homogenate containing virulent 
L. intracellularis (Winkelman et al., 2000a), when given simultaneously during an 
experimental L. intracellularis challenge (Winkelman et al., 2000b) and during naturally 
occurring outbreaks of PE in Denmark (Haugegaard et al., 2000). Results from these 
studies have shown that valenemulin hydrochloride was effective in the control of PE at 
25 ppm to 50 ppm in the feed by reducing clinical symptoms (diarrhea) and significantly 
(p<0.05) improving weight gain during the treatment period. 
The most common treatment of PHE in adult pigs is tiamulin at 120 ppm, tylosin at 
100 ppm, licomycin at 110 ppm, or chlorotetracycline at 300 ppm for 14 days delivered 
orally in pre-mixed feed (McOrist and Gebhart, 1999). Where PE is endemic in grower-
finisher pigs, the preferred treatment is continuous in-feed medication with tiamulin at 
50 ppm, chlortetracycline at 200 ppm, lincomycin at 110 ppm and tylosin at 100 ppm to 
minimize severe production losses caused by the disease (McOrist and Gebhart, 1999). 
Vaccines 
Immunological control of intracellular pathogens commonly involves cell mediated 
responses and is likely a primary factor in the control and prevention of L. intracellularis 
whether stimulation comes from inactivated, avirulent live, sub-unit or other vaccine types. 
Regardless of which approach is taken in the development, an effective vaccine must 
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protect against multiple strains of the pathogen. Presently, L. intracellularis is considered a 
monotypic, single strain organism with no known antigenic variation among various 
isolates around the world (McOrist et al., 2003). 
Multiple genomic and proteomic evaluations over the years have confirmed that 
L. intracellularis is monotypic. Western blots of 6 different antigenic outer membrane 
proteins (OMPs) of 77, 69, 54, 42, 36 and 18 kDa have reacted similarly to monoclonal 
antibodies and convalescent serum from pigs previously exposed to virulent 
L. intracellularis (McOrist et al., 1987; Guedes and Gebhart, 2003c). Additionally, these 
antigenic profiles are conserved among 6 different laboratory isolates of L. intracellularis of 
differing host sources and geographical origins (Guedes and Gebhart, 2003c). Monoclonal 
antibodies generated against Lawsonia surface antigens, LsaA and LPS, have been used as 
the primary detection antibodies in histological assays which have been successful in 
detecting various field isolates from affected pig tissues and other animals (Smith and 
Lawson, 2001; Boesen et al., 2005a). Primer sequences based on the highly conserved 16s 
rDNA gene of L. intracellularis used in the standard PGR protocol for detecting Lawsonia 
DNA in feces and tissue detected all evaluated isolates of US and European origins (Knittel 
et al., 1996). Furthermore, these isolates shared the same morphological features and 
growth characteristics in vitro (Knittel at al., 1996). Japanese researchers have reported that 
genetic sequence of 3 potential virulence factors or antigens (superoxide dismutase, LsaA 
and a 50 kDa OMP) derived from a Japanese porcine isolate of L. intracellularis show 
>99% homology to a UK isolate NCTC 12657 (Koyama et al., 2004). These results suggest 
high genetic similarity among various isolates of L. intracellularis. 
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The completion of the L. intracellularis genome sequence project will allow 
researchers to identify gene sequences involved in pathogenicity that could be viable targets 
for sub-unit vaccine approaches (Gebhart and Kapur, 2003). A partial DNA library was 
developed for obtaining clones for production of material for taxonomic, diagnostic and 
pathogenesis studies in addition to identifying potential protective antigens (Dale et al., 
1998). Thus far, no current information has been reported defining potential immunogens 
as possible vaccine candidates. 
Attenuated live vaccines have been the only approach proven successful for 
developing protective immunity towards intracellular pathogens such as Brucella spp and 
Chlamydia spp. (Su et al., 2000; Morrison et al., 2002; Ko and Splitter, 2003). Killed or 
subunit vaccine prototypes against intracellular agents (Chlamydia and Brucella) have been 
futile (Shaw et al., 2002; Ko and Splitter, 2003). Currently, an avirulent live 
L. intracellularis vaccine (Enterisol® ileitis) was developed by Boehringer Ingelheim 
Vetmedica, Inc. for use in pigs 3 weeks of age or older for control and prevention of gross 
and microscopic lesions typical of PE after virulent challenge (Knittel and Roof, 1999; 
Kroll et al., 2004a). This vaccine has been reported to stimulate both humoral and cell-
mediated immunity in pigs however, a direct correlation regarding the quantification of 
these immune response types to the level of protection have not been established (Kroll 
et al., 2005b; Guedes and Gebhart, 2003a). The L. intracellularis avirulent live vaccine was 
easily and effectively administered orally through the drinking water and provided 
significant (p<0.05) reductions in the prevalence and severity of gross and microscopic 
(IHC) lesions, colonization (PGR / IHC), fecal shedding (PGR) while significantly (p<0.05) 
improving average daily weight gains in pigs challenged with a virulent pure culture 
challenge (Kroll et al., 2004a). Onset and duration of immunity of this vaccine appears to 
be 3 to 4 weeks and > 22 weeks post vaccination respectively (Kroll et al., 2004b). Various 
global field trials evaluating the efficacy of Enterisol® Ileitis have revealed significant 
(p<0.05) benefits in growth performance and reductions in % mortality against a natural 
L. intracellularis exposure in pigs (Sick et al., 2002; Keita et al., 2004; Kolb et al., 2004). 
Safety of Enterisol® Ileitis has been described in pregnant sows (Kroll et al., 2005a) and in 
studies consisting of inoculating pigs with repeat doses and an overdose, administration in 
one week old piglets and demonstrating a lack of reversion to virulence (Kroll et al., 
2004b). 
Conclusions 
Proliferative enteropathy, an enteric disease of pigs and several other animal species, 
includes many different syndromes, all of which are caused by a monotypic obligate 
intracellular organism, Lawsonia intracellularis. Hallmarks of the disease include severe 
thickening of the mucosal epithelia of the small and sometimes the large intestines. This 
lesion is commonly illustrated as a garden hose because of the thick corrugated appearance 
of the affected tissue. Crypt hyperplasia and absence of goblet cells are due to unregulated 
proliferation caused by L. intracellularis infections. 
The intracellular bacteria can be cultivated in adherent or suspension co-culturing 
eukaryotic cell systems under reduced oxygen or anaerobic conditions. Advancements in 
the growth and propagation of L. intracellularis within controlled suspension systems have 
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allowed scientists to develop pure culture challenge models. These models provide a basis 
for better understanding of the pathogenesis of PE as well as the genotypic and phenotypic 
characteristics of the bacterium. Models also allow researchers to define processes for 
attenuated live vaccine development, and to develop new and improved diagnostic 
techniques. 
Laviw;m'a-specific diagnostic methods have improved to levels where veterinarians 
and producers can now accurately and consistently determine the onset of exposure and 
prevalence of L. intracellularis in swine farms. Diagnosis of PE in pigs is no longer 
restricted to post mortem analysis. Molecular-based techniques like real-time PCR and 
serological tools like IF AT, IPMA and ELIS As have increased our knowledge of disease 
prevalence and transmission among swine farms while speeding up the process of receiving 
high quality results in a timely fashion. 
Proliferative enteropathy is endemic among swine farms all over the world having 
significant impact on growth performance resulting in major financial losses for producers. 
Various antibiotics are commercially available that have significant activity against 
L. intracellularis and aid in the control and prevention of PE. Recently, an avirulent live 
L. intracellularis vaccine was made available to the global swine market for use as an 
alternative tool or in conjunction with antibiotics through prescribed strategies for effective 
control and prevention of PE. 
Despite all of the significant advancements made in the understanding of 
L. intracellularis and PE, much remains to be resolved regarding pathogenesis, 
identification of metabolic and virulence characteristics, and immune responses due to wild 
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type and vaccine exposure in pigs. Future research should focus on bioinformatics and the 
utilization of the genome sequence for identifying and characterizing important 
immunogens, enhancing molecular techniques for epidemiological research and improving 
growth in vitro. 
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CHAPTER 3. EVALUATION OF PROTECTIVE IMMUNITY IN PIGS 
FOLLOWING ORAL ADMINISTRATION OF AN AVIRULENT 
LIVE VACCINE OF LAWSONIA INTRACELLULARIS 
A paper published in American Journal of Veterinary Research1 
Jeremy J. Kroll, BS;2 3 Michael B. Roof, PhD;2 Steven McOrist, BVSc, PhD4 
Abstract 
Objective 
To evaluate the efficacy of an orally administered avirulent live vaccine to protect 
pigs against challenge exposure with virulent heterologous Lawsonia intracellularis. 
Animals 
One hundred eight weaned 3-week-old pigs (35 in experiment 1 and 73 in 
experiment 2). 
Procedure 
Two experiments were conducted. On day 0, vaccinates were orally administered 
vaccine via drench or in drinking water, whereas challenge-control pigs were administered a 
placebo. On day 21, pigs were challenge exposed with a virulent heterologous isolate of 
L. intracellularis. Clinical observations, weights, seroconversion, and fecal excretion of 
1 Am. J. Vet. Res. 2004; 65:559-565. Received August 20, 2003. Accepted October 20, 
2003. 
2 Department of Biological Research and Development, Boehringer Ingelheim Vetmedica 
Inc, 2501 N Loop Dr, Ames, LA 50010 
3 Address correspondence to Mr. Kroll. 
4 Department of Clinical Development, QAF Meats, Bunge, Australia, United Kingdom. 
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L. intracellularis were measured until day 42. At study termination, pigs were euthanatized 
and examined for L. intracellularis-sipecific lesion development of the ileum and colon. 
Results 
Pigs receiving a single dose of vaccine were protected when challenge exposed with 
virulent L. intracellularis (at least 1Q7'7 TCID50/dose). In experiment 1, vaccinates had 
significantly less fecal excretion (47% and 40% for days 35 and 42, respectively), compared 
to challenge-control pigs. In experiment 2, vaccinates had significantly less fecal excretion 
(50% and 58% for days 35 and 42, respectively), compared to challenge-control pigs. 
Significant reductions in lesion development were evident in the ileum of vaccinated pigs 
(70% and 56% at day 42 for experiments 1 and 2, respectively), compared to challenge-
control pigs. 
Conclusions and clinical relevance 
Oral administration by drench or via drinking water of an avirulent live vaccine 
against L. intracellularis resulted in substantial protection against proliferative enteropathy 
among vaccinates and offers a better way to reduce stress of pigs during vaccine 
administration. 
Introduction 
Proliferative enteropathy is a common enteric disease of pigs following weaning that 
is caused by the obligate intracellular bacterium, Lawsonia intracellularis}'2 The 
characteristic pathologic feature of the disease in all species is proliferation of immature 
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epithelial cells in the crypts of the ileum, large intestine, or both, leading to macroscopic 
thickening of the mucosa.3 Lawsonia organisms are invariably found in the apical 
cytoplasm of these proliferative enterocytes.2'3 Genome and protein analysis of this 
bacterium indicates a remarkably homogenous single strain, suggesting that this agent only 
recently evolved as a result of a large genetic shift from its ancestors in the Desulfovibrio 
family.1'4 Clinical signs in affected pigs after weaning can include diarrhea and uneven 
weight gain.3 In pigs >12 weeks old, there can be a more acute clinical form of the disease, 
with the proliferative lesions accompanied by rapid onset of diffuse hemorrhage from the 
affected mucosa, leading to melena and sudden death.5 Estimates of the annual economic 
losses attributable to the clinical and subclinical effects of this disease are approximately 
$100 million for the US swine industry alone.6 
In vitro culturing and the primary causative role of L. intracellularis in all forms of 
the disease in pigs was established in 1993.2'7 Before that time, an on-farm trial of a 
formalin-killed bacterin developed against a common secondary agent, Campylobacter 
mucosalis, resulted in equivocal results.8 It was concluded that an orally administered 
avirulent vaccine was the formulation most likely to be effective against L. intracellularis, 
which is an obligate intracellular pathogen. Uptake of L. intracellularis by intestinal 
mucosal macrophages, specific humoral responses, and antigen-related mitogenesis of 
porcine lymphocytes all are evident following oral infection.9"12 Pigs exposed orally to raw 
L. intracellularis-infected fecal material were judged to have developed protective 
immunity in on-farm studies.2'4 Also, protective immunity to infection by other pathogenic 
intracellular bacteria, such as Brucella spp or Chlamydia spp, has only been documented 
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following appropriate delivery of whole live-attenuated bacteria.12"15 Killed or subunit 
vaccines developed against these agents have been far less successful, despite numerous 
attempts.12'15 
In the study reported here, we evaluated the efficacy of an avirulent live vaccine 
developed by use of L. intracellularis (isolate B3903) and various methods of oral 
administration followed by challenge exposure with virulent heterologous L. intracellularis. 
Clinical evaluation of this vaccine was performed in 2 experiments: the first was to ensure 
proof of concept of the efficacy of the vaccine and the second to establish equivalence for 
the various methods of oral administration to ensure it could be practical and acceptable to 
the pork industry for use in the vaccination of pigs. 
Materials and Methods 
Animals 
Weaned 3-week-old pigs (n = 108) were used in the study. All pigs were confirmed 
to be negative for L. intracellularis by use of a polymerase chain reaction (PCR) assay 
conducted on fecal samples as well as analysis of serum samples prior to inoculation. Both 
experiments were conducted in accordance with established guidelines for good clinical 
practices.16 
Experimental protocol 
Two experiments were conducted. Both experiments were conducted by use of a 
double-blind approach in which the group identity for each pig was not disclosed to the 
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study monitor or investigators until processing of samples, laboratory testing, compilation 
of data, and statistical analysis were completed. 
Preparation of the vaccine 
Lawsonici intracellularis isolate B3903 was originally isolated by use of routine 
coculture methods6 from the ileum of a sow in Denmark in 1998. That sow had acute 
hemorrhagic proliferative enteropathy, as confirmed by the use of routine histologic 
techniques and immunohistochemical (IHC) staining methods. The vaccine used in both 
experiments was manufactured commercially, placed in sterile 100-mL glass bottles, 
lyophilized, and stored at 4°C. The master seed of the vaccine was tested independently at 3 
laboratory sitesa'b"L by use of routine cell culture and bactériologie methods to ensure that it 
did not contain other adventitious viruses or bacteria. 
Preparation of challenge-exposure inoculum 
A pure culture of virulent heterologous L. intracellularis used as the challenge 
isolate in both experiments was acquired from a 12-week-old pig from the United States 
that was affected by acute hemorrhagic proliferative enteropathy. This challenge isolate 
(L intracellularis N101494) was extracted from the severely infected ileum of the pig and 
cocultured by use of methods described elsewhere.6 Prior to the day of challenge exposure 
(day 21 of each experiment), routine tissue culture and bacteriologic methods2'6'17 were used 
a Boehringer Ingelheim Vetmedica Inc, St Joseph, MO. 
b Q-one Biotech Ltd, Glasgow, Scotland. 
c Center for Veterinary Biologies Laboratory, Ames, LA. 
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to propagate the challenge isolate in vitro. On the day of challenge exposure, each active 
culture was harvested and pooled with frozen-thawed concentrated ( 1 OX to 20X) stocks of 
low-passage L. intracellularis N101494. Each challenge inoculum was administered within 
1 hour after preparation. 
Bacterial quantification 
Quantification of the vaccine and challenge inoculum N101494 was accomplished 
by performing a TCID50 endpoint assay18 on a representative 1-mL aliquot. The vaccine 
was reconstituted with sterile water and serially diluted ten-fold in Dulbecco modified 
Eagle's medium fortified with Ham's F12d with heat-inactivated 5% newborn bovine 
serum.6 The total of live L. intracellularis (TCID^o/dosc) was calculated by use of the 
Reed-Muench method.19 Vaccinated pigs received a dose (1049 TCID50) of the vaccine 
L. intracellularis (isolate B3903). Pigs in challenge-exposed groups each received a dose 
(107 7 TCIDso) of a pure culture of virulent heterologous L. intracellularis N101494. 
Experiment 1 (proof of concept) 
The objective of the first experiment was to determine the efficacy of an orally 
administered avirulent live vaccine for L. intracellularis (isolate B3903) in pigs challenged 
with a virulent heterologous isolate. Thirty-five weaned 3-week-old pigs with negative 
results when tested for L. intracellularis were randomly allocated to 3 groups (15 
vaccinates; 10 unvaccinated challenge-control pigs; and 10 unvaccinated, unchallenge-
d DMEM F12, JRH Biosciences, Lenexa, KS. 
e Newborn Bovine Serum, JRH Biosciences, Lenexa, KS. 
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exposed, negative-control pigs). To avoid cross-contamination, each group was housed in a 
separate room but with the same conditions (temperature, ventilation, and pen size). Pigs in 
each room were housed in the same pen. On day 0 of the experiment, each of the 15 
vaccinates was orally administered a single 2-mL dose of commercially available 
L. intracellularis vaccine' in accordance with label instructions. Each dose was applied 
directly to the caudal portion of the oral cavity of each pig by use of a sterile plastic 10-mL 
syringe. Also on day 0, challenge-control and negative-control pigs were each orally 
administered a 2-ml dose consisting of uninfected tissue culture cells suspended in growth 
medium. 
On day 21, vaccinates and challenge-control pigs were challenge exposed with a 
7 7 
single dose of virulent heterologous L. intracellularis isolate N101494 containing 10 
TCID50; challenge exposure was achieved by use of oral gavage. The remaining 10 
negative-control pigs did not receive vaccine and were not challenge exposed during the 
experiment. 
All pigs were examined daily to monitor clinical signs (including diarrhea), 
behavior, and body condition. Mean clinical score of 1 to 4 was calculated for each group 
on each day (1, clinically normal; 4, severe illness). An indirect fluorescence antibody test18 
was conducted on serum extracted from blood samples that were collected weekly from 
each pig from days 0 to 42 of the experiment; results of the antibody test were used to 
determine rate of seroconversion to L. intracellularis. Fecal samples were collected weekly 
1 Enterisol® Ileitis, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO. 
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from days 0 to 42; these samples were analyzed with a PCR assay that used 
L. intracellularis-primers and methods described elsewhere.18'20'21 The L. intracellularis-
specific primers used in this PCR assay cannot differentiate between various 
L. intracellularis isolates. Extraction and purification of bacterial DNA from fecal samples 
were conducted by use of a rapid DNA extraction kit.8 
Weight measurements were obtained on days 0, 21, and 42 to determine mean daily 
weight gain of each group of pigs. Mean initial weights were uniform among all groups 
(variation of <0.2 kg/pig). Weight gains were calculated for 2 distinct phases of the 
experiment. The first phase (days 0 to 21) represented the period between inoculation and 
challenge exposure and was used to evaluate immediate effects of inoculation with the 
vaccine. The second phase (days 21 to 42) represented the period between challenge 
exposure and end of the experiment and was used to evaluate the effect of challenge 
exposure with a virulent heterologous organism. 
On day 42 of the experiment, all pigs in all 3 groups were euthanatized. Postmortem 
examinations were performed to determine the extent of macroscopic and microscopic 
lesions in the ileum and colon of the pigs. Macroscopic lesions in the ileum or colon were 
scored on the basis of the severity of mucosal thickness (1, normal; 2, mild thickening; 
3, moderate thickening-inflammation; and 4, severe thickening-inflammation-mucosal 
hemorrhaging or necrosis). 
8 IsoQuick DNA extraction kit, Orca Research Inc., Bothell, WA. 
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Samples of ileum and colon (2 to 4 cm in length), tonsils, and mesenteric lymph 
nodes were collected, fixed by immersion in buffered formalin, and processed for detection 
of microscopic lesions. This included staining with H&E and IHC staining by use of 
specific L. intracellularis monoclonal antibodies.4'22 Immunohistochemical analysis by use 
of L. intracellularis-specific monoclonal antibodies is currently considered the criterion-
referenced test for assessment of the actual infection status of a pig.23 Microscopic lesions 
in IHC-stained tissues were scored separately on the basis of severity of L. intracellularis-
specific cell proliferation (0, normal; 1, mild-focal; 2, moderate-diffuse; and 3, severe-
diffuse). Mean scores for microscopic lesions and the frequency of lesions detected in the 
affected tissues were calculated for group comparisons. 
In addition, 6 to 10 cm of fresh tissue samples from the ileum, colon, tonsils, and 
mesenteric lymph nodes were collected from each pig. Each fresh sample was subjected to 
extraction of bacterial DNA and the Lciwsonia-specific PCR assay described previously to 
determine the extent of possible tissue colonization. 
Experiment 2 (bioequivalence of oral administration) 
The objective of this experiment was to evaluate the efficacy of orally administering 
the avirulent live vaccine (L intracellularis isolate B3903) by 2 methods, followed by 
challenge exposure with virulent heterologous organisms. Seventy-three weaned 3-week-
old pigs with negative results when tested for L. intracellularis were randomly allocated to 
4 groups (20 vaccinates with vaccine orally administered via water delivery, 20 vaccinates 
with vaccine orally administered via a drench, 20 unvaccinated challenge-control pigs, and 
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13 unvaccinated, unchallenged, strict-control pigs). Housing and measures to ensure 
biosecurity for each group were similar to those described for experiment 1. 
On day 0, pigs in the water-delivery vaccinate group were orally vaccinated by 
ingesting the vaccine that was added to the drinking water. The reconstituted vaccine was 
added to a volume of water that we estimated would be consumed by 3-week-old pigs 
within a 4-hour time period (i.e., 2 L of vaccine-containing water in a clean trough); it was 
the sole water source available to the pigs. The amount of vaccine added to the group's 
drinking water was calculated to deliver 1 dose/pig. These pigs were not subjected to 
withholding of water prior to this vaccination process. 
Pigs vaccinated orally via drench were each administered a single 2-mL dose of the 
vaccine. Each dose was applied directly to the caudal portion of the oral cavity of each pig 
by use of a plastic 10-mL syringe with a plastic tip canula. Pigs in the challenge-control 
group were administered 2 mL of the tissue culture growth medium directly to the caudal 
portion of the oral cavity. Pigs designated as strict-control pigs were not administered 
vaccine or tissue culture growth medium and thus were unvaccinated not challenge exposed 
during the experiment. 
On day 21, both vaccinate groups and the challenge-control group was challenge 
exposed via oral gavage with a single dose of a virulent heterologous culture of 
L. intracellularis isolate N101494, as described for experiment 1. Collection of samples 
and clinical monitoring were conducted as for experiment 1. On day 42, pigs were 
euthanatized and postmortem examinations were conducted. All examinations were 
conducted in the same manner as for experiment 1, except for the scoring system for 
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macroscopic lesions. In experiment 2, this system for scoring macroscopic lesions was 
modified to increase scrutiny among degrees of lesion severity as follows: 0, normal; 
1, mild thickening; 2, moderate thickening-inflammation; 3, severe thickening-
inflammation; 4, severe thickening-inflammation-edema-mucosal hemorrhaging; and 
5, necrosis. Mean scores for macroscopic lesions were calculated for group comparisons. 
Statistical analysis 
All key variables were analyzed statistically. Macroscopic lesions, microscopic 
lesions, clinical scores, and body weight gains were analyzed by use of a 1-way ANOVA or 
Kruskal-Wallis test; whereas tissue colonization (PCR assay), fecal shedding (PCR assay), 
and seroconversion were analyzed by use of %2 or Monte-Carlo tests.24'25 For experiment 1, 
the primary indicator of vaccine efficacy was considered to be a significant (P<0.05) 
reduction in the prevalence and severity of macroscopic and microscopic lesions in the 
ileum and colon. This was used to document the degree of protection achieved for 
administration of the vaccine. For experiment 2, the primary indicator used to document 
efficacy of the 2 administration methods was a significant reduction (P<0.05) in prevalence 
and severity of macroscopic and microscopic lesions in the ileum and colon. 
Results 
Safety of the vaccine and administration procedures 
We did not detect adverse reactions attributable to the vaccine or vaccination 
procedure among any vaccinated pigs throughout the study. 
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Experiment 1 
Analysis of clinical observations did not reveal significant differences between 
vaccinates and unvaccinated challenge-control pigs for diarrhea, behavior, and body 
condition. Mean initial weight for vaccinates, challenge-control pigs, and negative-control 
pigs was 8.2, 8.0, and 8.0 kg/pig, respectively, whereas mean final weight for vaccinates, 
challenge-control pigs, and negative-control pigs was 32.9, 31.0, and 32.5 kg/pig, 
respectively. Average daily weight gain did not differ significantly among any of the groups 
during the first 21 days of each experiment. After challenge exposure (i.e., days 21 to 42), 
average daily weight gain did not differ significantly between vaccinates (0.73 kg/d) and 
negative-control pigs (0.74 kg/d); however, the challenge-control pigs had a significantly 
(P<0.05) lower average daily weight gain (0.66 kg/d), compared with values for the 
vaccinates and negative-control pigs. 
During the period before challenge exposure (days 0 to 21), Lawsonia-specific PCR 
analysis of fecal samples revealed that none of the groups had positive results for 
L. intracellularis (Figure 1). Initial PCR detection of L. intracellularis in the feces of pigs 
in any of the groups was on day 28 of the study (data not shown). On day 35 (14 days after 
challenge exposure), a significantly (P<0.05) lower proportion of vaccinated pigs (5/15, 
33%) had PCR-positive fecal samples, compared with the proportion in the challenge-
control group (8/10, 80%). On day 42 (termination of experiment), a significantly (P<0.05) 
higher proportion of pigs in the challenge-control group shed L. intracellularis (4/10, 40%), 
compared with the proportion for the vaccinated group (0/15, 0%). 
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Study 1 : Fecal Shedding 
Challenge Vaccination 
-A— Vaccinates 
-•—Challenge Controls 
- Negative Controls 
Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 
Figure 1. Fecal shedding of Lawsonia intracellularis in pigs orally vaccinated with an 
avirulent live vaccine and unvaccinated challenge-control pigs that were 
challenge exposed 21 days later with heterologous L. intracellularis during 
experiment 1. Fecal shedding was determined on the basis of positive results for 
a polymerase chain reaction assay. Fifteen pigs were vaccinated and challenged 
exposed (triangle), 10 pigs were unvaccinated and challenge exposed (square), 
and 10 pigs were unvaccinated and not challenge exposed (diamond). Day 0 is 
the day of oral administration of vaccine or culture medium. 
Study 1 : Seroconversion 
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Figure 2. Seroconversion to L. intracellularis in pigs orally vaccinated with an avirulent 
live vaccine and unvaccinated challenge-control pigs that were challenge exposed 
21 days later with heterologous L. intracellularis during experiment 1. 
Seroconversion was determined on the basis of results for an indirect 
fluorescence antibody assay. Fifteen pigs were vaccinated and challenge-exposed 
(square), 10 pigs were unvaccinated and challenge exposed (triangle), and 10 pigs 
were unvaccinated and not challenge-exposed (diamond). Day 0 is the day of 
oral administration of vaccine or culture medium. 
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The pattern of seroconversion during the course of the experiments was similar to 
the rates of fecal shedding among vaccinates and challenge-control pigs (Figure 2). All pigs 
were seronegative on the basis of analysis of indirect fluorescence antibody testing of sera 
obtained during the 3 weeks before and on the day of challenge exposure (i.e., days 0 to 21). 
On day 35 (14 days after challenge exposure), 4 of 15 (27%) vaccinated pigs were 
seropositive for L. intracellularis, whereas only 1 of 10 (10%) pigs were seropositive in the 
unvaccinated challenge-control group. On day 42 (termination of experiment), 6 of 15 
(40%) vaccinates were seropositive, whereas 8 of 10 (80%) challenge-control pigs were 
seropositive. We did not detect significant differences in the pattern of seroconversion 
among treatment groups at any time period throughout the experiment. 
Lawsonia-specific PCR analysis of various tissues revealed a higher proportion of 
mesenteric lymph nodes with positive results in the challenge-control group (3/10, 30%), 
compared with the vaccinates (0/15, 0%). Tissues obtained from the tonsils of all pigs were 
PCR-negative for L. intracellularis DNA during postmortem examination. Positive results 
by use of the PCR were less frequently found in tissues of the ileum and colon obtained 
from vaccinates (2/15 [13%] and 1/15 [7%], respectively), compared with results for ileum 
and colon obtained from challenge-control pigs (4/10 [40%] and 3/10 [30%], respectively). 
Evaluation of the variables used to determine primary efficacy revealed that the 
mean scores for macroscopic lesions were significantly lower for the ileum (PcO.OOl) and 
colon (P<0.05) in the vaccinates (1.5 and 1.0, respectively) than in the unvaccinated 
challenge-control group (3.6 and 2.0, respectively). Mean score for macroscopic lesions of 
the ileum and colon in the vaccinates was similar to the score in the unvaccinated, 
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unchallenged negative-control group (Table 1). The IHC evaluation of ileum and colon 
tissues revealed a significantly (P<0.001) higher number of Lawsonia-specific lesions in the 
challenge-control group (mean score for ileum, 2.4; mean score for colon, 1.5), compared 
with the vaccinates (mean score for ileum, 0.4; mean score for colon, 0.0). Mean score for 
microscopic lesions of the ileum and colon in vaccinates was similar to the mean score of 
those tissues in the unchallenged negative-control group. 
Experiment 2 
Analysis of clinical observations did not reveal significant differences among 
vaccinates (orally administered via drench or delivery in water supply) and challenge-
control pigs during the experiment. Mean initial weight for vaccinates via drench, 
vaccinates via water supply, challenge-control pigs, and negative-control pigs was 5.5, 5.5, 
5.4, and 5.4 kg/pig, whereas mean final weight for each group was 26.7, 26.0, 24.9, and 
27.3 kg/pig. Daily weight gains were numerically higher for pigs vaccinated via drench but 
not significantly different from values for the challenge-control pigs during the experiment. 
However, during days 21 to 42, average daily weight gain of the challenge-control group 
(0.49 kg/pig) was significantly (P<0.05) lower than that of the water-delivery vaccinates 
(0.55 kg/pig). 
Fecal shedding of L. intracellularis became detectable by use of the PCR assay on 
day 28 (7 days after challenge exposure) in 4 of 20 (20%) challenge-control pigs. On day 
35 of the experiment, significantly (P<0.05) more PCR-positive pigs were evident in the 
challenge-control group (14/20, 70%) than in the water-delivery and drench vaccinates 
Table 1. Mean ± SE scores for macroscopic and microscopic lesions in samples of ileum and colon obtained from 3 groups* of 
pigs in experiment 1 
Group 
Pigs per 
group 
M 
Group 
identification 
t Average 
macroscopic lesion 
scores (ileum) 
t Average 
macroscopic lesion 
scores (colon) 
^Average 
microscopic lesion 
scores (ileum) 
t Average 
microscopic lesion 
scores (colon) 
1 15 Vaccinates 1.5 (±0.19)' 1.0 (±0.0)' 0.4 (±0.19)' 0.0 (±0.0)' 
2 10 Challenge 
Controls 
3.6 (±0.22)" 2.0 (±0.39)" 2.4 (±0.34)" 1.5 (±0.43)" 
3 10 Negative 
Controls 
1.1 (±0.1 )a 1.0 (±0.0)a 0.0 (±0.0)' 0.0 (±0.0)' 
* Groups consisted of pigs vaccinated by oral administration of an avirulent live vaccine of Lawsonia intracellularis on day 0 
and challenge exposed on day 21 with virulent heterologous L. intracellularis (vaccinates), pigs that were orally administered 
culture medium on day 0 and challenge exposed on day 21 with virulent heterologous L. intracellularis (challenge-control 
pigs), and pigs that were orally administered culture medium on day 0 and were not challenge exposed (negative-control 
pigs). 
^Macroscopic lesions were scored on a scale from 1 (normal) to 4 (severe thickening). 
^Microscopic lesions were scored on a scale from 0 (normal) to 3 (severe-diffuse). 
a,b Like letters indicate no significant difference (p>0.05). 
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(2/20 [10%] and 6/20 [30%], respectively). On day 42, significantly (P<0.05) more PCR-
positive pigs were again evident in the challenge-control group (15/20, 75%) than in the 
water-delivery and drench vaccinates (2/20 [10%] and 4/20 [20%], respectively). 
All pigs were seronegative on the basis of analysis of serum samples obtained 
during the 3 weeks before and at the time of challenge exposure. Seroconversion first 
became apparent on day 28 of the experiment. At that time, 4/20 (20%) pigs in the drench-
vaccinate group were seropositive, whereas anti-Lawsonia IgG antibodies were not detected 
in the serum samples obtained from any other group, including the challenge-control group. 
On day 35, the proportion of seropositive pigs was 3 of 20 (15%) for water-delivery 
vaccinates, 9 of 20 (45%) for drench vaccinates, 4 of 20 (20%) for challenge-control pigs, 
and 0 of 13 (0%) for unvaccinated, unexposed negative-control pigs. On day 42, the 
proportion of seropositive pigs was 4 of 20 (20%) for water-delivery vaccinates, 10 of 20 
(50%) for drench vaccinates, 12 of 20 (60%) for challenge-control pigs, and 0 of 13 (0%) 
for unvaccinated, unexposed negative-control pigs. On days 35 and 42, there were no 
significant differences among both groups of vaccinates and challenge-control pigs with 
regard to the proportion of seropositive pigs. 
Lawsonia-specific PCR testing for tissue colonization yielded negative results for 
the tonsils and mesenteric lymph nodes. On day 42, the proportion of ileum samples with 
positive results when tested by use of the Lawsonia-specific PCR assay was 0 of 20 (0%) 
for water-delivery vaccinates, 2 of 20 (10%) for drench vaccinates, 4 of 20 (20%) for 
challenge-control pigs, and 0 of 13 (0%) for unvaccinated, unchallenged negative-control 
pigs. On day 42, the proportion of colon tissues with positive results when tested by use of 
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the La wson /a- spec ific PCR assay was 1 of 20 (5%) for water-delivery vaccinates, 4 of 20 
(20%) for drench vaccinates, 4 of 20 (20%) for challenge-control pigs, and 0 of 13 (0%) for 
unvaccinated, unchallenged negative-control pigs. No significant differences among groups 
were detected for L. intracellularis tissue colonization by use of the PCR assay. 
Evaluation of the primary variables used to determine vaccine efficacy revealed that 
in the challenge-control group, mean scores for macroscopic lesions was significantly 
(P<0.05) higher (i.e., lesions were more severe) in the ileum (2.55) and colon (0.75) than in 
those tissues for either the water-delivery (0.2 and 0.2, respectively) or drench (0.6 and 0.2, 
respectively) vaccinates. Similarly, the proportion of samples with positive results for the 
Lawsonia-sptcific IHC analysis and the mean scores for microscopic lesions in the ileum 
was significantly (P<0.05) lower in both vaccinate groups, compared with values for the 
challenge-control pigs (Table 2). Mean scores for microscopic lesions in the colon were 
significantly (P<0.05) reduced in both vaccinates groups (water delivery, 0.15; drench, 
0.25), compared with the mean score for the challenge-control group (0.7). 
Discussion 
Results of these experiments document that oral administration of an avirulent live 
vaccine against L. intracellularis by direct drench or via drinking water to young pigs 
provides substantial amounts of protection against subsequent challenge exposure with 
virulent heterologous L. intracellularis. This was confirmed by a significant (P<0.05) 
reduction in development of lesions as indicated by the prevalence and severity of 
Table 2. Mean ± SE scores for microscopic lesions and percentage of tissues with positive results for immunohistochemical 
(IHC) analysis by use of Lawsonia-specific monoclonal antibodies in samples of ileum and colon obtained from 4 
groups* of pigs in experiment 2 
Group 
Pigs per 
group 
(") 
Group 
identification 
t Average 
microscopic lesion 
scores 
(ileum) 
% IHC positive 
(ileum) 
f Average 
microscopic 
lesion 
scores (colon) 
% IHC positive 
(colon) 
1 20 Water 
Delivery 
0.30 (±0.18)a 15a 0.15 (±0.1 l)a 10'" 
2 20 Oral Drench 0.65 (±0.25)' 30' 0.25 (±0.18)'"" 10'" 
3 19** Challenge 
Controls 
2.32 (±0.29)" 79" 0.70 (±0.29)" 35" 
4 13 
Strict 
Controls 0.0 (±0.0)' ()"' 0.0 (±0.0)' 0° 
* Groups consisted of pigs vaccinated by oral administration of an avirulent live vaccine of Lawsonia intracellularis on day 0 via 
addition to the water supply and challenge exposed on day 21 with virulent heterologous L. intracellularis (vaccinates-water 
delivery), pigs vaccinated by direct oral drench administration of a 2-mL volume to each pig and challenge exposed on day 21 
with virulent heterologous L. intracellularis (vaccinates-drench), pigs administered culture medium on day 0 and challenge 
exposed on day 21 with virulent heterologous L. intracellularis (challenge-control pigs), and pigs that were not administered 
vaccine or culture medium and were not challenge exposed (strict-control pigs). **One ileum sample had inflammation and 
fibrosis indicative of proliferative enteropathy and as a result, mucosal crypts had been shed and could not be evaluated. 
tMicroscopic lesions were scored on a scale from 0 (normal) to 3 (severe-diffuse). 
a b,c Within a column, values with different superscript letters differ significantly (P<0.05) 
° Group not included in the statistical analysis of percentage IHC positive samples. 
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macroscopic and microscopic lesions in the ileum of vaccinated pigs. Significant (P<0.05) 
higher average daily weight gains (experiment 2) and reduced fecal shedding of 
L. intracellularis (experiments 1 and 2) were also detected in vaccinated pigs after 
challenge exposure. 
Vaccinates did not shed or seroconvert during the period prior to challenge 
exposure; however, we did not begin to collect samples until 7 days after vaccination. It is 
possible that collection of samples prior to day 7 or improved PCR assays may reveal 
shedding in vaccinates prior to day 7 after vaccination. However, the lack of detectable 
L. intracellularis in the feces of all vaccinated pigs during the 3-week period after 
vaccination suggests that the isolate used in the live avirulent orally administered vaccine is 
not likely to have a great potential to spread to other pigs via the feces. It is common for 
avirulent bacterial isolates to have a reduced capacity for replication in the host and, hence, 
a reduced ability to spread to penmates.21 This compares to virulent isolates, including 
those of L. intracellularis, which typically are adapted to maximize their animal-to-animal 
spread and can attain high amounts of organisms in the feces.17'21'23 Analysis of results of 
these studies on shedding of vaccine isolates of L. intracellularis suggests that this 
organism also fits the pattern of bacterial adaptation and virulence. Therefore, feces from 
vaccinates should not be considered a reliable source of useful material from which to 
obtain vaccine isolates. The lack of detectable seroconversion following vaccination in 
both of the experiments reported here was consistent with our experiences involving this 
vaccine isolate and was not an unexpected result for oral versus parenteral administration of 
vaccine. In these experiments, seroconversion was not necessary for protecting vaccinated 
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pigs from disease, suggesting that nonhumoral factors stimulated by vaccination are perhaps 
more important for immunity to L. intracellularis. 
A general advantage of the use of an avirulent live vaccine is that the efficacy and 
duration of immunity are usually superior to those for inactivated vaccines, because the 
host's immune system is exposed to all of the antigenic properties of the organism in its 
native state. Specifically for intracellular bacterial agents such as L. intracellularis, a live 
avirulent vaccine offers excellent protection for vaccinated animals because of a complete 
T-cell-based immune response, possibly in conjunction with a complete humoral or 
mucosal immune response.17 This response develops even with administration of small 
doses of avirulent agent and is in contrast with the variable or poor immunity associated 
with the use of subunit or killed vaccine types for intracellular bacteria.14'15 This is also true 
for obligate intracellular bacteria (Chlamydia spp) that cause pathogenic infections within 
mucosa.12'13 Challenge exposure of pigs via oral administration of live L. intracellularis 
consistently leads to intracellular infection in the crypt epithelial cells of the intestinal 
mucosa.2'4 Many studies10'11 22 have also revealed that mucosal macrophages immediately 
beneath the intestinal epithelium regularly have intracellular infections attributable to 
Lawsonia sp during the active infection phases. This infection of macrophages implies a 
clear exposure of the host's immune system to L. intracellularis and presentation of its 
antigens to other components of the immune system in the intestinal mucosa and beyond, 
probably via a Thl-based immune response typical of that to intracellular organisms.13 In a 
clinical study17 of pigs orally exposed to wild-type Lawsonia sp or to another live avirulent 
vaccine isolate, investigators determined that pigs developed intestinal infections and cell 
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mediated T-cell responses in a similar manner. The B cell or humoral and mucosal 
antibody responses of pigs to L. intracellularis infection have been characterized in several 
studies.9'11'18'26'27 Similar to most bacterial infections, an initial IgM antibody response is 
followed by a peak of IgG antibody concentrations with a subsequent decrease during the 
next few weeks. In most cases of acute hemorrhagic proliferative enteropathy, the IgG peak 
is much higher and its subsequent decrease is much slower than in animals with the chronic 
form of the disease.24'27 Mucosal infection is associated with a high amount of IgA mucosal 
antibody." Therefore, both T- and B-cell responses are associated with the development of 
protective immunity in pigs infected with L. intracellularis. A study13 that investigated 
immunity developed against other intracellular bacteria revealed that the T-cell response is 
the more active response for inducing actual immune protection, although local antibody 
responses are also likely to be important in the target mucosa. 
Possible immunogenic sites on L. intracellularis have not been fully explored. A 
wide range of outer membrane proteins and glycoproteins have been identified in initial 
studies.1'4 Some of these were found on bacteria located in the intestines in pigs with 
natural infections.28'29 One of these surface antigens was characterized and cloned in a 
subsequent study, but its exact role in the immune process in natural infection is not 
clear.28'29 Detailed studies14'15'30'31 of several other intracellular bacteria have established 
that single antigen peptides used in vaccines are highly unlikely to produce a meaningful or 
protective immune response in animals, compared with the excellent protection afforded by 
use of whole live avirulent bacteria. 
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The vaccine isolate of L. intracellularis used in the experiments reported here 
(B3903) originated from an acutely infected pig in Denmark, whereas the challenge isolate 
(N101494) originated from a pig born in the United States that was afflicted with the same 
form of disease (hemorrhagic proliferative enteropathy). Therefore, the respective 
L. intracellularis isolates used in our experiments were separated by a time frame of 3 years 
and a distance of thousands of miles. Despite these differences, genomic and proteomic 
analysis of L. intracellularis indicated that it is a single strain or monotypic organism with 
no variant strains yet detected.1'3 This is also consistent with the suggestion that 
L. intracellularis is a recently evolved intracellular organism that has had a large genetic 
shift from its free-living Desulfovibrio family ancestors.1'3 The difficulty of culturing 
virulent L. intracellularis precluded the use of challenge exposures with a wide range of 
heterologous organisms. However, we consider that heterologous protection was achieved 
in these initial controlled experiments. 
Some of the reasons to investigate vaccination via a water-delivery system are 
concerns about stress and injury to pigs, amount of human-animal contact time, costs, and 
labor (including possible difficulties with full compliance and injury to humans 
administering the vaccine). These factors are frequently seen as a result of numerous 
vaccinations to each pig in a herd, compared with the ease and consistency of 
administration of vaccine via the drinking water. Additional advantages of oral 
administration of vaccine via drenching of each animal or for a herd via the water supply 
include elimination of the possible transmission of major blood-borne infections (e.g., 
porcine reproductive and respiratory syndrome virus) via multiple-use needles.32 Oral 
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administration of vaccine would reduce concern among meat retailers about injection-site 
reactions or broken needles retained in carcasses after attempted injections.33 Methods for 
mass vaccination have been widely and effectively used on poultry farms for many years, 
and we speculate that they will become more widely used on swine farms as the number of 
pigs per farm increases. An additional possible benefit of an effective vaccine against 
L. intracellularis is that the total antibiotic usage for prevention and treatment of 
proliferative enteropathy on swine farms may be reduced. It is possible that antibiotic use 
could be reduced considerably if this endemic disease could be controlled through use of 
vaccines alone or vaccines used in combination with strategic, periodically administered 
feed-additive antibiotics rather than constant use of feed-additive antibiotics. 
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CHAPTER 4. MATERNAL ANTIBODY EXPOSURE AND VACCINATION 
WITH AN ORAL A VIRULENT LIVE LAWSONIA INTRACELLULARIS 
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Abstract 
The efficacy of a vaccination strategy applied at or after weaning for subsequent 
enteric diseases entails assessment of whether maternal (passive) immunity present after 
weaning could interfere with protective vaccinal (active) immunity. Our primary objective 
in this study was to assess vaccine efficacy in piglets with maternal antibodies against 
proliferative enteropathy (PE, ileitis). Secondly, we assessed whether passive immunity 
alone protects piglets against PE. Results demonstrated vaccine efficacy in piglets born 
from both Lawsonia-mxive and hyperimmune sows indicating that vaccination is efficacious 
even in the face of maternal immunity when administered to maternally positive pigs at 3 
weeks of age. Furthermore, results suggest passive immunity provides some protection in 
piglets against virulent challenge exposure for at least six weeks after birth. We concluded 
1 Corresponding author (jkroll@bi-vetmedica.com). 
2 Boehringer Ingelheim Vetmedica Inc., 2501 North Loop Drive, Ames, IA 50010, USA. 
3 QAF Industries, Redlands Road, Corowa, NSW 2646, Australia. 
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that administering a live, attenuated Lawsonia intracellularis vaccine (Enterisol® Ileitis) to 
piglets with maternal immunity did not reduce the overall efficacy of the vaccine. 
Introduction 
Proliferative enteropathy (PE, ileitis) is a common enteric disease of pigs 
worldwide, caused by the obligate intracellular bacterium, Lawsonia (L.) intracellularis 
(McOrist et al., 1993 and 1995). The characteristic pathologic feature is a proliferation of 
immature enterocytes in the intestinal crypts of the ileum and colon. These cells contain the 
1.5 |J.m long, vibroid shaped L. intracellularis bacteria within their apical cytoplasm 
(Rowland and Lawson, 1974). In many cases, these bacteria can also be visualised within 
macrophages located in the lamina propria between crypts, and in mesenteric lymph nodes 
(Frisk and Wagner, 1977; Roberts et al., 1980). Genome and protein analysis of 
L. intracellularis indicates a remarkably homogenous "single strain," suggesting that this 
agent only recently evolved in a large genetic shift from its Desulfovibrio family ancestors 
(McOrist et al., 1995). The clinical signs in affected post-weaned animals can include 
diarrhea and uneven weight gain of varying degree. In pigs older than 12 weeks, a more 
acute clinical course can occur, with the proliferative lesions accompanied by rapid onset of 
diffuse haemorrhages from the affected mucosa, leading to melanemia and sudden death 
(McOrist and Gebhart, 1999). The prevalence and economic costs of the disease are rising 
in Europe possibly due to factors such as a recent reduction in the use of in-feed antibiotics 
(Stege et al., 2000; McOrist et al., 2003). 
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The in vitro culture and primary causative role of L. intracellularis in all forms of 
PE was established in 1993 (Lawson et al., 1993; McOrist et al., 1993). In the development 
of potential L. intracellularis vaccines, an oral attenuated vaccine was the formulation most 
likely to be effective for L. intracellularis (Kroll et al., 2004). Ingestion of 
L. intracellularis by intestinal mucosal macrophages, specific humoral, cell-mediated and 
mucosal responses and antigen-related mitogenesis of pig blood lymphocytes all occur 
following oral infection (Roberts et al., 1980; McOrist et al., 1992; McOrist and Lawson, 
1993; Knittel et al., 1998; Guedes and Gebhart, 2003). Pigs exposed orally to 
L. intracellularis-infected fecal material were considered to have developed protective 
immunity in previous on-farm studies (Love and Love, 1977). Also, protective immunity to 
infection by other pathogenic intracellular bacteria, such as Brucella sp or Chlamydia sp, 
has only been convincingly demonstrated following appropriate delivery of whole live 
attenuated bacteria (Su et al., 2000, Morrison and Caldwell, 2002). Killed or subunit 
vaccine approaches to these agents have been far less successful, despite many attempts. 
An attenuated live vaccine formulation of Lawsonia intracellularis was therefore 
developed (Enterisol® Ileitis, Boehringer Ingelheim Vetmedica, Inc.) and tested in 
controlled challenge studies to evaluate the efficacy of this orally delivered vaccine (Kroll 
et al., 2004). The efficacy of a vaccination strategy applied at or after weaning for enteric 
diseases entails assessment of whether maternal immunity present after weaning could 
interfere with the onset of protective immunity. Therefore, the primary objective of this 
study was to evaluate efficacy against PE in vaccinated pigs derived from hyperimmunized 
sows. Secondly, maternal immunity was assessed in pigs derived from hyperimmune sows 
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for protective immunity against PE. Lastly, a safety assessment was performed to 
determine the effects of an attenuated live L. intracellularis vaccine on pregnant sows after 
repeated oral administrations during gestation. 
Materials and Methods 
General study requirements 
This study was conducted according to the International Cooperation on 
Harmonization of Technical Requirements for Registration of Veterinary Products (VICH) 
guidelines of Good Clinical Practices (GCP). In addition, this study was conducted in a 
double blind approach in which the group treatment identities were not disclosed to the 
study monitor or the study investigators until sample processing, laboratory testing, data 
compilation and statistical analysis was complete. The care and use of test animals in this 
study complied with the USDA guidelines set forth in the Code of Federal Regulations 
No. 9. When necessary, animals were euthanised using a humane, professionally acceptable 
method (electrocution) as per the 2000 Report of the American Veterinary Medical 
Association Panel on Euthanasia. 
Test animals 
Sixteen healthy pregnant sows in their second trimester of gestation were acquired 
for this study. The source herd from which the sows were chosen from had not been 
recently vaccinated or treated with medication for any reason and had no recent clinical 
history of L. intracellularis infection. Regardless, each pregnant sow was determined 
negative for L. intracellularis by Lawsonia-specific polymerase chain reaction (PCR) and 
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serum analysis (immunofluorescence antibody test, IFAT) prior to the first treatment. Upon 
farrowing, a total of 100 viable and healthy piglets were randomly chosen for participation 
in the study from hyperimmunized and placebo-administered sows and subjected to a 
complete serological and fecal shedding analysis as previously mentioned. 
Study design 
Prior to study initiation, 16 healthy, pregnant and L. intracellularis negative sows 
were randomly allocated into 2 groups; 8 hyperimmunized (Group A) and 8 placebo-
administered controls (Group B). On Days -55, -35 and -14 prior to farrowing, each sow in 
Group A was hyperimmunized with commercially available Enterisol® Ileitis by direct oral 
drench. The administration of the vaccine dose by this method involved applying the 
vaccine to the posterior portion of the oral cavity using a sterile, plastic 10 ml syringe. The 
control group (Group B) received an equivalent dose of placebo consisting of uninfected 
McCoy cells suspended in growth medium. Hyperimmunization of pregnant sows in 
Group A was performed in an attempt to induce a high level of maternal immunity prior to 
farrowing. Each pregnant sow group was housed in separate rooms to avoid cross 
contamination and under the same conditions (temperature, ventilation, and pen size). 
Sows in each room were kept in the same pen. 
Although efforts were made by the study investigator to have uniform conception 
and farrowing dates, sows did not all farrow on the same day. Instead, farrowing occurred 
during a 10-day period. To prevent having multiple vaccination and challenge dates which 
could lead to excessive variability among pig groups in the study, the mean date of farrow 
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during the farrowing period was established as Day 0 of the study. Thus, pigs were 3 weeks 
± 5 days of age at the time of vaccination (Day 21). 
On Day 21, one hundred healthy, weaned piglets were sorted by litter and randomly 
assigned to six treatment groups. Housing restrictions and conditions were similar to the 
sow groups mentioned above. Piglets derived from hyperimmunized sows (Group A) were 
randomly assigned to Groups 1 through 3 and were identified as "hyperimmune-derived" 
piglets for the remainder of the study. Piglets derived from control sows (Group B) were 
randomly assigned to Groups 4 through 6 and were identified as "placebo-derived" piglets 
for the remainder of the study. Groups 1 and 4 (20 pigs/group, respectively) were given a 
single 2-ml dose of Enterisol® Ileitis by direct oral drench. Groups 2 and 5 (20 pigs/group, 
respectively) were given an equivalent dose of placebo (uninfected McCoy cells + media). 
Groups 3 and 6(10 pigs/group) were designated "strict negative controls" which did not 
receive a vaccine or placebo treatment and were not challenged during this study. On Day 
22, after the weaning period, sows were humanely euthanized and necropsied for 
evaluations of intestinal lesion development due to PE. 
On Day 42 of the study, Groups 1, 2, 4 and 5 received 1 x 107'3 TCID^/dose of 
heterologous virulent pure culture L. intracellularis isolate N101494 via intragastric 
gavage. All piglets were examined daily 21-days post challenge for clinical symptoms 
related to PE; diarrhea, behavior and body condition and were given a score of 1 to 4 
dependent on severity (1 = clinically normal; 4 = severe illness). Pigs were weighed on 
Days 21, 42 and 63 of the study to calculate an average daily weight gain per pig group. 
Average daily weight gains (ADWG) were calculated to analyse the effects of treatment in 
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relation to normal growth performance in pigs. Pigs were initially weighed to obtain a 
baseline average group weight prior to receiving a vaccine or placebo treatment. All groups 
were found to be uniform in size (variation of <0.63 kg/pig). The first key ADWG 
evaluation period among groups occurred from Day 21 (vaccination) to Day 42 (challenge 
exposure) to measure the immediate effects of vaccination or placebo inoculation. The 
second evaluation period was from Day 42 to 63 (necropsy) to measure the effects of 
challenge exposure with a virulent pure culture L. intracellularis. 
On Day 63 of the study, all pigs were humanely euthanized and necropsied for 
evaluations of intestinal lesion development due to PE. A summary of the experimental 
design is illustrated in Chart 1. 
Gross pathology 
Gross pathological lesions indicative of PE were evaluated as a primary parameter 
for determining vaccine efficacy against virulent L. intracellularis challenge. Gross 
examination of each ileum and colon was conducted for the degree of thickening and 
folding of the mucosa by an investigator blinded to the pig group. Gross lesions were 
scored according to the severity of mucosal thickening; 1 = normal, 2 = mild thickening, 
3 = moderate thickening-inflammation, 4 = severe thickening-inflammation, 5 = severe 
thickening-inflammation and mucosal haemorrhaging (blood present), 6 = necrosis. Mean 
scores for gross lesions were calculated for group comparisons. 
Chart 1. Summary of treatment allocation and the experimental study design 
Pig # Pigs / Sow Pig Treat­ Treatment Route Day Challenge Route Day of Day of 
Group Group Treatment ment ID of Chall. Study Term. 
Vacc. 
1 20 Vaccine Vaccine Enterisol® Oral 21 Lawsonia IG 42 63 
(Sow Grp. A) Ileitis drench intracellularis 
N101494 
2 20 Vaccine Placebo McCoy Oral 21 Lawsonia IG 42 63 
(Sow Grp. A) cells drench intracellularis 
N101494 
3 10 Vaccine None None None None None None None 63 
(Sow Grp. A) 
4 20 Placebo Vaccine Enterisol® Oral 21 Lawsonia IG 42 63 
(Sow Grp. B) Ileitis drench intracellularis 
N101494 
5 20 Placebo Placebo McCoy Oral 21 Lawsonia IG 42 63 
(Sow Grp. B) cells drench intracellularis 
N101494 
6 10 Placebo None None None None None None None 63 
(Sow Grp. B) 
131 
Histology 
Samples 2 to 4 cm in length of ileum and colon were fixed in 10% buffered 
formalin, embedded in paraffin wax, after which 5 |im thick sections were cut in duplicate. 
One section was Hematoxylin and Eosin (HE) stained and examined for crypt cell 
proliferation, inflammatory response, crypt abcessation, and a possible reduction in the 
number of goblet cells. Another unstained section of each ileum and colon was used in an 
immunohistochemical (IHC) procedure for L. intracellularis, incorporating an indirect 
immunoperoxidase stain based on a mouse monoclonal antibody (McOrist et al., 1987). For 
this procedure, each section was dewaxed, rehydrated, rinsed with demineralised water 
(dHiO) and PBS and digested with 0.06% trypsin in PBS. Endogenous peroxidase activity 
was blocked by incubation with 3% HiOo in PBS for 30 min at 20°C. Non-specific 
antibody binding was prevented by pre-incubation with 20% normal goat serum (Dako, 
Denmark) for 60 min at 20°C. Sections were then incubated with the IG4 Lawsonia-
specific monoclonal antibody (McOrist et al., 1987) 1:800 for 30 min, then goat-anti-
mouse-biotin (Dako) 1:200 for lb, then streptavidin-horseradish peroxidase (Dako) 1:200 
for lh, all at 20°C. The slides were washed with PBS between each step. After a rinse with 
dH20, enzyme substrate of 0.03% HiOo and 0.05% aminoethyl carbazol in 0.01 M sodium 
acetate buffer, pH 5.2, was added, and then sections were counterstained with Mayer's 
hematoxylin (Dako), washed and mounted. The IHC stained ileum and colon sections were 
scored individually on the level of severity of L. intracellularis infection and microscopic 
lesion development; 0 = normal, 1 = mid-focal, 2 = moderate-diffuse and 3 = severe-
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diffuse). Mean scores for microscopic lesions and the frequency of lesions detected in the 
affected tissues were calculated for group comparisons. 
DNA-isolation from feces and mucosal samples 
Epithelial cells from the ileum and colon mucosa were obtained by scraping the 
mucosa of each ileum with a sterile microscope slide. These samples and fecal swabs were 
place in Nalgene micro-centrifuge tubes containing 200 [xl of reagent buffer A 
(IsoQuick™). From each of these samples genomic DNA was extracted using reagents and 
procedures outline in the IsoQuick™ DNA extraction kit (Orca Laboratories, Inc). 
PGR 
For all DNA extractions from feces, ileum mucosa or colon contents, the DNA 
template was incorporated into PGR reactions incorporating specific primers to 
L. intracellularis as described by Jones et al. (1993). 
Immunoassays 
Serum samples from the blood of each sow and pig were tested for the presence of 
IgG antibodies against L. intracellularis by the immunofluorescence antibody test (IFAT) 
using fixed whole Lawsonia antigen on 96-well polystyrene microliter plates and FITC-
labelled antibodies directed against porcine IgG (Knittel et al., 1998). Sows were bled at 
Day -54, -35, -14 and 0 (farrowing) to determine the rate of seroconversion due to 
hyperimmunisations with Enterisol® Ileitis. Pig blood samples, 6-10 ml each, were 
collected weekly from the farrowing period (Day 0) to study termination (Day 63). Percent 
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IFAT positives were calculated for group comparisons to determine the level of IgG 
maternal antibodies present from birth through vaccination and the frequency of 
seroconversion in pigs due to vaccination or challenge exposure. 
The IF A test was modified slightly by using FITC-labelled antibodies directed 
against porcine IgM and IgA. This modified serological procedure was used to detect these 
antibodies in addition to IgG in each sow's colostrum for determining the concentration of 
different Lawsonia-specific immunoglobulins present at the time of farrowing. Colostrum 
was collected from each sow in Groups A and B immediately before piglets were allowed to 
suckle during the farrowing period. The colostrum was diluted 2-fold in duplicate in PBS 
and transferred (100 |il/well) to two sets of Lawsonia coated 96-well plates as mentioned 
above. The inoculated plates were allowed to incubate for 30 minutes at 37°C then, washed 
3 times with PBS. An anti-swine IgM or IgA FITC-conjugated antibody (Kirkegaard and 
Perry Laboratories, Inc.) previously diluted 1:200 in PBS was added to the plates and then, 
incubation and wash steps were repeated. The titer of each specific anti-Lawsonia antibody 
was detected using UV microscopy. Percent IFAT positives and mean titer values for each 
immunoglobulin were calculated for group comparisons to determine the frequency and the 
level of IgG, IgM and IgA colostrum antibodies present among sows. 
Data analysis 
Key study parameters including gross and microscopic lesions, clinical scores, fecal 
shedding, tissue colonization, weight gain, and seroconversion were statistically analysed. 
In addition, the following group comparisons were performed to analyse single study 
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parameter measurements to meet the defined study objectives: Group 1 vs. 2 to determine 
if maternal antibodies present in Lawsonia positive piglets interfere with vaccine efficacy, 
Group 2 vs. 5 to evaluate the potential maternal immunity derived in Lawsonia positive 
piglets compared to Lawsonia negative pigs, Group 4 vs. 5 to determine vaccine efficacy in 
vaccinated Lawsonia negative pigs compared to non-vaccinated Lawsonia negative control 
pigs and Group 1 vs. 4 to compare efficacy of the vaccine in piglets derived from sows with 
a positive or negative background for Lawsonia. A summary of treatment allocations to pig 
groups is illustrated in Chart 1. 
Vaccine efficacy was demonstrated in pigs by significant (p<0.05) reductions in the 
primary parameters; gross and microscopic lesion development. Group average gross and 
microscopic (IHC) lesion scores were statistically analysed by mixed model split plot 
ANOVA and %2 tests. Average clinical scores and weight gains were also analysed by 
mixed model split plot ANOVA among pig groups. Non-parametric study parameters such 
as tissue colonization (PGR), fecal shedding (PCR) and seroconversion (IFAT) were 
analysed by use of %2 or Monte Carlo tests. 
Results 
General observations 
Test animals receiving a vaccination or placebo treatment did not endure any direct 
adverse reactions caused by to the vaccine, placebo or administration procedures throughout 
the study. Sows that were hyperimmunized with vaccine did not have any adverse reactions 
to the vaccine or administration procedures throughout the gestation or farrowing periods. 
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Clinical observations (diarrhea, behavior, and body condition) among sow or piglet 
treatment groups (prior to challenge) did not reveal any significant differences. Pigs in 
Groups 3 and 6 (strict controls) were negative for L. intracellularis as determined by IFAT, 
PCR or IHC analysis throughout the study and confirmed the validity of the pig source and 
the clinical evaluations. 
Maternal antibody detection 
Lawsonia intracellularis-specific IgG, IgA and IgM antibodies were detected in the 
sera and colostrum of sows in Group A (hyperimmunized) during the farrowing period. 
Sixty three percent (5/8 sows) of Group A sows were serum antibody positive for anti-
Lawsonia IgG antibodies while 0% (0/8) of the sows in Group B were positive at farrowing. 
In addition, serum IgG antibodies were detected in piglets derived from Group A sows only 
from farrowing (Day 0) to 5 weeks of age (Day 28), see Figure 1. Anti-Lawsonia IgG, IgA 
and IgM were detected in the colostrum of Group A sows at 50%, 75% and 12.5%, 
respectively. Average antibody titers in the colostrum samples of Group A sows were 1:14 
(IgG, range = 1 to 1:64), 1:10 (IgA, range = 1 to 1:32) and 1:4 (IgM, range 1 to 1:4). Sows 
in Group B did not have any detectable IgM or IgG mt\-Lawsonia antibodies in their 
colostrum during this time period. One pig in sow Group B was positive for IgA at a titer 
of 1:16. 
Seroconversion in piglets to L. intracellularis 
Lawsonia-specific antibody detection by IFAT in pigs due to passive transfer from 
hyperimmune sows or exposure to vaccine and challenge are summarized in Figure 2. Pigs 
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Figure 1. Percentages of maternally derived anti-Lawsonia IgG antibodies (IFAT) in the 
offspring of sows hyperimmunized orally with an avirulent L. intracellularis 
vaccine or placebo. Boxed percentage values represent mean IFAT positives 
from pigs in Groups 1 through 3. Unboxed percentage values represent mean 
IFAT positives from pigs in Groups 4 through 6 
in the strict control group (Group 6) that were derived from Lawsonia-negative sows 
(Group B) were IFAT negative throughout the study. However, Group 3 strict control pigs 
derived from hyperimmunized sows (Group A) were IFAT positive for Lawsonia-specific 
IgG antibodies on Days 0, 7, 14, 21 and 28 of the study (10%, 30%, 30%, 20%, and 30%, 
respectively). 
Hyperimmune-derived pigs in Groups 1 and 2 were IFAT positive ranging from 
10% to 35% on Days 0 to 14 of the study. On Day 21 (vaccination), these pigs were IFAT 
positive for mti-Lawsonia IgG antibodies at 10% and 15%, respectively. Low levels of 
positive seroconversion to L. intracellularis continued to be detected via IFAT one week 
137 
100 
Group 1 
80 
*- Group 2 
-A- Group 3* 
0) Vaccination Challenge -X— Group 4 
V) 
O 
OL 
< 
LL 
2 60 
40 
0 
Farrow Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 Day 49 Day 56 Cay 63 
<t> (J) °° O °° x « x x <t> uj O 
Figure 2. Rates of maternal antibody (IgG) detection and seroconversion to 
L. intracellularis (IFAT) among piglet treatment groups. 
Treatment Key: Group 1 = Sow A-vaccinate, Group 2 = Sow A-placebo, Group 
3 = Sow A-strict controls, Group 4 = Sow B-vaccinate, Group 5 = Sow 
B-placebo, Group 6 = Sow B-strict controls. 
x Overall comparison is not significantly different. 
^ Group 1 and 2 comparison is significantly (p<0.05) different. 
00 Group 2 and 5 comparison is significantly (p<0.05) different. 
° Group 1 and 4 comparison is significantly (p<0.05) different. 
Group 3 and 6 were not included in the statistical analysis 
after vaccination (Day 28) in Groups 1 and 2 (15% and 20% respectively) but then were 
IFAT negative until 2 weeks after challenge exposure (Day 56) in which 5% of the pigs in 
Group 2 only were IFAT positive. On the last day of the study, low levels of IFAT 
positives were detected in these groups at 11% and 40%, respectively. 
Placebo-derived pigs in Groups 4 and 5 was IFAT negative until Day 42 (challenge) 
when 5% of Group 4 pigs that received the vaccine treatment on Day 21 were IFAT 
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positive. On Day 49, one week post challenge exposure, both groups were IFAT positive at 
10% and 5%, respectively. Rates of seroconversion continued to increase in Group 4 (20% 
and 25%, respectively) and Group 5 (11% and 50%, respectively) at two and three weeks 
post challenge exposure (Days 56 and 63, respectively). 
Significant (p<0.05) differences in percent IFAT positives among Group 1 and 2 
pigs were evident on Day 63 of the study only. Significantly (p<0.05) more IFAT positives 
were detected in Group 1 compared to Group 4 at farrowing, Day 7 and 14 of the study. 
Group 1 had significantly (p<0.05) less IFAT positive pigs than Group 4 on Day 56 only. 
Groups 2 and 5 comparisons revealed significantly (p<0.05) more IFAT positives in Group 
2 on Day 7 and 14 of the study. 
Vaccine efficacy in Lawsonia-miive pigs 
Pigs derived from Group B sows (controls) were first analysed to confirm that the 
pig source was susceptible to virulent L. intracellularis challenge. Secondly, a comparison 
of Group 4 (vaccinated) and Group 5 (non-vaccinated) piglets which were derived from 
Lawsonia-negative sows was conducted to evaluate the efficacy of the vaccine against 
virulent L. intracellularis challenge. 
Average gross and microscopic lesion scores among all groups are summarized in 
Table 1. Group 5 had 77% of the pigs positive for Lawsonia-specific lesions in the ileum 
and colon compared to only 7.5% of the pigs in Group 4. Group 4 pigs had significantly 
(p<0.05) lower gross and microscopic (IHC) average lesion scores in the ileum and colon 
compared to Group 5 at Day 63 of the study. 
Table 1. Average gross and microscopic (IHC) lesion scores among treatment groups 
Group 
Sow 
treatment 
Pig 
treatment 
Average gross 
lesion scores 
(Ileum) 
Average gross 
lesion scores 
(colon) 
Average IHC scores 
(Ileum) 
Average IHC 
scores (colon) 
1 Hyperimm. Vaccinated 0.16ab 0.26* 0.35* 0.15" 
(Sow A) (±0.09) (±0.18) (±0.2) (±0.11) 
2 Hyperimm. Non-vaccinated 0.85^ 0.45 0.70e 0.55' 
(Sow A) (±0.24) (±0.22) (±0.26) (±0.23) 
3 Hyperimm. Strict controls 0.00* 0.00* 0.00* 0.00* 
(Sow A) 
0.15ad 0.05"^ 0.15"^ 4 Placebo Vaccinated 0.05^ 
(Sow B) (±0.08) (±0.05) (±0.11) (±0.3) 
5 Placebo Non-vaccinated 2.35^ 0.80" 2.42^ 1.35'^ 
(Sow B) (±0.39) (±0.29) (±0.19) (±0.3) 
6 Placebo Strict controls 0.00* 0.00* 0.20* 0.00* 
(Sow B) (±0.2) 
a Group 1 and 4 comparison is not significantly different. 
b Group 1 and 2 comparison is significantly (p<0.05) different. 
c Group 2 and 5 comparison is significantly (p<0.05) different. 
d Group 4 and 5 comparison is significantly (p<0.05) different. 
° Group not included in the statistical analysis. 
( 1 Standard Error 
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Fecal PCR results among all test groups are summarized in Figure 3. No detectable 
shedding of L. intracellularis in the feces by PCR was evident in either group on Days 21 
(vaccination) to 35 of the study. Group 4 pigs were initially fecal PCR positive on Day 42 
(challenge) and remained positive until Day 63 (study termination) with 5% to 25% of the 
pigs shedding L. intracellularis during this time period. In comparison, Group 5 pigs were 
Group 2 
Group 4 
Challenge Group 5 
Vaccination 
Figure 3. Rates of L. intracellularis fecal shedding (PCR) among piglet treatment groups. 
Treatment Key: Group 1 = Sow A-vaccinate, Group 2 = Sow A-placebo, Group 
4 = Sow B-vaccinate, Group 5 = Sow B-placebo. 
x Overall comparison is not significantly different. 
03 Group 2 and 5 comparison is significantly (p<0.05) different. 
0 Group 4 and 5 comparison is significantly (p<0.05) different. 
* Groups 3 and 6 not shown due to being PCR negative for Lawsonia throughout 
the study and therefore, not included in the statistical analysis. 
Note: No significant differences among Groups 1 vs. 2 and 1 vs. 4 in fecal 
shedding during this study 
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initially fecal PCR positive on Day 49 with 15% to 72% of the pigs' shedding 
L. intracellularis until Day 63 of the study. Significantly (p<0.05) less fecal shedding was 
detected by PCR after receiving a virulent challenge in Group 4 compared to Group 5 on 
Days 56 and 63 of the study (5%, 10% and 42%, 72%, respectively). However, Group 4 
pigs (25%) had significantly (p<0.05) more fecal PCR positives than Group 5 (0%) on the 
day of challenge exposure (Day 42). 
Tissue PCR results of ilea samples revealed significantly (p<0.05) more 
colonization of L. intracellularis in Group 5 pigs (45%) compared to Group 4 (5%) on Day 
63 of the study. The mesenteric lymph nodes and colon samples were tissue PCR positive 
(5% and 10%, respectively) for L. intracellularis in Group 5 pigs only. No detection of 
Lawsonia DNA was found in the tonsils of either group. 
Average weight gain comparisons among all test groups are summarized in Table 2. 
Average initial weights were uniform among Groups 4 and 5 on Day 21 (vaccination) with 
pigs weighing 6.44 and 6.10 kg/pig, respectively. No significant difference in ADWG 
among Groups 4 (0.44 kg/pig) and 5 (0.41 kg/pig) from Day 21 (vaccination) to Day 42 
(challenge). However, significantly (p<0.05) higher ADWG was evident in Group 4 pigs 
(0.51 kg/pig) than Group 5 pigs (0.40 kg/pig) during the 21-day evaluation period from Day 
21 (challenge) to Day 63 (study termination). 
Maternal protection 
The comparison of unvaccinated, control pigs in Group 2 (pigs derived from sow 
Group A) to Group 5 (pigs from sow Group B) was conducted to evaluate the potential of 
Table 2. Average daily weight gains among treatment groups 
Average initial weight ADWG ADWG 
Sow Pig (kg) on Day 21 to 42 (kg) Day 21 to 42 (kg) 
Group treatment treatment Day 21 vaccination challenge 
1 Hyperimm. Vaccinated 6.53* 0.41* 0.45' 
(Sow A) (±0.83) (±0.03) (±0.0.3) 
2 Hyperimm. Non-vaccinated 6.35" 0.4* 0.46^ 
(Sow A) (±0.68) (±0.0.4) (±0.05) 
3 Hyperimm. Strict controls 6.71* 0.46* 0.52* 
(Sow A) (±0.8) (±0.07) (±0.07) 
4 Placebo Vaccinated 6.44* 0.44* 0.51c-e 
(Sow B) (±0.62) (±0.03) (±0.03) 
5 Placebo Non-vaccinated 6.08* 0.41* 0.4^ 
(Sow B) (±0.79) (±0.05) (±0.06) 
6 Placebo Strict controls 6.35* 0.45* 0.5* 
(Sow B) (±0.89) (±0.05) (±0.04) 
a Overall comparison is not significantly different. 
b Group 1 and 2 comparison is significantly (P<0.05) different. 
c Group 1 and 4 comparison is significantly (P<0.05) different. 
d Group 2 and 5 comparison is significantly (P<0.05) different. 
e Group 4 and 5 comparison is significantly (P<0.05) different. 
° Group not included in the statistical analysis. 
( f Standard Error 
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maternal protection against virulent L. intracellularis exposure derived from sows 
hyperimmunized with vaccine (Group A sows). 
Average gross and microscopic lesion scores among all groups are summarized in 
Table 1. Pigs in Group 5 (77%) had a higher percentage of Lawsonia-specific lesions in the 
ileum and colon than Group 2 pigs (27.5%). Group 2 pigs had significantly (p<0.05) lower 
average gross lesion scores in the ileum and average microscopic (IHC) lesion scores in the 
ileum and colon compared to Group 5 at Day 63 of the study. 
No detectable shedding of L. intracellularis in the feces by PCR was evident among 
Groups 2 and 5 on Days 21 (vaccination) to 42 (challenge) of the study, see Figure 3. 
Groups 2 and 5 were initially fecal PCR positive beginning on Day 49 and remained 
positive until Day 63 (study termination) with 5% to 25% and 15% to 72%, respectively, of 
the pigs shedding L. intracellularis during this time period. Significantly (p<0.05) less 
fecal shedding was detected by PCR in Group 2 (25%) compared to Group 5 (72%) on Day 
63 of the study. 
A higher percentage of tissue PCR positives were found in the ilea of pigs in Group 
5 (45%) compared to Group 2 (25%) at Day 63 of the study. Pigs in Group 2 were PCR 
negative for L. intracellularis in the tonsil, mesenteric lymph node and colon. Various PCR 
positives were observed in the colon and mesenteric lymph tissue of Group 5 pigs as 
mentioned above. 
Average weight gain comparisons among all test groups are summarized in Table 2. 
Average initial weights were uniform among Groups 2 and 5 on Day 21 (vaccination) with 
pigs weighing 6.35 and 6.10 kg/pig, respectively. No significant difference in ADWG 
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among Groups 2 (0.40 kg/pig) and 5 (0.41 kg/pig) from Day 21 (vaccination) to Day 42 
(challenge). However, significantly (p<0.05) higher ADWG was evident in Group 2 pigs 
(0.46 kg/pig) than Group 5 pigs (0.40 kg/pig) during the 21-day evaluation period from Day 
42 (challenge) to Day 63 (study termination) of the study. 
Vaccine efficacy in hyperimmune-derived pigs 
The comparison of pigs vaccinated with Enterisol® Ileitis in Group 1 to 
unvaccinated, control pigs in Group 2 was conducted to confirm that vaccination in the face 
of maternal immunity could be accomplished by evaluating protective immunity against PE 
after vaccination of pigs at 3 weeks of age. Both groups of pigs were derived from sows 
hyperimmunized with vaccine (Group A sows). Furthermore, primary and secondary 
efficacy parameters were analysed between vaccine-treated pigs of Group 1 and Group 4 to 
determine if vaccine efficacy is similar against virulent L. intracellularis challenge. 
Average gross and microscopic lesion scores among all groups are summarized in 
Table 1. Pigs in Group 2 (27.5%) had a higher percentage of Lawsonia-specific lesions in 
the ileum and colon than Group 1 (12.5%). Group 1 pigs had significantly (p<0.05) lower 
average gross lesion scores (ileum) and numerically lower average microscopic (IHC) 
lesion scores (ileum and colon) compared to Group 2 at Day 63 of the study. In addition, 
there were no significant differences among average gross and microscopic lesion scores or 
lesion severity in pigs receiving a vaccination (Groups 1 and 4). 
No detectable shedding of L. intracellularis in the faeces by PCR was evident in 
either group (1 or 2) on Days 21 (vaccination) to 35 of the study, see Figure 3. Group 1 pigs 
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were initially fecal PCR positive on Day 42 (challenge) and remained positive until Day 63 
(study termination) with 11 % to 16% of the pigs shedding L. intracellularis during this time 
period. Pigs in Group 2 were initially fecal PCR positive on Day 49 and remained positive 
until Day 63 (study termination) with 5% to 25% of the pigs shedding L. intracellularis 
during this time period. Pigs in Group 4 were not PCR positive for Lawsonia DNA until 
Day 42 (challenge) and remained positive until Day 63 (study termination) with decreasing 
rates of shedding from 25% to 5%. No evidence of a significant difference in the rates of 
fecal shedding of L. intracellularis between Groups 1 and 2 and Groups 1 and 4 during the 
study. 
A slightly higher percentage of tissue PCR positives were found in the ilea of pigs in 
Group 2 (25%) compared to Group 1 (20%) at Day 63 (study termination) of the study. A 
lower frequency of tissue PCR positives was evident in Group 4 (5%) than Groups 1 and 2 
at study termination. No significant differences in PCR positives were noted among Groups 
1 and 2 and Groups 1 and 4, respectively. Pigs in all three groups were PCR negative for 
L. intracellularis in the tonsil, mesenteric lymph node and colon. 
Average weight gain comparisons among all test groups are summarized in Table 2. 
Average initial weights were uniform among Groups 1 and 2 on Day 21 (vaccination) with 
pigs weighing 6.53 and 6.35 kg/pig respectively. Uniform average weights were also 
observed among Groups 1 and 4 on Day 21 (6.53 kg/pig and 6.44 kg/pig, respectively). No 
significant difference in ADWG among Groups 1 (0.40 kg/pig) and 2 (0.41 kg/pig) or 
among Groups 1 and 4 (0.44 kg/pig) from Day 21 (vaccination) to Day 42 (challenge). 
Significant differences (p<0.05) in ADWG was evident in Group 1 pigs (0.45 kg/pig) 
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compared to Group 4 pigs (0.51 kg/pig) during the 21-day evaluation period from Day 21 
(challenge) to Day 63 (study termination). No significant differences in ADWG among 
Groups 1 and 2 were noted from Day 21 to Day 63 in this study. 
Pregnant sow safety 
Although not the primary study objective, safety in pregnant sows due to 
hyperimmunisation with Enterisol® Ileitis was evaluated among Groups A and B in this 
study. Sows in Groups A and B was fecal PGR negative for L. intracellularis after 
receiving vaccine or placebo on Days -55, -35 and -14 of the study. Moreover, the ilea and 
colon samples from these animals were tissue PGR negative for L. intracellularis at Day 22 
(termination of the sow analysis portion) of the study. Gross and histological analysis 
reveal no evidence of L. intracellularis or lesions suggestive of PE in the intestines of sows 
in Groups A or B at Day 22 of the study. Despite the fact that vaccine was administered 
during the 2nd and 3rd trimesters of pregnancy, no abnormal general health observations 
were recorded for any sow during the study. Farrowing results between Groups A and B 
was also very similar with an average of 9.4 and 7.6 live born pigs in each group, 
respectively. Group A sows had an average of 1.8 stillborn pigs per litter and no mummies 
or farrowing mortalities. Group B sows had an average of 0.9 stillborn pigs per litter, 0.1 
mummies, and 0.1 pigs that died for various reasons at farrowing. Diagnostic evaluation of 
these stillborn pigs indicated they were L. intracellularis negative. 
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Discussion 
Comparison of the various groups of pigs in the second phase of this study indicates 
that the avirulent live L. intracellularis vaccine applied at three weeks of age was effective 
in protecting naïve piglets, born from Lawsonia-negative sows, from a virulent challenge at 
6 weeks of age (Group 4 vs. 5). Group 4 pigs had significantly (p<0.05) less prevalence and 
severity of gross and microscopic (IHC) lesion development in the ileum and colon 
compared to Group 5 pigs. This confirms previous reports (Kroll et al., 2004) that 
Enterisol® Ileitis provides efficacious protection after a single oral administration in naïve 
pigs. The non-vaccinated, control pigs (Group 5) were affected with PE of varying severity; 
3 pigs had gross pathology indicative of acute PE (mucosal haemorrhaging, blood-filled 
lumen) while the rest had lesions ranging from mild to severe thickening of the terminal 
ileum and colon reflective of subclinical or chronic PE. The specific lesions present in 
Group 5 confirms studies done by several others in validating use of the L. intracellularis 
pure culture challenge model in this study which recognized experimental replication of all 
syndromes of PE in pigs (McOrist et al., 1993, Guedes et al., 2003, Schwartz et al., 1999). 
The results of this study also indicate that maternal immunity passed to offspring by 
a Lawsonia-positive sow (Group A) is not likely to cause significant interference with 
efficacy of this oral vaccine and subsequent protection from virulent challenge in vaccinated 
piglets (Group 1 vs. 2). Significantly (p<0.05) less gross lesion development occurred in 
the ileum of vaccinated pigs (Group 1 ) compared to non-vaccinated control pigs (Group 2) 
post mortem. This finding was substantiated by numerically higher average microscopic 
lesion scores in the ileum and colon in Group 2 pigs. There appears to be no significant 
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difference in vaccine efficacy against PE for pigs with or without maternal immunity 
(Group 1 vs. 4). Vaccination of pigs derived from hyperimmune sows did not significantly 
differ in their level of protection against virulent challenge compared to L. intracellularis-
negative, vaccinated pigs. Although average gross and microscopic intestinal lesion scores 
were slightly higher among vaccinates in Group 1 than Group 4, both provided significant 
(p<0.05) protection against L. intracellularis infection compared to their respective control 
groups (Groups 2 and 5). 
Lactogenic antibodies were present in the colostrum from Group A sows. This 
observation is supported by the presence of systemic IgG antibodies detected in some of 
these pigs beginning on the day of farrowing, through the weaning period and up to 5 weeks 
of age. In addition, significant (p<0.05) differences in gross and microscopic lesion 
development in the comparison of control Groups 2 and 5, demonstrated that residual 
maternal immunity protected some piglets in Group 2 from virulent challenge at 6 weeks of 
age. Various concentrations of Lawsonia-specific IgG, IgA and to a lesser extent, IgM were 
found in the colostrum of hyperimmunized sows (Group A) suggesting that these particular 
immunoglobulins may play a role in maternal protection against L. intracellularis infections 
in weanlings. It is interesting to note that on the day of challenge (Day 42), all pig groups 
but one, Group 4, were seronegative by IFAT. Seroconversion due to vaccination was 
slightly evident in Group 4 with only 1 pig (5%) IFAT positive. This observation confirms 
that IFAT positives in Groups 1 through 3 were maternal antibody derived and likely not 
due to vaccination. These observations may imply that the serological assay used in this 
trial does not provide an accurate indicator of vaccination and immunity against virulent 
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L. intracellularis exposure. Pigs in all groups were seronegative on Day 35 (2 weeks after 
vaccination) suggesting that maternal antibodies may have decayed to undetectable levels 
between Day 28 and 35 of the study when pigs were 5 to 6 weeks of age. 
Pig farms in Europe typically operate on a single farm site, with various ages of pigs 
within the same perimeter fence and few barriers for the movements of fecal material 
around the farm. This system is known to be associated with exposures and onset of 
L. intracellularis infections around 1 to 2 months after weaning, a peak of clinical signs and 
lesions early in the grower-finisher period, and serologic evidence of infection among many 
breeding-age animals (M0ller et al., 1998; McOrist et al., 1999; Stege et al., 2000; Chouet 
et al., 2003). It is therefore likely that many pigs at least 6 weeks old will be exposed to 
virulent L. intracellularis, as evaluated here through a controlled challenge exposure study. 
It is also likely that piglets at three weeks of age on many European farms will be exposed 
to maternal antibodies to L. intracellularis, which will persist for some weeks after 
weaning, depending on the amount originally ingested. Neonatal piglets ingest maternal 
antibodies, particularly IgG but also other bioactive compounds including IgA and IgM 
through colostrum intake; their levels of plasma IgG are directly related to their colostral 
IgG intake (Rooke and Bland, 2002). In some cases, the presence of lactogenic IgG 
antibodies in piglets is thought to render parenteral vaccines given to those piglets 
ineffective for pathogenic enteric infections (Bertschinger et al., 2000). 
The results of this study indicate that these antibodies will not substantially interfere 
with use of the oral live attenuated vaccine approach for L. intracellularis when 
administered to pigs derived from hyperimmune sows at 3 weeks of age. This finding is not 
150 
entirely unexpected for this type of vaccine in post-weaned pigs. Consistent protection of 
pigs from virulent post-weaning Escherichia coli strains such as oedema disease F18 has 
only been convincingly demonstrated in piglets which received a specific vaccine delivered 
orally around the time of weaning (Bertschinger et al., 2000). This is despite the presence 
of lactogenic immunity in these piglets at the time of their vaccination. The enhanced 
efficacy of oral vaccines delivered to piglets for post-weaning enteric infections, even in the 
face of lactogenic immunity, may be due to the an enhanced ability of mucosal surfaces of 
these piglets to bind and process orally delivered antigens (Weltzin et al., 1989; 
Bertschinger et al., 2000). Given the etiologic nature of L. intracellularis as a mucosal 
intracellular pathogen and the use of an avirulent live vaccine, cellular immunity may play a 
greater role in controlling PE (Guedes and Gebhart, 2003; Kroll et al., 2004). 
Most previous challenge exposure studies of L. intracellularis infections have been 
performed in recently weaned pigs derived from "clean" farms having Lawsonia-negative 
sows. In these situations, virulent oral challenge by L. intracellularis is followed by 
mucosa infection of the ileum and onset of acute or chronic PE lesions following 2 to 3 
weeks after initial exposure (Mapother et al., 1987; McOrist et al., 1993; Schwartz et al., 
1999). In contrast, use of this oral live attenuated L. intracellularis vaccine itself is not 
linked to development of any lesions in both sows and piglets. The exact nature of vaccinal 
stimulation of a pig's immune system is not yet clear, but clearly involves some antigen 
processing as IHC analysis of intestinal tissue shortly after immunization revealed 
Lawsonia vaccine antigen internalized by macrophages (Kroll, unpublished data). The 
recent successful use of an attenuated L. intracellularis vaccine across North America and 
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in controlled challenge exposure studies suggests that colonization of avirulent isolates can 
provide potent immunity to the agent (Kroll et al., 2004). This immunity was observed here 
as vaccinated pigs regardless of sow source had significant (p<0.05) reductions in tissue 
colonization and lesion development compared to non-vaccinates after virulent challenge. 
Shedding of L. intracellularis in vaccinated pigs (15% to 25% PCR +) prior to 
challenge indicates that the live oral vaccine isolate used has the potential to shed, but at 
very low levels. It is usual for attenuated bacterial isolates to have a somewhat reduced 
capacity for replication in the host, and hence a reduced ability to spread to sentinels (Jones 
et al., 1993). This compares to virulent isolates, which normally are adapted to maximise 
their animal-to-animal spread, including L. intracellularis, which can attain high levels in 
faeces (Guedes and Gebhart, 2003; Jones et al., 1993; Smith and McOrist, 1996). This 
challenge exposure study of L. intracellularis suggests that it also fits this pattern of 
bacterial adaptation and virulence. 
Average weight gains and fecal shedding (PCR) were monitored to support the 
efficacy of the attenuated live L. intracellularis vaccine. These secondary efficacy 
parameters revealed that immunized pigs increased ADWG and reduced levels of shedding 
L. intracellularis in the feces compared to unvaccinated pigs after virulent challenge; a 
trend consistent with previous studies (Kroll et al., 2004). Significant (p<0.05) reductions 
in fecal shedding were evident in vaccinated pigs (Group 4) compared to unvaccinated, 
control pigs (Group 5) at 2 and 3 weeks after challenge exposure. Vaccinates derived from 
hyperimmunized sows (Group 1) weren't significantly different than Group 2 pigs in the 
percentage of fecal PCR positives during the same time period. We speculate that maternal 
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immunity in these groups reduced the ability of the virulent challenge to sufficiently infect 
and reach high levels of antigen in the feces post challenge. Pigs gained significantly 
(p<0.05) more weight daily in Group 4 (0.51 kg/pig) compared to the unvaccinated, controls 
(Group 5, 0.4 kg/pig) verifying that vaccination of Lawsonia-ndive. pigs increases ADWG 
after challenge exposure. No evidence of significant differences in ADWG among 
maternally positive Groups (1 and 2) was observed throughout this study. Maternal 
protection among these groups may have been enough to allow uniform increases in weight 
gains after receiving virulent challenge. Group 4 vaccinates (0.51 kg/pig) had significant 
(p<0.05) increases in ADWG compared to Group 1 vaccinates (0.45 kg/pig) after challenge 
however, the mean difference in average weight gain was only 0.06 kg/pig. Even though 
the ADWG among these groups significantly differed, the comparisons among lesion 
development did not. This observation may be explained by the slightly higher incidence of 
L. intracellularis colonization and lesion development involved in Group 1 vaccinates 
compared to Group 4 vaccinates at Day 63 of the study. 
The normal reproductive and health performance of sows given three high doses of 
the live avirulent vaccine in the second and third trimester of gestation indicates an 
excellent safety profile. This is in contrast to virulent L. intracellularis infections in field 
situations, where acute haemorrhagic proliferative enteropathy in pregnant sows often 
causes spontaneous abortions (McOrist and Gebhart, 1999). 
In conclusion, this study demonstrates that maternal immunity does provide some 
level of protection to pigs born from hyperimmune sows. Oral vaccination in the face of 
this passive immunity induces a protective, acquired immune response equivalent to that of 
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a Lawsonici-n'àivz pig. In addition, this study demonstrated sow safety to repeated exposure 
of an avirulent live L. intracellularis vaccine during gestation. 
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CHAPTER 5. A LIPOPOLYSACCHARIDE BASED ENZYME-LINKED 
IMMUNOSORBENT ASSAY FOR EXPERIMENTAL USE IN 
DETECTION OF ANTIBODIES TO LAWSONIA INTRACELLULARIS IN PIGS 
A paper published in the Clinicial and Diagnostic Laboratory Immunology 
J. J. Kroll,1'2 M.A. Eichmeyer,1 M. L. Schaeffer,1 
S.McOrist3, D.L. Harris,4 and M. B. Roof1 
Abstract 
An enzyme-linked immunosorbent assay (ELISA) for Lawsonia intracellularis was 
developed and compared with a whole cell antigen based immunofluorescence antibody test 
(IFAT). The antigen containing lipopolysaccharide (LPS) was derived from Percoll 
gradient purified cultures of L. intracellularis using a modification of the Westphal hot 
phenol procedure. The antigen was bound directly to polystyrene 96-well microtiter plates 
and the assay performed in an indirect ELISA format. Specificity and sensitivity values 
based on 80 known positive and 80 known negative serum samples from controlled 
experimental trials were 93.7% and 88.7%, respectively. Serological results from a 
controlled L. intracellularis challenge exposure study confirmed the high specificity and 
sensitivity of this assay (100% and 99.5% respectively). Comparisons between the LPS-
ELISA and the IFAT in detecting mti-Lawsonia antibodies in this controlled study revealed 
significantly more LPS-ELISA positive pigs than IFAT positives on Days 21, 28, 35 and 42 
1 Department of Research and Development, Boehringer Ingelheim Vetmedica, Inc., 
2501 North Loop Drive, Ames, Iowa 50010. 
2 Corresponding author. Phone: 515 296 6625. E-mail: jkroll@bi-vetmedica.com. 
3 QAF Industries, Corowa, NSW 2646, Australia. 
4 Iowa State University, Ames, Iowa 50011. 
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(p = 0.003, 0.030, 0.002 and 0.006, respectively). This indirect ELISA (LPS-ELISA) test is 
an improved method in detecting antibodies soon after exposure to L. intracellularis in pigs 
regardless of isolate type (vaccine or wild-type) in experimental studies. The LPS-ELISA 
may be used as a tool to support future research trials on vaccine efficacy and to further 
understand the immune response induced by L. intracellularis. 
Introduction 
Proliferative enteropathy (PE) is a common enteric disease of pigs after weaning that 
is caused by the obligate intracellular bacterium, Lawsonia intracellularis (20, 21). The 
infection and disease are widespread in pig farms across America and Europe and 
prevalence among groups of pigs on these affected farms can be over 30% (4, 23, 29, 31). 
This leads to a considerable economic impact of the disease due to diarrhea, weight loss and 
subclinical illness in growing pigs (22, 31). Since identification of L. intracellularis as the 
cause of PE in 1993, a number of studies aimed at establishing the best diagnostic methods 
for identifying Lawsonia exposure in live animals have been conducted. These have 
focused on DNA detection via Polymerase Chain Reaction (PCR) of feces and whole-cell 
immunoassays (8, 12, 13, 15, 17), due to extreme difficulty in isolation of the obligate 
intracellular L. intracellularis from the contaminated environment of feces (13, 17, 18). In 
situations where samples of ileum are available, immunohistochemistry (IHC) is considered 
to provide the criterion-referenced or "gold standard" for assessment of the actual infection 
status of an individual pig (9, 16, 19, 26, 28). 
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PCR testing of fresh feces involves considerable laboratory effort and cost to extract 
amplifiable bacterial DNA from each sample (9, 11, 13, 15). False positives due to pre-
laboratory sample contamination along with collecting numerous samples from a group of 
pigs, or due to contamination during the laboratory testing phase may occur. False 
negatives due to the regular presence of PCR inhibitors in feces may also occur (9, 10, 11). 
Serologic testing methods have therefore also been widely explored for detecting 
L. intracellularis exposure in pigs. Indirect immunoflourescence or immunoperoxidase 
assays have been used to examine antibody responses in pigs infected experimentally with 
L. intracellularis in virulent challenge exposure studies and in pigs with PE from farms (3, 
4, 7, 11, 14, 29). An indirect enzyme-linked immunosorbent assay (ELISA) was developed 
previously for testing pig serum antibodies, with crude antigen derived directly from pig 
intestines affected with PE (12). However, the antigen used in that study was not fully 
characterized for L. intracellularis content. The development of a specific L. intracellularis-
antigen based ELISA would therefore be of considerable benefit in improving the feasibility 
of a more universally available and standardized diagnostic assay to study the epidemiology 
of this economically significant disease. 
We describe the development of an ELISA for detecting L. intracellularis infection, 
based on a lipopolysaccharide antigen extract in an indirect ELISA format. 
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Materials and Methods 
Bacterial antigen preparation 
The LPS used in this study was derived from L. intracellularis isolate #15540. This 
isolate was acquired from a Danish sow affected with acute hemorrhagic proliferative 
enteropathy (confirmed by routine histology and immunohistochemistry staining 
techniques), whose intestines were co-cultured to obtain a pure culture of L. intracellularis 
by methods previously described (18, 21). Multiple 30 L batches of L. intracellularis 
#15540 (ATCC #PTA-4927) were propagated using fresh McCoy cell (ATCC #1696) 
suspensions in bioreactors (Applicon, Inc., Foster City, CA). Active cultures were allowed 
to reach 80-100% cell infectivity and then, harvested by centrifugation using an Avanti 
Beckman J-20I centrifuge, JA-10 rotor at 17,000 g for 15 minutes at 4°C. The supernatants 
of each batch were discarded and cell pellets containing both harvested extracellular 
L. intracellularis and McCoy cells infected with L. intracellularis were resuspended in 
30 ml sterile 0.2 M phosphate-buffered saline (PBS) at pH 7.3 and stored at -80°C. 
For purifying L. intracellularis from McCoy cells, a discontinuous Percoll gradient 
was prepared following methods previously described with slight modifications (12). 
Briefly, 225 ml of Percoll (Amersham Biosciences, Uppsala, Sweden) was mixed with 
260 ml of distilled water and 15 ml of 5M NaCl to form the stock Percoll gradient. 
Harvested L. intracellularis culture was passed at least 20 times through a 25 Ga. needle 
and 5 ml of this bacterial/McCoy cell homogenate was mixed with 25 ml of the stock 
Percoll gradient in polycarbonate tubes. Tubes were then centrifuged at 37,000 g for 1 h at 
4°C. The ensuing suspension contained scattered cellular debris in the upper 50% of the 
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tube while one distinct cellular banding pattern was visualized at a buoyant density of 
1.075 g/ml. This band was carefully collected into a 5 ml polypropylene pipette and 
transferred to new tubes containing 20 ml of sterile PBS. These tubes were centrifuged 
(Avanti Beckman J-20I, JA-17 rotor) at 37,000 g for 15 minutes at 4°C and this washing 
process was repeated 3 times to remove Percoll material from each sample. After the final 
centrifugation step, the bacterial pellets were suspended in sterile PBS and aliquoted into 
1.8 ml cryovial tubes and stored at -80°C. Dark field microscopies of sampled material 
confirmed highly concentrated tiny curved rods and absence of intact McCoy cells. 
The LPS component was extracted from this purified L. intracellularis #15540 
antigen using a hot aqueous phenol method (Westphal method) with slight modification 
(34). Briefly, 4.5 ml of a pre-heated purified L. intracellularis suspension was gently mixed 
in a tube containing 4.5 ml of 90% v/v hot aqueous phenol suspension for 25 minutes at 
65°C, then cooled overnight at 4°C. Each tube was centrifuged at 7,700 g for 25 minutes at 
4°C and the LPS-containing supernatant fluid contained in the upper portion of the bi-
phasic aqueous layer within each tube was retained and transferred into pre-sterilized 
dialysis tubing. The tubing was then dialyzed repeatedly against cold reagent grade (reverse 
osmosis) water for 48 hours to remove the phenol. The L. intracellularis LPS extract was 
collected and centrifuged at 10,000 g for 15 minutes at 4°C to remove any remaining 
particulates and stored in sterile vials at -80°C. 
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Antigen characterization 
The LPS extract was analyzed by SDS-PAGE using a 4-12 % Bis-Tris gel in MOPS 
running buffer (Invitrogen) and compared to Percoll-purified whole-cell L. intracellularis 
and uninfected whole McCoy cells. Samples for SDS-PAGE were prepared by diluting 
each 1:2 into 4X lithium salt dodecyl sulfate denaturing buffer (Invitrogen) and incubated in 
an 85°C water bath for 10 minutes. Gels were periodate silver stained (30) using a slight 
modification of the commercially available Bio-Rad Silver Stain. Briefly, gels were 
oxidized with 0.7% periodic acid immediately after fixing and prior to the second fixation 
step (10% ethanol and 5% acetic acid), and an additional reduction step with 160 pM 
dithiothrietol (DTT) was included before the silver reagent step. In other experiments, the 
LPS extract was subsequently transferred from unstained SDS PAGE gels to polyvinylidene 
difluoride (PVDF, Invitrogen) membranes for Western blot analysis. The separated 
molecules were electrophoretically transferred in Towbin buffer using the Novex™ blot 
module at 30 V constant for 1 hour. After transfer, the blots were cut into strips and 
blocked for at least 1 hour in 50 ml of a blocking solution consisting of Tris-buffered saline 
with 0.05% Tween 20 (v/v) (TTBS) and 2% non-fat dry milk (w/v) (NFDM, BioRad). 
Blots were incubated with numerous primary antibody sources and dilutions; 1) LPS-ELISA 
positive control hyperimmunized pig serum (1:2500), 2) LPS-ELISA negative control pig 
serum (1:2500), 3) Swine anti-Lawsonia convalescent serum (1:10, 20, 100) and 4) Swine 
Lawsonia-negative convalescent serum (1:100) to illustrate the specificity of anti-Lawsonia 
antibodies to the primary antigen of the extract, Lawsonia LPS. The primary antibody 
dilutions used for this Western analysis were similar to those used in the LPS-ELISA. The 
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primary antibodies were diluted in the blocking reagent described above and incubated with 
each respective membrane at room temperature for 1 hour. The blots were washed three 
times for two minutes at room temperature in TTBS, after which the membranes were 
incubated in 50 ml of the secondary antibody conjugate (goat anti-swine horseradish 
peroxidase, Kirkegaard and Perry Laboratories, Inc.) at a 1:1000 dilution in blocking 
reagent for 1 hour at room temperature. The blots were washed twice in TTBS and once in 
PBS prior to incubation at room temperature for 30 minutes in 10 ml of Opti-4CN substrate 
(BioRad) solution. The colorimetric reaction was stopped by rinsing the blots with reagent 
grade (RG) water. 
Lastly, the LPS extract was analyzed for a specific concentration by the bacterial 
endotoxin test (BET) with the Limulus Ameobacyte Lysate assay (Endosafe™). The 
concentration of LPS within the extract was expressed as endotoxin units per ml (EU/ml) 
using the kinetic chromogenic method as described by the manufacturer's instructions. 
Optimization of the LPS-ELISA 
The ELISA was optimized following standard assay development procedures 
described elsewhere (6, 27). Concentrations of key reagents used in this LPS-ELISA such 
as the primary antigen (LPS extract), primary antibodies and HRP-conjugated secondary 
antibodies were optimized to achieve a desired and consistent working dilution using 
checkerboard titrations (6, 27). Other influencing factors key to assay success such as 
blocking and wash buffers, substrates, incubation temperatures and duration of incubation 
time periods were also evaluated according to standard procedures to achieve optimum 
levels (6, 27). 
LPS-ELISA for anti-Lawsonia IgG antibodies 
The Lawsonia intracellularis LPS at a concentration of 34.8 EU/ml was coated at 
100 ^l/well onto Immulon 2HB plates (Dynex) at a 1:1000 dilution in 0.05M sodium 
carbonate coating buffer, pH 9.6 (2) and incubated at 20°C for 24 hours. Each plate was 
then washed in a buffer containing 0.05% Tween 20 (v/v), 0.137 M NaCl, 0.005 M KC1, 
0.009 M NaaHPO/i, and 0.001 M KH2P04, pH 7.2 to 7.4, in distilled water. Antigen-coated 
plates were then blocked at 300 pi/well with a blocking buffer containing 5% (w/v) NFDM 
(Bio-Rad) in SeaBlock™ (Pierce Biotech) at 4°C for 24 hours to prevent non-specific 
binding of test serum to the plates. Each plate was then washed for 3 cycles as above. Each 
test and control serum sample was pre-diluted 1:40 in blocking buffer. Fifty (il per well of 
each diluted serum sample was incubated with antigen at 37°C for 1 hour. After 3 washing 
steps, 50 [il/well of a 1:500 dilution of goat anti-swine IgG heavy and light chain specific 
HRP conjugate (Kirkegaard and Perry Laboratories, Inc.) in blocking buffer was added and 
incubated at 37°C for 1 hour. After 3 washing steps, 50 p,l/well of peroxidase color 
substrate (3,3',5,5' tetramethylbenzidine) was applied to each plate and incubated at 20°C 
for 5 minutes then stopped with 2 M H2SO4 solution. Absorbance values at 450 nm 
wavelength (A45o) were obtained for each sample well. A range of control serum samples 
from high to low positive and negative antibodies against the L. intracellularis LPS extract 
were generated and included in each plate. Control sera were initially diluted 1:2560 in 
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blocking buffer and then, serially diluted 2-fold a total of 5 times (1:2,560, 5,120, 10, 240, 
20,480 and 40, 960) immediately prior to sample testing. A 50 (il aliquot of each diluted 
positive and negative control sample is transferred and typically placed in wells A through 
E in columns 11 and 12 of the test plate. A test plate was considered valid if the coefficient 
of determination (r-value) of these standards' A450 values were >0.9 in a linear regression 
analysis (Microsoft™ Excel), with empty wells reading blank. 
Serum samples derived from clinical pig trials 
Serum samples were obtained from pigs in the following studies for use in 
validating the LPS-ELISA: 
Study 1. Two 3-week-old Lawsonia-negative pigs were hyperimmunized for 
antibodies to the L. intracellularis LPS extract, by deep intramuscular injection with 2 ml of 
the L. intracellularis LPS extract mixed 1:2 with a commercial Freund's incomplete 
adjuvant (Sigma Aldrich). Another control 3-week-old pig received a placebo injection of 
cell culture medium containing 5% (v/v) bovine serum, mixed 1:2 with this adjuvant. 
Booster injections of each inoculum were administered 3 and 6 weeks post initial 
inoculation (p.i.) and final specimen collections were 8 weeks p.i. Serum samples of each 
pig were collected on Days 0, 21, 42 and 59 of the study and tested for presence and 
concentration of anti-Lawsonia IgG antibodies in an indirect immunofluorescence assay 
incorporating L. intracellularis whole cell antigen as described previously (IFAT) (15). 
Study 2. Challenge exposure studies with L. intracellularis isolates were conducted 
in Lawsonia-negative 6- to 9-week-old pigs as described previously (16, 33). Serum 
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samples from the virulent L. intracellularis challenge exposed and strict control pigs (non-
vaccinated, non-challenged pigs) in these studies were tested to investigate the cut-off limits 
for anti-Lawsonia LPS antibody positive/negative absorbance values. The Lawsonia IFAT 
was also conducted on these samples. 
Study 3. A "proof of concept" vaccine efficacy study was conducted following 
Good Clinical Practices (GCP) guidelines as previously reported (16). This study utilized 
conventional pigs that were Lawsonia-negative at the time of vaccination. On Day 0 of the 
study, vaccinates (n = 15) were given an oral 2 ml dose of Enterisol® Ileitis (Boehringer 
Ingelheim Vetmedica, Inc.) per manufacturer's label instructions while pigs in the challenge 
control group (n = 10) were given an equivalent dose of placebo consisting of uninfected 
McCoy cells in growth media. Strict control pigs were not given vaccine, placebo or 
virulent challenge during the study and were kept in separate pens to ensure biosecurity 
among treatment groups. On Day 21, vaccinated and challenge control pigs were given a 
10 ml intragastric dose of virulent L. intracellularis isolate N10194 at 107 7 Tissue Culture 
Infective Dose 50 (TCIDS0)/dose. On Day 42 of the study, pigs were humanely euthanized, 
necropsied and evaluated for Lawsonia specific gross and microscopic lesions. Average 
gross and microscopic lesion scores (IHC), average daily weight gains, seroconversion rates 
(IFAT), L. intracellularis fecal shedding rates (PCR) and average daily clinical scores after 
challenge of this clinical trial were previously reported (16). Serum samples were 
subsequently tested with the LPS-ELISA for direct comparison to the IFAT for differences 
in detecting mti-Lawsonia antibodies in vaccine and challenge exposed pigs. 
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Statistical Analysis 
Statistical comparisons in seroconversion among assays and treatment groups 
utilized Fisher's Exact T-test and Two Sample Test of Proportions (5, 25). Statistical 
determinations of positive and negative A4S0 cut-offs as well as assay sensitivity, specificity, 
95% confidence intervals and the area under the Receiver Operating Characteristic (ROC) 
curve was conducted with ROC curve analysis using Medcalc version 7.2.1.0. These 
additional parameters were observed to identify the assay's ability in detecting Lawsonia-
specific antibodies in pigs and to gauge the assay's ability to distinguish between Lawsonia-
exposed and Lawsonia-nsiive pigs. 
Results 
Characterization of the L. intracellularis LPS extract as the primary ELISA antigen 
The visualization of the L. intracellularis LPS component by the SDS-PAGE/ 
periodate silver staining of the LPS extract revealed a glycosylated molecule approximately 
18-25 kDa (Figure 1). Glycosylation was confirmed by the reddish staining imparted on the 
species via the reaction of aldehyde groups formed by periodate oxidation of the sugars with 
the silver reagent. This LPS fraction was differentially stained reddish-brown to 
specifically identify glycosylated moieties in comparison to other extracted components. 
The LPS was observed in the samples containing the LPS extract and whole cell 
L. intracellularis and not in the uninfected McCoy cell sample suggesting that this molecule 
is of prokaryotic origin. The periodate silver stained gel also revealed the presence of other 
higher molecular weight proteins that seem to appear at lower concentrations compared to 
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Figure 1. SDS-PAGE / Periodate Silver Staining of L. intracellularis LPS 
Lane 1: 10-220 kDa Benchmark™ pre-stained protein marker (Invitrogen) 
Lane 2: L. intracellularis LPS extract 
Lane 3: Whole cell L. intracellularis DK15540 
Lane 4: Uninfected McCoy cells 
Lane 5: Blank 
* Arrow indicates the migration range of L. intracellularis LPS 
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the LPS extract. These extraneous proteins perhaps are due to inadvertent carry-over of 
particulates from the biphasic layer during the purification step or they could be the results 
of incomplete degradation of proteins during the hot aqueous phenol phase of the LPS 
extraction. 
Western blots of the LPS extract were performed to determine the specificity of anti-
Lawsonia antibodies to the LPS component and to assess the degree of cross-reactivity to 
the extraneous proteins (Figure 2). Results of the Western blots demonstrated that the LPS-
ELISA negative control (1:2500) and Lawsonia-negative pig sera (1:100) did not react to 
any of the extraneous proteins in the LPS extract and reacted very lightly (weak signal 
strength) to the LPS component itself. Positive LPS-ELISA control sera (1:2500) reacted 
very strongly (strong signal strength) to the LPS component and to a lesser extent, the 
extraneous proteins. Slight cross-reaction of the positive control was expected since 
hyperimmunized pigs would have generated antibodies to both the LPS component and the 
extraneous proteins. However, the Western signal for this particular interaction was very 
light making up <1% of the total signal strength compared to the target LPS antigen. 
Additionally, Western analysis of the LPS extract to Lawsonia-positive convalescent pig 
serum at dilutions of 1:10, 1:20 and 1:100 revealed strong reactions to the LPS component 
whereas very light reactions were noted with the higher molecular weight extraneous 
proteins at 1:10 and 1:20 dilutions only (<1% of total signal strength). An extraneous 
protein of lower molecular weight than the LPS component (approximately 15 kDa) did 
react to Lawsonia-positive convalescent pig sera but represented only -9% of the total 
signal strength of the reaction compared to the LPS component. 
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Figure 2. Western blots of Lawsonia intracellularis LPS using ELISA control or positive 
and negative convalescent swine sera 
Each gel lane was loaded with the same amount of LPS material, and replicate 
lanes were cut into strips after transfer to PVDF for incubation with different 
primary antibodies. Secondary antibody in each case was goat anti-swine-HRP 
(1:1000). M, molecular weight marker. A) Lane 1, Strict Control Negative 
Serum (1:100); 2, ELISA Negative Control Serum (1:2500); 3, ELISA Positive 
Control Serum (1:2500); 4, Goat anti-swine-HRP conjugate only (1:1000); 
5, Silver stained SDS-PAGE gel. B) Primary antibody was swine anti-Lawsonia 
convalescent serum at different dilutions. Lane 1, 1:10; 2, 1:20; 3, 1:100 
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Results from the BET for quantifying the amount of endotoxin in the purified 
sample of L. intracellularis LPS extract revealed an endotoxin level of 34,750 EU/ml. 
Furthermore, the reagent grade water used to store the LPS extract contained <0.05 EU/ml 
thus indicating the buffer was endotoxin-free and provided no interference in obtaining the 
true endotoxin concentration of the LPS extract. 
Individual LPS-ELISA plate validation via hyperimmunized pig sera 
The positive LPS-ELISA control sera was generated from two 3-week-old 
Lawsonia-mg'dtive pigs hyperimmunized with Lawsonia LPS extract. The negative control 
sera were generated from one 3-week-old pig receiving adjuvant alone. Pigs that received 
an LPS extract inoculation were IE AT positive on Days 21, 42 and 59 of the study with 
mean anti-Lawsonia antibody titers 1:200, 1:16,000 and 1:16,000, respectively. Reactivity 
of the positive and negative control sera against the Lawsonia LPS antigen extract (1:1000) 
in the LPS-ELISA plates was confirmed by performing two-fold titrations in blocking 
buffer of each control across the plate. The positive control A450 value at a 1:40 dilution 
(optimal detection antibody dilution for this assay) was 1.9 and was determined to have a 
total anti-Lawsonia LPS endpoint titer of 1:10,000 to 1:20,000 by the LPS-ELISA. The 
negative control A450 value at a 1:40 dilution was <0.2. Linear regression analysis of the 
positive control demonstrated an r2 value of 0.96. Based on the linearity of the positive 
control, an individual LPS-ELISA assay is considered valid in detecting Lawsonia specific 
antibodies when each plate demonstrates an r2 value of 0.9 or greater. 
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Determination of cut-off limits 
One hundred and sixty pig sera samples from two L. intracellularis challenge 
exposure studies were evaluated to determine the anti-Lawsonia positive and negative 
antibody cut-off limits for the LPS-ELISA assay. In addition, these serum samples were 
used to determine assay specificity, sensitivity, 95% confidence intervals and the area under 
the ROC the curve analysis. Eighty pigs were previously identified to be positive for 
L. intracellularis by both IF AT and tissue IHC analysis (16, 33). Another eighty pigs from 
strict control (non-vaccinated, non-challenge exposed) and negative control (received a non-
Lawsonia placebo) groups were previously identified to be negative for L. intracellularis by 
the same detection methods (16, 33). 
A ROC curve analysis, a graph that plots the true positive rate in function of the 
false positive rate at different cut-off points, identified the critical cut-off criterion for these 
samples to be an A4S0 of >0.15 (Figure 3). This value was rounded to the nearest tenth of an 
A450 value to 0.2 to simplify future interpretations of LPS-ELISA results. Therefore, pig 
serum containing an A<so value of 0.2 or lower is considered Lawsonia antibody negative 
whereas serum containing an A450 higher than 0.2 is considered Lawsonia antibody positive. 
In addition, the ROC analysis revealed the specificity of this assay to detect anti-
Lawsonia antibodies in pigs was 93.7% and the sensitivity was determined to be 88.7% 
(Figure 3). The 95% confidence interval for this assay was 0.933 to 0.991 and the ROC 
under the curve analysis revealed a value of 0.972 with a standard error of 0.013. 
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Figure 3. Scatter Plot of the Mean A450 Values for Anti-Lawsonia Antibody Positive and 
Negative Sera Samples 
1. y-axis depicts mean A450 values 
2. x-axis depicts sample set identification (0 = negative, 1 = positive for anti-
Lawsonia antibodies) 
3. Dashed black line across A450 0.15 signifies the pos./neg. cut-off value 
LPS-ELISA validation in a controlled, L. intracellularis challenge exposed study 
Pigs in the strict control group remained L. intracellularis EFAT and LPS-ELISA 
negative through the study. From Day 0 (vaccination) to Day 14 (one week before 
challenge) of the study, vaccinated and unvaccinated, challenge control groups were IFAT 
and LPS-ELISA negative for anti-L. intracellularis antibodies. On Day 21 (challenge 
inoculation) of the study, all groups were IFAT negative (0%) whereas 53% of the 
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vaccinated pigs exhibited LPS-ELISA positives. One week after challenge (Day 28), again 
only the LPS-ELISA was able to detect specific seroconversion to <mi\-Lawsonia antibodies 
in both the vaccinated and challenge control groups (47% and 30%, respectively). On Days 
35 and 42 of the study, the number of pigs in both the vaccinated and challenge control 
groups gradually increased in seroconversion due to virulent L. intracellularis exposure. 
Serological results from Days 35 and 42 in the vaccinated pigs were 26.7% and 40% IFAT 
positive and 73% and 93% LPS-ELISA positive, respectively. The challenge control group 
was 10% and 80% IFAT positive and 60% and 90% LPS-ELISA positive at Days 35 and 
42, respectively. 
The seroconversion rates based on the LPS-ELISA identified significant (p<0.05) 
increases in percent anti-Lawsonia antibody positives in the vaccinate group compared 
challenge control and strict control pigs at Day 21, and compared to strict control pigs only 
on Days 28, 35 and 42 of the study. Non-vaccinated, challenge controls were significantly 
higher in % LPS-ELISA positives than the strict controls on Days 35 (p=0.001) and 42 
(pcO.OOO 1 ) of the study. No significant differences were noted between vaccinates and 
challenge controls on Days 35 and 42. Significant (p=0.02) increases in % IFAT positives 
to L. intracellularis challenge exposure were evident in vaccinated pigs compared to strict 
control pigs on Day 35 of the study. Vaccinates and challenge controls were significantly 
(p=0.003) more IFAT positive compared to the strict control group on Day 42 of the study. 
No significant differences in % IFAT positives were evident between vaccinates and 
challenge controls on Days 35 and 42. Group comparisons in seroconversion rates between 
assays and treatment groups are summarized in Figure 4. 
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Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 
* * * * 
Figure 4. IFAT vs. Indirect LPS-ELISA; Rates of Seroconversion to L. intracellularis 
Among Treatment Groups 
* Significant differences in seroconversion among groups and assay types (Chi 
square/Fisher's Exact Test and two sample test of proportions, p<0.05) 
1. Bar graph represents mean % IFAT positives for treatment groups throughout 
the study; vaccinates = grey bar, challenge controls = black bar and strict 
controls = white bar (not visible = 0%). 
2. Line graph represents mean % LPS-ELISA positives for treatment groups 
throughout the study; vaccinates = solid line with grey triangles, challenge 
controls = large dashed line with black squares and strict controls = small 
dashed line with white circles. 
3. X-axis represents each day of the study serum samples were tested for anti-
Lawsonia IgG. 
4. Y-axis represents mean % anii-Lawsonia antibody positive pigs. 
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Comparisons between the LPS-ELISA and the IFAT in detecting anti-Lawsonia 
antibodies in this study revealed significantly more LPS-ELISA positive pigs than IFAT 
positives on Days 21, 28, 35 and 42 (p=0.003, 0.030, 0.002 and 0.006, respectively). 
The ROC analysis of the results from this study revealed the specificity of the LPS-
ELISA to be 100% and the sensitivity 99.5%. The 95% confidence interval was 0.976 to 
0.999 and the ROC under the curve analysis revealed a value of 0.995 with a standard error 
of 0.007. 
Discussion 
We have developed a novel EPS-based indirect ELISA that specifically detects anti-
Lawsonia IgG in the sera from Lawsonia-negative pigs exposed to either a modified live 
vaccine and/or virulent challenge exposure. This immunoassay could improve the early 
detection of L. intracellularis exposure in pigs by providing a user-friendly and time-
efficient research tool for use in controlled clinical evaluations in pigs. Incorporation of this 
Lawsonia-specific and sensitive antibody-antigen reaction into direct or sandwich ELISA 
approaches may allow other novel immunoassays to be developed for research purposes. 
Modifications to the conjugate in this LPS-ELISA would also allow for detection of other 
anti-Lawsonia specific IgA or IgM in pigs, or antibodies in other host species. 
Modifications to the method for preparation of the test sample may also allow testing of 
tissue, feces or sow milk samples for the test antibody. 
The use of this type of LPS-ELISA format has been successfully deployed in 
serologic assays for other enteric and intracellular bacteria, such as Salmonella dublin and 
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Brucella spp (1,2, 32). The diagnostic performance of this assay is not expected to be 
affected by alterations in the antigen's lipid A structure or contaminating outer membrane 
proteins, that may occur in different antigen preparations (1,2, 24). The standard carbonate 
buffer coating conditions used in our study is considered suitable for the LPS-ELISA format 
for smooth LPS antigen (2). There was also a good correlation of the LPS-ELISA results in 
a range of field studies for Salmonella dublin infection on farms (32), and these results were 
superior to previous Salmonella immunoassay formats (32). The LPS-ELISA described 
here is therefore likely to provide a robust, widely applicable diagnostic screening tool, with 
broad benefits for disease interpretation among groups of pigs. 
Current serological-based assays for L. intracellularis infection and disease are the 
indirect immunofluorescence antibody test (IFAT) (15) and the immunoperoxidase 
monolayer assay (IPMA) (7, 8), both incorporating whole cell antigen on carrier wells in 
plates or slides. They demonstrate good sensitivity (91% and 89%, respectively) and 
specificity (100% for both assays) in detecting anti-Lawsonia antibodies ante-mortem in pig 
serum. However, both assays are probably not sensitive enough to detect anti-Lawsonia 
antibodies in lower concentrations in pig serum during the initial exposure and onset of 
infection periods. In addition, these assays rely on highly skilled technicians to accurately 
conduct these tests and interpret the results. Results are subjectively obtained by spending 
many hours looking into a microscope, analyzing wells illuminated by UV or natural light, 
searching for L. intracellularis or L. intracellularis-'mfectcd cells stained fluorescent green 
or enzymatic red respectively that represents a "positive" sample. A previous attempt to 
develop an ELISA for detection of anti-Lawsonia antibodies in pigs failed to produce a 
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sensitive and specific assay, due to its variable and non-specific quality of antigen (derived 
directly from pig intestines) and limitations in sampling size related to known disease 
parameters in test pigs (12). 
In the LPS-ELISA described here, we used an antigen source consisting of phenol 
purified LPS derived from pure cultures of L. intracellularis; with a specific cut-off value 
(A450 0.200) that has been determined for identifying anti-Lawsonia antibody positive and 
negative pig sera. The ability of the LPS-ELISA to accurately distinguish Lawsonia 
exposed pigs has been established by observing the results of the ROC under the curve 
value and 95% confidence intervals in the controlled challenge exposure study. The strong 
ROC under the curve value of 0.995 and 95% confidence intervals of 0.976 to 0.999 
identifies the LPS-ELISA as a highly accurate serological test for detecting anti-Lawsonia 
antibodies in pigs exposed to L. intracellularis in these experimental trials. Serological 
results from a controlled, L. intracellularis-challenge-exposed study reveal the superiority 
of the LPS-ELISA in detecting early antibody onset following vaccine and virulent 
challenge exposure in pigs compared to the IFAT. Significantly (p<0.05) more vaccinated 
pigs (53%) were LPS-ELISA positive prior to receiving a virulent challenge (Day 21) 
compared to non-vaccinated challenge controls (0%). The LPS-ELISA was the only test 
sensitive enough to detect seroconversion in pigs specifically due to vaccination at 3 weeks 
p.i. (Day 21). The LPS-ELISA significantly (p<0.05) detected more mti-Lawsonia 
positives than the IFAT in pigs regardless of treatment groups on day of challenge (Day 21) 
and one, two and three weeks post virulent challenge. The implications for detecting earlier 
onset of L. intracellularis exposure in pigs using the LPS-ELISA will allow a more precise 
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and rapid implementation of L. intracellularis control strategies such as vaccination to 
control and reduce PE. 
Numerical trends in percent mean LPS-ELISA positives were higher in vaccinated 
pigs (47%, 73% and 93%, respectively) compared to the challenge controls (30%, 60% and 
90%, respectively) each day post challenge exposure. Whereas, the IFAT results revealed 
first evidence of seroconversion in vaccinated pigs at 2 weeks post challenge (26.7%) which 
gradually increased to no more than 40% of the pigs IFAT positive on the last day of the 
study. The challenge controls demonstrated sharp increases in percent IFAT positives at 
10% and 80% on Days 35 and 42 of the study. The LPS-ELISA seems more sensitive in 
identifying more anti-Lawsonia positive pigs in the vaccinates versus non-vaccinates after 
virulent challenge; a trend that differs in comparison to previous studies using the IFAT 
(16). 
Specificity and sensitivity values based on 80 known positive and 80 known 
negative test samples were 93.7% and 88.7%, respectively. Sera tested from the challenge 
exposure study confirmed this by demonstrating similar specificity (100%) and sensitivity 
(99.5%) in detecting anti-Lawsonia antibodies in pigs. Western blot analysis of the LPS 
extract supports this high specificity in detecting anti-Lawsonia antibodies with the LPS-
ELISA even though the LPS extract contained extraneous protein carry-over. It appears that 
at the dilutions used, the reagents of the ELISA are quite specific for what is believed to be 
a component of Lawsonia LPS. The low level of carry-over protein within the LPS extract 
contains no confounding effects in the assay's ability to specifically detect Lawsonia-
specific antibodies in pigs. Furthermore, quantification of total protein in the undiluted LPS 
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extract by the BCA Protein Assay (Pierce Laboratories, Inc.) revealed concentration levels 
too low (0.11 mg/ml) for establishing adequate antigen-antibody complexes. 
Despite the positive results noted in this investigation, there are some factors which 
limit the application of the described LPS-ELISA beyond the research laboratory. Other 
antigen preparations of differing purities were examined and found not to have sufficient 
sensitivity and specificity for use in Lawsoma-specific research trials (data not shown). The 
requirement of antigen derived from Percoll gradients (low/free from Eukaryotic cellular 
debris) and phenol extraction methods make Lawsonia LPS antigen availability practical for 
only limited numbers of assays and is probably cost prohibitive beyond research trials. 
Secondly, limited evaluation of this assay under field conditions suggests there may be 
differences in animal backgrounds and LPS reactivity, especially in adult pigs. If this assay 
were to be applied as a routine diagnostic assay, it is possible that different cut-off values 
would be required and sensitivity and specificity would be lower. 
The technical advantages as outlined above make the EPS-based indirect ELISA test 
an improved serological method in detecting L. intracellularis exposure in pigs over the 
IFAT because it successfully and accurately identified early onset exposure to this organism 
regardless of isolate type (vaccine or wild-type) as well as providing a rapid and user-
friendly tool for identifying specific seroconversion to L. intracellularis in experimental 
studies. 
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CHAPTER 6. SUMMARY AND CONCLUSIONS 
In the studies described herewith, we validated the efficacy of a new European-
derived, oral, avirulent live Lawsonia intracellularis vaccine against virulent challenge 
exposure in pigs. Various clinical applications were investigated that show efficacy against 
L. intracellularis infections using a virulent pure culture challenge model in PE-susceptible 
pigs. These applications consisted of delivering the live vaccine orally by direct oral drench 
or in the drinking water to Lawsonia-nmvc pigs of susceptible age to PE. Successful 
delivery of a vaccine through a pig's drinking water minimizes stress and injury to pigs, 
amount of human-animal contact time, costs and labor. Needle-less vaccine administration 
provides a higher quality of pork due to less needle breaks and damage to meat at injection 
sites in addition to eliminating the transmission of blood-borne diseases among vaccinates. 
A new clinical application demonstrated vaccine efficacy in the face of maternally 
derived, anti-Lawsonia antibodies in recently weaned piglets against a subsequent virulent 
L. intracellularis challenge. Implementation of this application method allows veterinarians 
and pig producers to vaccinate pigs earlier in the nursery without the fear of maternal 
interference and induce protective immunity before pigs become exposed upon entry into 
the grower-finisher units. 
Investigations in maternal protection showed that pigs derived from hyperimmune 
sows had some level of protection against a virulent challenge exposure. These data 
suggested that passive immunity plays an active role in protecting piglets from early 
infection that may result from transmission of virulent L. intracellularis from dam to piglet. 
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The safety of multiple, high dose inoculations of an avirulent live L. intracellularis vaccine 
in sows during the 2nd and 3,d trimester suggested that pregnant sows are not at risk when 
repeatedly exposed to this vaccine during the most sensitive periods of gestation. 
A new technique was developed for detecting anti -Lawsonia IgG antibodies in pig 
serum. This technique consisted of immobilizing purified LPS from L. intracellularis onto 
microliter plates as the primary antigen in an indirect enzyme-linked immunosorbent 
antibody assay. This ante mortem serological method has proven to be highly sensitive and 
specific for detecting antibodies derived from vaccine or virulent L. intracellularis 
challenge exposure in pigs. The LPS-ELISA may be able to accurately identify early onset 
of L. intracellularis exposure in pigs in order to better determine when to incorporate 
antibiotic or vaccine treatment for disease prevention. 
The clinical applications described within this dissertation will give swine producers 
and veterinarians more options for effective and safe administration of this vaccine to 
induce protective immunity against L. intracellularis infections within affected herds. Most 
producers use antibiotics and other antimicrobial compounds as in-feed additives for growth 
promotion during all stages of pig development. Future research is needed to determine the 
effects of antimicrobials on the development of protective immunity following vaccination 
and perhaps defining a withdrawal period to ensure optimal delivery of this vaccine to pigs. 
The use of antibiotics may be reduced significantly through proper use of this vaccine alone 
or in combination with strategic medication regimens to control PE in endemic herds. New 
studies are warranted to evaluate efficacy of other novel vaccine strategies and delivery 
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systems which will provide producers with new options for optimal vaccination and 
protection against this economically important disease. 
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